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Abstract
A new method for deconvolution of electrospray ionisation mass spectrom-
etry (ESI-MS) spectra was produced, allowing for the masses of overlapping
charge state series to be correctly indentified. The algorithm also determines
the abundance of individual molecular species with a much higher accuracy
for congested spectra.
Several new methods for representing TWIM-MS data were developed. The
combination of the deconvolution algorithm with travelling wave ion mobility
data creates plots with collision cross section (CCS) axes which can be directly
compared with X-ray crystallography structures and computational models.
Difference plots have allowed multidimensional analysis of changes in con-
dition, and spectral averaging can produce a single representative spectrum
from multiple replicates.
Gas-phase unfolding experiments using TWIM-MS are a popular method
for probing protein stability in response to conditions such as ligand binding.
The algorithms for processing these data are however in their infancy. This
thesis describes the first deconvolution algorithm for gas-phase unfolding data,
allowing for the accurate interpretation of conformation cross sections and
abundances during the unfolding procedure.
The methodologies developed were then applied to α1-antitrypsin, a meta-
stable, aggregation prone protein. The protein was bound to a ligand, Ac-
TTAI-NH2, which has been shown to block aggregation as a titration and
the MS deconvolution method was used to quantify the abundances of each
bound state in each mass spectrum.
The first use of IM-MS to analyse ex vivo aggregates are shown, and the
ion mobility methods created were used to determine the CCS values of the
monomeric and dimeric species. The interaction between α1-antitrypsin and
Ac-TTAI-NH2 was probed using gas-phase unfolding experiments, determin-
ing that the ligand stabilises the protein, with a specific pattern of gas-phase
unfolding observed for each state.
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Chapter 1
A selective history of mass
spectrometry
Mass spectrometry is a technique that allows the accurate determi-
nation of the mass-to-charge ratio (m/z) of gas-phase ions, with the
change in mass of 1 Da (the mass of a proton), in a 18,000 Da protein
being detectable[1]. It is used in a wide variety of applications, rang-
ing from the identification of illict compounds in the blood of olympic
athletes [2] to analysing intact virus capsids [3]. This chapter will
give a brief history of mass spectrometry, focusing on developments
in instrumentation relevant to this thesis.
The inventor of the mass spectrometer was the English physicist Joseph
John Thomson, usually referred to as J.J. Thomson. Following his early career
as a theoretical physicist, he was awarded a professorship at the University
of Cambridge as an experimental physicist. He investigated the movement of
electricity through gas, in particular cathode rays. The research determined
that a cathode ray could be deflected using magnets, and this information
was used to posit that the cathode rays were made up of particles more
than 1,000 times lighter than a hydrogen atom by calculating its z/m ratio.
This revelation in 1897 was the discovery of the first subatomic particle, the
electron and for which he was awarded the Nobel Prize in Physics in 1906.
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Figure 1.1: Parabola spectrographs. Figure adapted from [4].
The work was extended to look at positive ions in an instrument called
the parabola spectrograph. By deflecting ions using magnetic and electric
fields onto photographic plates, spectra like those shown in Figure 1.1 were
acquired. Thomson postulated that any ion would have a different parabolic
trace provided that they had different m/z values. The discovery of an addi-
tional trace at 22 Da appeared to be neon, as had been suggested by Thomson.
By building the first mass spectrometer his protege Francis William Aston, in
1919 [5],was able to label these as isotopes and classified several other isotopes
[5]. He also measured the mass of as many elements as he could, which lead
to him defining the whole number rule that states that every elements mass is
an integer multiple of the mass of a hydrogen atom [6]. These two discoveries
led to him being awarded the Nobel Prize for Chemistry in 1922.
In the early days mass spectrometers were mainly used by physicists on
subjects such as determining features of atoms. Alfred Nier was a pioneer
who popularised the instrumentation outside the field of physics. He was
an electrical engineer and physicist by training and used these attributes to
create many mass spectrometers including the Nier-Johnson mass spectrom-
eter. His promotion of mass spectrometry included using his instruments to
filter carbon allowing for the collection of enriched 13C for use in biological
applications. His most famous contribution however was to the Manhattan
Project. It was known that one of the isotopes of uranium was fissile, but
it was not yet known which. In 1939 he was recruited by Enrico Fermi to
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separate the two isotopes; work which led to the discovery that 235U was ca-
pable of nuclear fission thereby bringing in the nuclear age [7]. Throughout
the Manhattan Project mass spectrometers he designed were used to assess
the purity of enriched uranium.
Important developments continued to be made in mass spectrometry in-
strumentation in the late 1940s and 1950s. The time-of-flight (ToF) mass
analyser was devised in 1946 by Stephens [8], it was then built by Cameron
and Eggers with the results published in 1948 [9]. The ToF mass analyser
was based on simple physics, accelerating ions by their charge and determining
the mass by the velocity achieved over the distance of a vacuum tube. Mod-
ern day implementations of the instrumentation are now capable of analysing
very high mass ions. The linear quadrupole mass analyser was introduced
in 1953 by Paul and Steinwedel [10], and can be used as an ion guide or a
mass filter [11]. These two components can be combined to create a Q-ToF.
This instrumentation has become very popular in biological and analytical
chemistry applications, including being linked to liquid chromatography for
proteomics studies and for studying intact proteins.
The analysis of small molecules had become routine before the 1980s but it
was still not possible to analyse large biological molecules like proteins. This
was due to ionisation techniques of the time which consisted of bombarding
the analyte in the gas-phase with charged particles. This technique deposited
too much energy onto proteins causing them to fragment. Later techniques
such as fast atom bombardment were able to ionise the analyte when not in
the gas-phase which was an improvement, but was very inefficient and still
would not work for larger biomolecules [12].
In 1985 Koichi Tanaka filed a patent for a new method of ionisation [13].
His method involved mixing the analyte with glycerol and metal powder, fol-
lowed by ionisation with a laser, and was called soft laser desorption (SLD). He
found that the inclusion of the metal reduced the transfer of energy to the ana-
lyte and allowed for larger molecules to be analysed. This work was presented
at the Annual Conference of the Mass Spectrometry Society of Japan and led
to him being awarded the Nobel Prize for Chemistry in 2002 with John Fenn
[14]. This method, however, is presently rarely used for biomolecule analysis.
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A variant, invented alongside SLD, was MALDI (matrix assisted laser des-
orption ionisation) which was developed by Karas and Hillenkamp [15]. By
1988 Karas and Hillenkamp were able to analyse molecules over 10,000 Da
[16] and MALDI has widespread usage for analysing biomolecules to this day.
In 1968 Dole et al. introduced the concept of electrospray ionisation (ESI)
by ionising large polystyrene molecules up to 400 kDa, a feat which was
previously not possible due to the alternative method at the time, evaporation
through heating, degraded large molecules [17]. Several years later John Fenn
introduced the use of electrospray ionisation mass spectrometry for use with
large biological molecules, at first with small organic molecules in 1984 [18],
this was then extended to proteins up to 40 kDa in 1988 [19] and by 1989 he
had successfully analysed the dimeric species of bovine serum albumin (130
kDa) [20, 21]. This technique ionised the analyte while in solution phase,
which allowed for very gentle ionisation and was ideally suited for analysis
of intact proteins. Additionally ESI created multiply charged ions and this
allowed high mass analytes to be analysed using mass analysers with limited
m/z ranges. The technique is now very common, and all spectra in this thesis
were obtained using nano-ESI, a variation of the ESI method which will be
described in Section 2.1.
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Mass spectrometry
This chapter introduces the components of the Waters Synapt G1
mass spectrometer that was used during the Ph.D. The instrument
consists of a nanoelectrospray ionisation source, a quadrupole mass
analyser, a travelling wave ion mobility separation device (Covered
in Chapter 3), a time-of-flight mass analyser and an ion detection
device. An example mass spectrum acquired on the instrument is
shown in Figure 2.1. This is followed by examples of mass spectrom-
etry experiments that are relevant to this thesis and the challenges
raised by each.
2.1 Electrospray ionisation
Samples for ESI are loaded into a metal needle or a gold coated glass capillary
and there is a potential applied between the needle and the entrance to the
mass spectrometer (Figure 2.2A). In positive ion mode, which is normally
used for protein analysis and is used exclusively in this thesis, the positive
voltage is applied to the needle, and the negative voltage is applied to the
counter-electrode in the instrument. This leads to a build up of charge in
the form of protons at the tip of the needle. At first this leads to a spherical
body of analyte solution forming on the tip of the needle, and as the voltage
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Figure 2.1: Example nESI mass spectrum, containing the monomer,
dimer and trimer of human serum albumin. Gaussian distributions
are fit to the peak tops of each molecular species and are displayed
as faded lines. Additionally the charge states of the monomer peaks
have been labelled.
increases the shape distorts. Finally when the surface tension limit is reached
the solution forms a Taylor cone [1], and emanates a spray of fine droplets
which are drawn towards the counter-electrode (Figure 2.2B). The flow of
protons out of the capillary is offset by the transport of electrons across the
voltage source to the counter-electrode. This maintains the charge difference
and allows electrospray to continue.
The droplets leaving the capillary are large and as the molecule travels,
the buffer evaporates reducing the size of the droplet. The concentration of
positive charges inside the droplet increases as the volume decreases and the
coulombic repulsion makes the droplet unstable and eventually causes droplet
fission. The Rayleigh limit, shown in Equation (2.1) [3], defines the point at
which the coulombic repulsion overcomes the surface tension. This is reached
when q (charge of the droplet) becomes greater than the Rayleigh limit, qr,
other terms in the equation are: 0 the electrical permittivity of a vacuum, γ
and R are the droplet surface tension and radius respectively. After droplet
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Figure 2.2: Schematic diagrams of the electrospray ionisation pro-
cess. The formation of droplets at the tip of an electrospray needle
(A) and the formation of a Taylor cone (B). Figure adapted from
[2].
fission, the daughter droplets undergo further solvent evaporation, leading
to further fission events, this process continues iteratively until very small
droplets remain which contain a single analyte molecule [4].
qr = 8pi
√
0γR3 (2.1)
The final stage of ESI is still not fully understood. There are three main
theories about what happens to produce the final analyte ion which is analysed
by the mass spectrometer. The first model proposed was in the original
electrospray ionisation publication by Dole et al. [5], the theory is known as
the charged residue model (CRM) and it states that the fission-evaporation
cycle continues until the analyte, adducted with the remaining charges, is left
in a dehydrated state. The second theory, stated by Iribarne and Thomson
in 1976 [6], is known as the ion evaporation model (IEM). In an electrospray
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droplet the charges are at the highest concentration at the surface, due to
coulombic repulsion. The IEM suggests that the analyte would be forced
through the surface of the droplet, during this process the analyte becomes
the least electrostatically repulsive portion of the droplet, causing it to pick
up several charges, and be ejected in a dehydrated state.
The desolvation of small molecular weight ions has been attributed to the
IEM [6], with larger compact ions such as globular proteins following the CRM
[7, 8]. A recent molecular dynamics study has revealed a third method of ion
desolvation called the chain ejection model (CEM) [9]. The CEM is thought
to explain the desolvation of proteins that are unfolded in solution, and is
a similar process to the IEM. The hydrophobic core of unfolded proteins is
exposed to solvent and so the protein quickly migrates to the surface of a
droplet. One end of the protein chain will start to exit the droplet, due to
charge repulsion. The chain is then steadily drawn out of the droplet, whilst
picking up charges, until completely free of the original droplet [9].
2.1.1 Interpreting ESI mass spectra
Electrospray ionisation usually results in multiply charged ions [10], and an
example mass spectrum is shown in Figure 2.1. The charge of protein ions
is due to protonation of basic amino acid side chains [11]. The protonation
process results in a mass spectrum with multiple peaks with intensities similar
to that of a Gaussian distribution [12]. The explanation for this is the central
limit theorem, a mass spectrum is the summation of a large number of ion
detections, and the number of protons adducted to an analyte are consecutive,
have an average value, and a certain variance which leads to the Gaussian-like
distribution.
As analytes in an ESI spectrum have multiple m/z values, it can make
mass analysis more complicated than a technique like MALDI, which typically
only produces singly charged ions. The mass (M) can be determined by the
number of charges (z) and m/z value (mx), and a straight forward calculation
is described here. Two adjacent peaks originating from the same analyte will
have a charge difference of 1. This allows Equations 2.2 & 2.3 to be true (H+
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is the mass of a proton).
m1 =
M + z · H+
z
(2.2)
m2 =
M + (z + 1) · H+
(z + 1) (2.3)
n = m2 − H
+
m1 −m2 (2.4)
Solving the simultaneous equations for charge gives Equation 2.4, which
determines the charge for Equation 2.2. Equation 2.2 can be rearranged to
give Equation 2.5 and from this, the mass of the ion can be calculated.
M = z(m1 − H+) (2.5)
2.1.2 Nanoelectrospray ionisation
Electrospray ionisation was improved with the developments of microelectro-
spray ionisation (µESI) [13, 14] and then nanoelectrospray ionisation (nESI)
[15]. The prefixes of these new ionisation techniques were based on the sample
flow rate during experiments. ESI experiments typically have a flow rate of
1-20 µl/min whereas the rate for nESI is only ∼20 nl/min, this difference is
due to a difference in the orifice size of the electrospray needle, with inner
diameters of 100 µm for ES [16] and 1-2 µm for nESI.
The reduced flow rate of nESI meant that the droplets leaving the needle
were considerably smaller, with less solvent, the result of which was that the
droplet had to undergo less desolvation in order to accurately assess the mass
of proteins in the gas-phase. The reduction in solvent volume in a droplet
results in a lower total number of salt ions, leading to a lower concentration
of salts as the droplet undergoes desolvation. This results in less cation ad-
duction and thinner peaks in a mass spectrum [17]. This also facilitated a
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shorter necessary distance between the needle tip and the entrance of the mass
spectrometer, and concomitantly reduced the necessary voltage difference for
ionisation resulting in less energy being transferred to the analyte molecule,
and achieving ‘softer ionisation’.
The large droplet sizes of electrospray ionisation preclude the use of aqueous
solvents, and for this reason organic solvents with their low boiling tempera-
tures were used instead. An example solvent mixture for the ESI analysis of
proteins (Cytochrome c) would be 45 % methanol, 45 % acetonitrile, 10 %
water and 167 ppm trifluoroacetic acid [18].
The reduction in the required energy for ionisation afforded by nESI allowed
the use of the volatile salts, ammonium acetate or ammonium bicarbonate
dissolved in water [19]. Volatile salts evaporate readily during the desolvation
process, this leaves the analyte with considerably less adducts than when
using non-volatile buffer salts (e.g. NaCl). Ammonium acetate is primarily
used [19], and the salt aids in the ionisation process as it competes for adduct
formation with basic side chain residues with cations such as Na+, this is due
to the process whereby NH+4 ions protonate the sidechains leaving volatile
ammonia that subsequently evaporates [20]. Additionally ammonium acetate
has a similar ionic strength to sodium chloride, meaning that they can be
used in place of NaCl in order to retain physiological salt levels.
The organic solvents and energy conditions of electrospray ionisation make
it difficult to analyse proteins in their native conformation as organic solvents
disrupt hydrophobic interactions causing the protein to denature [21]. The
use of aqueous buffers at physiological ionic strengths, meant that nESI ex-
periments were able to analyse the native-like structure of larger proteins [22]
as well as analysing small proteins more easily. This has led to nESI mass
spectrometry becoming an essential tool in the analysis of protein-ligand [23],
protein-protein [24] and protein structural information [25].
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2.1.3 Mass spectrometry peak shapes
An unadducted ion mass spectrum peak is Gaussian when analysed using a
Waters Synapt G1 [26]. Proteins, however, have additional peaks correspond-
ing to adduction as well. This can be seen clearly in a mass spectrum of the
small protein β-lactoglobulin in Figure 2.3A. The first peak, indicated by the
arrow, is the protein in its unadducted state, and the theoretical and experi-
mental masses as calculated using this peak are very accurate. The additional
peaks at higher m/z values indicate cation adduction, normally a mixture of
sodium and potassium ions. These peaks are not baseline separated, and so
the intensity of several combinations of adduct peaks combine to form the
reducing intensity tail of the charge state peak.
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Figure 2.3: Comparison of different m/z value peak shapes. Arrows
point to unadducted protein peak for β-lactoglobulin monomer (A),
α1-antitrypsin (B) and bovine serum albumin (C).
Figure 2.3B shows a charge state peak of the larger protein, α1-antitrypsin,
once again with the arrow indicating the unadducted ion. With this protein,
however, the unadducted ion is only detected as a peak and is difficult to
distinguish from the rest of the charge state. The highest point of the peak
has now moved to a higher m/z than the theoretically calculated value. The
summing of many adduct Gaussian shaped peaks causes baseline lift and forms
the new peak shape typical of proteins, with a sharp increase in intensity at
the lowerm/z values, followed by a rounding off and slower decline in intensity
towards the upper m/z range of the peak.
29
Chapter 2. Mass spectrometry
With larger proteins it is often difficult to distinguish any of the individual
ion or ion-adduct peaks from the overall charge state peak. An example of
this is shown in Figure 2.3. Experiments can be designed to try to minimise
this effect, such as denaturing mass spectrometry which, will be discussed
further in Section 2.1.5.
There are several reasons for this deterioration in data quality. One such
reason is that larger proteins are able to be adducted more, resulting in the
larger number of adduct peaks. The mass resolution of the Waters Synapt G1
(and most mass spectrometers), reduces the higher the m/z value, meaning
that it is more difficult to separate peaks. This feature will be discussed in
more detail in Section 2.2.
The spacing of adduct peaks also changes for larger proteins. Typically
larger proteins have a higher number of charges, in the example shown the
most abundant charge states were used and they were +8 for β-lactoglobulin,
+13 for α1-antitrypsin and +15 for bovine serum albumin. A sodium adduct
peak adds a mass of 23 Da to the mass of the protein. For a +7 protein, the
m/z difference between the unadducted ion and an ion with a single sodium
adduct is 3.3 (m/z = 23/7), whereas for a +15 protein, the m/z difference
would only be 1.5. This increases the extent of the overlap between adducted
and unadducted peaks, making analysis more difficult.
In order to analyse higher mass protein ions, the ions need to be cooled
after exiting the spray tip. This is achieved by applying a counter current
drying gas that helps with desolvation [27]. Additionally the buffer gases
within the mass spectrometer, in regions such as the collision cell, should also
have higher gas pressures than when analysing smaller proteins [28]. Higher
mass ions require higher collision energy voltages in order to achieve the same
acceleration, and so this also needs to be adjusted for when analysing larger
proteins.
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2.1.4 Non-covalent mass spectrometry
Non-covalent mass spectrometry aims to analyse proteins or other analytes
without disrupting non-covalent interactions, it is also sometimes referred to
as native mass spectrometry. Some examples of uses for these experiments
are to analyse protein complexes without dissociating subunits and analysing
protein ligand interactions.
In order to analyse proteins without disrupting the protein structure, care-
ful consideration must be taken to the conditions of the sample prior to the
introduction into the mass spectrometer as well as to the settings of mass
spectrometer itself. Proteins and protein complexes dissolved in organic sol-
vents can have structural elements broken down due to the reduced entropy
maintaining the hydrophobic core of the protein. This can lead to structural
re-arrangements which cause the dissociation of ligands or subunits. Acidic
buffers can also negatively affect structure, as native protein structure is de-
pendent on physiological pH levels. In order to maintain the non-covalent
interactions, it is therefore beneficial to use aqueous buffers with physiological
pH and ionic strengths to best preserve protein structure. For these exper-
iments, an appropriate example solution for a protein analyte would be 150
mM ammonium acetate (which has similar ionic strength to sodium chloride)
at pH 7. An example spectrum can be seen in Figure 2.1.
The protonation of globular and disordered proteins varies due to the spa-
tial arrangement of basic residues (the site of protonation). In globular pro-
teins these side chains are close to each other and charge repulsion between
protonated side chains will reduce the level of protonation. This is in com-
parison to unfolded proteins where the side chains will be more spread out,
lessening the coulombic repulsion. A measure for this is the solvent accessible
surface area (SASA), which has been shown to be directly related to the level
of protonation and ultimately, charge state distributions [29].
Due to the changes in protonation, the extent of protein folding can be seen,
to some extent, in a mass spectrum. More globular proteins have a narrower
charge state distribution (number of charge state peaks), in comparison to
unfolded proteins with disrupted non-covalent interactions, as can be seen in
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Figure 2.4. Myoglobin has been analysed using ammonium acetate at ph 7.5
and acidic organic buffers. The protein analysed in aqueous buffer has a far
tighter charge state distribution, and the haeme group is still attached. This
is in comparison to methanol and acetic acid, which shows many charge states
as well as having the haeme group, which is natively non-covalently bound,
dissociated (the pronounced low m/z peak).
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Figure 2.4: Nanoelectrospray ionisation mass spectra of myoglobin in
different sample buffers. (A) Non-denaturing conditions (ammonium
acetate at pH 7.5), and denaturing buffer (methanol and acetic acid)
(B). An enlarged view is also shown for a charge state peak under
non-denaturing conditions (C) and denaturing conditions (D).
After it has been ensured that non-covalent interactions have been main-
tained and proteins have retained their structure, the mass spectrometer set-
tings should be assessed. The Waters Synapt G1 mass spectrometer has
several user defined settings, and some of the most important ones to non-
covalent interactions will be discussed. The capillary voltage and cone volt-
ages determine the voltage difference which creates the Taylor cone and begins
the electrospray process. These should be kept to a minimum so as not to
transfer too much energy into the analyte, which could potentially break hy-
drogen bonds. The added acceleration which high capillary and cone voltages
would create would also affect the next important region, the T-wave device
(discussed in more depth in Chapter 3). These are gas filled chambers and
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the user can set the voltage difference between the entrance and exit of each
chamber. These voltage differences should also be kept to a minimum. This
is because increasing the voltage, causes increased acceleration of the analyte
ions, which results in more violent collisions with the buffer gas and due to
friction this causes the ions to heat and can potentially break non-covalent
interactions. If these voltages have been kept low enough, non-covalent inter-
actions should be maintained throughout the mass spectrometry experiment.
Ion mobility mass spectrometry has been used to show that this is true and
the subject is discussed in more depth in Section 3.4.
Non-covalent mass spectrometry is necessary for determining the mass of
protein complexes together because if a subunit dissociates the recorded mass
will be incorrect.
Determining binding stability
Figure 2.5: Analysis of the interaction between GyrA59 and SD8.
The fractional occupancy is calculated from the percentage of apo,
single and double bound peak intensities in mass spectra. The abun-
dance of each species is recorded for different concentrations of lig-
ands (square markers) and the models for calculating Kd values are
shown as the fitted curves. Figure reproduced from [30].
Protein-ligand experiments that determine binding stability in terms of
calculating the dissociation constant (Kd)of an interaction are well suited to
non-covalent mass spectrometry analysis. As previously mentioned it is vital
that the solution conditions and mass spectrometer parameters do not disrupt
hydrogen bonding, which could lead to the dissociation of the ligand. A good
example of the benefits of mass spectrometry for these types of experiments
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is a 2011 study by Edwards et al. [30]. The study analysed the interaction
between GyrA59 and SD8. It was found that the GyrA59 protein associates
as a dimer, with one ligand bound to each subunit. It was then shown that
the binding was cooperative by altering the concentration of the ligand and
measuring the mass spectrometry intensities of each bound state as seen in
Figure 2.5.
A mathematical model was developed to describe the binding interaction
and the results are shown as the fitted curves in Figure 2.5 using the abun-
dance of each bound state. Non-covalent mass spectrometry was ideal for
analysing this interaction, due to the Kd calculations being complicated by
stoichiometries, which can cause issues for other analytical tools [30].
Subunit exchange
As well as studying equilibrium state interactions such as determining Kd
values, non-covalent mass spectrometry can be used to analyse protein dy-
namics, in particular, subunit exchange. These are time-resolved experiments
that monitor the rate at which protein subunits spontaneously exchange in
solution. For these types of experiments to be analysed by mass spectrometry,
there needs to be a mass difference between the subunits. The experiment is
carried out by mixing the two subunits in solution, then repeatedly acquiring
mass spectra of the sample at a given time interval. Each combination of
subunits will have a different mass, thereby resulting in a separate peak in
the mass spectrum. An example would be a heterodimer with subunits A and
B, this will result in mass spectrum peaks associated with 2A, 2B and AB.
The abundance of these subunits can then be analysed using the heights of
these peaks and can be plotted (as in 2.6).
A particularly interesting example was published in 2011, which involved
monitoring a homodimer [31]. This was achieved using nitrogen labelling,
with 14N and 15N protein being used.
The protein, glucosamine-6-phosphate synthase (GlmS) had been well stud-
ied by X-ray crystallography, but had not been investigated for subunit ex-
change. GlmS converts D-fructose-6-phosphate (Fru6P) into D-glucosamine-
6-phosphate (GlcN6P) and the interaction uses L-glutamine as a nitrogen
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Figure 2.6: Monitoring the rate of subunit exhange of GlmS, with
extent of exchange reported as the percentage of 14N/15N. The re-
sults are shown with 4 µM GlmS alone (a), as well as in the presence
of glutamine or glutamate at 5 µ M (b), 10 µ M (c) and 100 µ M
(d). The rate of subunit exchange is also reported for 20 µ M GlmS
with 100 µ M of Fru6P or GlcN6P (e). Figure reproduced from [31].
donor, which is then converted to glutamate.
The researchers monitored the rate of subunit exchange in the presence
of both L-glutamine and Fru6P. The sample monitored would contain both
the initially added molecules and the reaction products, and the results are
shown in Figure2.6. It was shown that the complex naturally undergoes
subunit exchange, and that this rate is increased as the concentration of the
nitrogen donor is increased. The presence of the substrate, however, stopped
subunit exchange all together [31].
2.1.5 Denaturing mass spectrometry
It is sometimes advantageous to intentionally unfold a protein in solution.
This can be achieved by varying buffer conditions and some examples will be
given here.
When analysing an unknown protein complex it is beneficial to break the
complex into its component parts to determine the subunits. Unfolding the
protein causes disruption of the interface between protein subunits, causing
them to separate. This can be achieved by using acidic organic solvents as
previously described. Subunit dissociation can also be achieved using collision
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induced dissociation (CID) which is discussed in Section 2.2.3.
The assembly pathway of protein complexes can also be analysed using
denaturing conditions. The principle of this experiment is to increase the
harshness of the solution by increasing either organic solvent or ammonium
acetate concentration, and to observe which subunit dissociates first. An
example of this type of experiment is shown in Figure 2.7. As the ammonium
acetate concentration is increased the abundance of dimers and momomers
also increases with no trimeric species observed. This shows that the assembly
pathway of the hexamer is through the association of three dimers, and not
consecutive adding of monomers or the association of pairs of timers [32].
Figure 2.7: Mass spectra of ExsG at varying ammonium acetate con-
centrations. The hexameric (blue), tetrameric (red), dimeric (pur-
ple) and monomeric (green) protein has been coloured. Spectra are
shown for 150 mM (A), 400 mM (B), 600 mM (C) and 800 mM (D)
ammonium acetate. Figure adapted from [32].
Another reason for carrying out solution denaturing experiments is to de-
termine highly accurate protein masses. As previously mentioned, proteins
are adducted by salts during the desolvation process. This results in a pro-
tein (M) charge state peak being composed of several ion mass peaks (e.g.
M + Na and M + 2Na). This makes it difficult to determine the mass of
a protein as the peaks are an aggregate of several different peaks of varying
masses.
By unfolding the protein in solution the level of adduction can be greatly
reduced, due to the final stage of desolvation. Globular proteins follow the
charged residue model (CRM), where the final droplet evaporates with the
protein still within it, which causes the remaining non-volatile salts from the
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Figure 2.8: Mass spectrum (main) and MaxEnt spectrum (inset)
of denatured AioB. The MaxEnt spectrum shows the distribution
of masses in the unfolded region of the mass spectrum (<2,200
m/z). The theoretical mass of AioB without the disulphide bond
is 17863.76 Da and with the bond is 17861.75 Da. The mass deter-
mined by denaturing MS was 17863.551, showing that the bond had
not formed. Figure reproduced from [33].
buffer to be adducted onto the protein. Unfolded proteins follow the chain
ejection model (CEM), whereby they migrate to the surface of the droplet
and are ejected out, which results in few salt adduction events.
An example of this type of experiment is shown in Figure 2.8. In this study
it was necessary to determine whether an 18 kDa protein (AioB) had formed a
disulphide bond using mass spectrometry. The reaction is shown in Equation
2.6 and shows that the mass difference is 2 Da (H2).
2Cys− SH→ Cys− S− S− Cys + 2H+ + 2e− (2.6)
In order to achieve mass accuracy to this level, the protein must be analysed
without any adducts and so a solution denaturing experiment was conducted.
The result was that the mass was calculated to within 0.25 Da of the calculated
value [33].
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2.2 Mass analysis and ion detection
Different types of mass analysers have different characteristics and so are use-
ful for different types of analysis. The way in which they determine m/z can
be different, scanning analysers such as the quadrupole scan regions of the
mass spectrum in separate acquisitions, whereas a continuous m/z analyser
such as time-of-flight (ToF) mass analysers acquire a full m/z range simulta-
neously.
There are three important characteristics about the data acquired by each
instrumentation, mass range limit, mass accuracy and mass resolution (and
resolving power). The mass range limit refers to the range of possible m/z
values that a mass analyser can detect. Quadrupoles have limited m/z ranges,
with the standard Waters Synapt G1 quadrupole only being able to acquire
up to 8,000 m/z, whereas ToFs have theoretically unlimited m/z ranges [34].
The mass accuracy of a mass analyser is determined by calculating the
difference in the theoretical and experimental mass and is measured in parts
per million [35]. The ToF instrument used in this thesis is calibrated using
a solution of caesium iodide, which forms many different sized crystals, and
the target accuracy is better than 10 pm.
The resolving power (R) is also an important feature of mass analysers.
It shows how close in m/z two ions can be and still be separated by the in-
strument. Through the years, the resolving power of mass analysers have im-
proved greatly with Aston’s parabola spectrograph achieving R = 13, whereas
the time-of-flight mass analyser in the Waters Synapt G1 has a resolving power
of 10,000.
Mass resolution (∆m)is typically measured as the full width half maximum
(FWHM) of a particular ion, as seen in Figure 2.9A. The relationship is
described in Equation 2.7, where m1 is the lower m/z boundary of the peak
at 50 % of the peak height and m2 is the upper boundary.
∆m = m2 −m1 (2.7)
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A B
C
Figure 2.9: Figure showing the variables involved in the calculation
of mass resolution (∆m) and resolving power (R). (A) the deter-
mination of resolution is calculated as per Equation 2.7. (B) repre-
sentation of alternate valley heights in the calculation of resolution,
the example shows the separation required for a 10 % valley. (C)
demonstrates how the m/z value affects resolving power. At a given
resolving power peaks at a lower m/z range are more separated than
peaks at a higher mass range, which shows that, in order to analyse
higher m/z ions, the mass analyser requires a higher resolving power
to separate peaks. Figure adapted from [2].
This means that if two ion peaks at the same intensity were separated by
∆m m/z, the trough between the peaks would be at 50 % of the peak height,
as seen in the centre panel of Figure 2.9C.
The resolving power of a mass analyser additionally includes them/z region
(m) at which a particular resolution is achieved, and the relationship is shown
in Equation 2.8.
R = m∆m (2.8)
Sometimes rather than analysing resolution and resolving power as the
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ability to separate peaks to half height, the value can be reported in terms of
other heights such as the 10 % valley. With this definition it is necessary for
peaks to be separated to an extent that the trough between them is at 10 %
of the total peak height as shown in Figure 2.9B [36].
2.2.1 Linear quadrupole mass analyser
Linear quadrupoles consist of 4 parallel metal rods each with a circular or
hyperbolic cross section (Figure 2.10).
Figure 2.10: Illustration of the workings of a quadrupole mass anal-
yser. Blue and red lines indicate the path of ions, caused by the
alternating electric field applied by the quadrupole. Figure adapted
from [2].
The rods have a direct potential (U) and a radio frequency (RF) voltage
(amplitude is V ) applied to them. The alternating pairs of rods are oppo-
sitely charged as described in Equations 2.9,2.10 where the angular frequency
(rotation rate) is shown as ω. The RF potential frequency (v) can then be
calculated from the angular frequency using Equation 2.11.
Φ0 = +(U − V cosωt) (2.9)
−Φ0 = −(U − V cosωt) (2.10)
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ω = 2piv (2.11)
Ions travel along the z axis at a constant velocity, but the combination of
RF and direct current voltages cause the ions to undergo complex oscillations.
Particular combinations of RF and direct current voltages are required for the
ion to maintain a stable trajectory through the quadrupole. By altering these
voltages particular m/z ions can be selected, whereas other ions will collide
with the rods and leave the quadrupole.
Quadrupoles can also be used as ion guides, which has the effect of high
mass filtering. This is achieved by running the quadrupole in RF only mode.
The maximum m/z (Mmax) for a given quadrupole is given by Equation 2.12
where r is the radius of the quadrupole.
Mmax =
7 · 106V
v2r2
(2.12)
In the instrument used for the experiments described in this thesis, both
8,000 and 32,000 m/z upper mass limit quadrupoles were used. The 32,000
quadrupole has a modified RF voltage generator allowing for lower frequency
radio wave generation allowing the analysis of higher masses.
2.2.2 Time-of-flight mass analyser
In order to determine the m/z ratios of ions, packets of ions are accelerated, at
a common energy per unit charge, into a time-of-flight (ToF) mass analyser.
The ions then traverse the field-free region, where they undergo no further
acceleration. Given two ions with different mass but the same charge, the
velocity through the field-free region is higher for the lower mass ion. The
m/z ratio is then calculated from the time taken for ions to travel from the
start of the field-free region until reaching an ion detector at the end of the
ToF.
The electrical potential energy (E) gained from the acceleration stage (prior
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to entering the field-free region) can be calculated from the potential (V ) and
the charge q. In mass spectrometry charge is referred to in terms of the charge
of an electron (e) multiplied by charge state (z) of the ion, and so the potential
energy of an ion can be calculated using Equation 2.13. The potential energy
is converted to kinetic energy, which relates to the mass (m) and velocity in
the field-free region (v) as shown in Equation 2.14.
E = zeV (2.13)
E = mv
2
2 (2.14)
Combining Equations 2.14 and 2.13 produces Equation 2.15 which allows
the calculation of velocity directly. As the ion moves through the flight tube
without obstruction, the velocity is constant following the acceleration step.
This means the time taken (t) for an ion to traverse the length of the flight
tube (d) can be calculated with Equation 2.16.
v =
√
2zeV
m
(2.15)
t = d
v
(2.16)
Substituting v into the equation for time, results in Equation 2.17. The
charge of an electron, length of the flight tube and electric potential across
the tube remain constant. This means that changes in the m/z value of an
ion will directly affect its time to traverse the flight tube; increasing z will
reduce the time and increasing m increases the time.
t2 = m
z
·
(
d2
2eV
)
(2.17)
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Limiting factors in mass resolution
The mass resolution of ToF mass spectrometers when analysing large ana-
lytes such as proteins is now described. The measurement of the time taken
to traverse the field-free region and reach the detector has a certain precision
that depends on the instrument and which cannot be improved by the user.
nESI analysis of proteins produce peaks which typically have several adducted
cations (in positive ion mode). The broadening of peaks makes it difficult to
separate peaks, and causes overlapping and masked peaks in mass spectra.
In positive ion mode the adduction is typically from sodium or potassium
ions. It is therefore essential to minimise the concentration of these ions and
their salts in the sample solution in order to produce well defined peaks. This
can be achieved by using buffer exchange before mass spectrometry analysis
and replacing the initial buffer with an appropriate mass spectrometry buffer,
such as 150 mM ammonium acetate. This is demonstrated in Figure 2.11,
when in sodium phosphate buffer the peaks are very broad due to the ad-
duction of sodium ions. After three steps of concentration-dilution using 10
kDa molecular weight cut off Millipore Amicron Ultra centrifuge filters, into
150 mM ammonium acetate, the sample was analysed again. The peaks were
much narrower, and more separated, resulting in a higher mass resolution of
the mass spectrum.
The resolving power of ToF mass analysers is constant across the m/z
range [35]. The result of this is that the mass resolution is worsened as the
m/z the analyte increases. Equation 2.8, shown previously, can be rearranged
to calculate the mass resolution (∆m) from the ion m/z value (m) and the
resolving power of the ToF (R), as seen in Equation 2.18.
∆m = m
R
(2.18)
Equations 2.19 and 2.20, show the calculation for mass resolution for a low
and high m/z ion respectively, using the 10,000 R ToF used in the Waters
Synapt G1 [26].
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B
A
Figure 2.11: Mass spectra of a 45 kDa protein analysed under dif-
ferent buffer conditions; (A) analysed in 50 mM sodium phosphate
buffer and 50 mM ammonium acetate. (B) same sample after 1,000
times dilution of original buffer into 150 mM ammonium acetate.
1000
10000 = 0.1 (2.19)
16000
10000 = 1.6 (2.20)
The 1000 m/z ion in Equation 2.19 has a mass resolution of 0.1, meaning
that two ion peaks that are 0.1 m/z apart will be separated to half of their
maximum height. Conversely when analysing an ion with m/z of 16,0000
(Equation 2.20) only peaks which are at least 1.6 m/z will be separated.
The resolution of linear ToFs is also limited due to variation in the initial
energies of ions. When analysing ions of the same m/z value, more energetic
ions reach the end of the ToF more quickly, as seen in Figure 2.12A. As the
ToF mass analysers use time to measure m/z, this results in a spread of m/z
being recorded for ions of a particular m/z value, as shown in Figure 2.12B.
In 1973, research out of the USSR [37] introduced the reflectron ToF which
solved this issue. Ions are initially accelerated into the field-free region as
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A B
C D
Figure 2.12: The difference between linear and reflectron time-of-
flight (ToF) mass analysers. Molecules with the same m/z value will
receive differing kinetic energy levels. Shown are two molecules with
the same m/z value which receive less (blue) and more (less) kinetic
energy. In a linear ToF (A) the ions reach the detector at different
times and result in a broad mass spectrum peak (B). The reflectron
(B) causes an equalisation of kinetic energy received by ions, leading
to a narrower mass spectrum peak (D). Figure adapted from [2].
normal, but the ion beam is then reflected back by a second round of accel-
eration by electrode rings. The effect of this is that ions which received more
energy at the initial acceleration stage go deeper into the reflectron region
(Figure 2.12C). This equalises the total time of flight for ions with the same
m/z, leading to the same m/z value being recorded, as seen in Figure 2.12D.
2.2.3 Tandem mass spectrometry
The use of multiple mass analysers allows for tandem mass spectrometry
experiments, where a certain ion or m/z range is selected by the first mass
analyser, and analysed by the second. Two common forms of instrumentation
are triple quadrupole mass spectrometers, often shortened to triple-quad, and
quadrupole time-of-flight mass spectrometers, abbreviated to Q-ToF and this
report will focus on the latter.
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Tandem mass spectrometry instrumentation is often combined with a colli-
sion cell, allowing for a technique called collision induced dissociation (CID),
and was introduced in the 1960s by Jennings [38] and McLafferty [39].
The collision cell has an electric potential across it (often referred to as
collision energy) and is filled with inert buffer gas. The electric field increases
the kinetic energy of the ion, accelerating it through the collision cell. As the
ion traverses the collision cell, the ions experience collisions with the buffer gas
molecules, which causes the kinetic energy to be converted to internal energy
through friction. This process is dependent on the pressure of the buffer
gas, higher gas pressures results in more collisions, increasing ion heating.
Similarly changing the voltage difference across the collision cell causes the ion
to have more violent collisions with the gas molecules, thereby also increasing
the internal energy of the ions.
The final factor that affects collisions is the m/z value. The force expe-
rienced by the ion is proportional to the charge of the ion, as per Newton’s
second law of motion, a lighter ion, with the same charge as a higher mass
ion, will be accelerated faster through the collision cell. Thereby smaller ions
will experience more violent collisions than larger ions.
The internal energy of ions can be increased to the extent that non-covalent
interactions are broken. An example use of this, is increasing the collision
energy in order to improve desolvation or for stripping adducted cations, which
results in increased mass resolution.
Another use case for this technology is the sequencing of peptides. The
quadrupole is used to select a particular ion, the collisions with the inert gas
in the collision cell cause peptide bonds to fragment with different patterns,
and the ToF is used to determine the mass of the fragments. Software is then
used to determine the sequence of the original peptide [40].
CID can also be used to dissociate subunits of non-covalently bound multi-
subunit proteins. A CID collision deposits energy onto the polypeptide chain,
which then diffuses across it. The weakest interaction is eventually broken,
in the case of peptide fragmentation the peptide bond fragments. Conversely
in multiprotein complexes, the non-covalent interactions holding the complex
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together are weaker and so are broken first. The data acquired for subunit
dissociation demonstrates an asymmetric charge distribution, with the disso-
ciated monomer having proportionally higher levels of protonation [41] which
is not seen in solution thermal dissociation [42, 43].
A B
Figure 2.13: Collision induced dissociation (CID) used to analyse a
heterogeneous sample with heavily overlapped peaks. Native condi-
tion mass spectrum of DegQ lysozyme complex (A). Mass spectrum
of quadrupole isolatedm/z region after CID (B - centre), with left in-
set showing the mass spectrum region of ejected apo DegQ monomer,
and the right inset showing the charge reduced mass spectrum of 11-
mer DegQ bound to 6 (green) and 5 (purple) lysozyme molecules.
Figure adapted from [44].
Another use for the dissociation of non-covalent complexes, via CID, is
when the charge state peaks of the complex in a mass spectrum are overlap-
ping to an extent where they are indistinguishable. Using CID to dissociate
a subunit from a complex results in uneven charge distribution, the reduced
charge of the larger complex results in charge state peaks which have a greater
difference in m/z value so that mass assignment is possible. Additionally, the
ejected subunit is of low mass, and so experiences high energy collisions due
to the high charge density, which usually results in narrow peaks which can
be easily assigned. An example of this process was conducted by Malet et al.
[44] and demonstrated in Figure 2.13.
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2.2.4 Microchannel plate detector
The microchannel plate (MCP) detector is commonly used with ToF mass
analysers as it has a very quick response time. The MCP detects the time
of the collision, and the difference between when the ion enters the field-free
region of the ToF and collides with the MCP is used to calculate the m/z
ratio of an ion.
It is a circular plate with holes or channels bored into it at an angle. When
an ion reaches the MCP it enters one of these channels and collides with the
wall and the angle of the channels ensures this happens. This collision causes
the channel to emit electrons, and as the electrons pass through the channel,
additional collisions generate more electrons in a cascade. This amplifies the
current generated by a single ion so that it is more easily detected. The fact
that there are multiple channels means that several ion m/z values can be
recorded simultaneously. A potential issue with this instrumentation, however
is saturation. Preceding an ion impact event a channel will have a certain dead
time before being able to register another ion. An additional feature is that
as ions are separated by velocity, higher m/z ions hit the channels at lower
velocity which results in a lower signal intensity being recorded.
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Ion mobility mass
spectrometry
Ion mobility mass spectrometry (IM-MS) was first reported in 1962 by Mc-
Daniel et al., which used a Nier 60◦ magnetic sector mass analyser [1], and in
1967 work at Bell Labs introduced the first ion mobility mass spectrometer
which utilised a ToF for mass analysis [2, 3].
Figure 3.1: Schematic representation of ion mobility separation. The
same protein with the same mass and charge is present in an open
(yellow) and closed (red) conformation (left). As the ions traverse
the ion mobility cell, the more closed conformation experiences less
collisions, allowing it to traverse the cell faster (centre). The data
are then acquired as an arrival time distribution (ATD), with time
on the x axis and ion current on the y axis (right).
IM-MS adds another dimension of separation to mass spectrometry exper-
iments, based upon the shape of ions. Ions are pulled through a chamber
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filled with inert gas, typically helium [4] or nitrogen [5] by an electric field.
As the ion traverses the chamber it experiences collisions with the gas, as
seen in Figure 3.1 and the chance of a collision is dependent upon the cross
section of the side of the ion facing the direction of travel. As the ion tumbles
as it traverses the cell, the number of collisions experienced is dependent on
the rotationally averaged collision cross section (CCS), which can be used to
analyse the shape of an ion. It is measured as the time taken to traverse the
ion mobility chamber and is dependent on the mass and charge of an ion,
higher mass ions are accelerated less by the same force and the propulsive
kinetic energy applied to the ion is proportional to its charge.
Ion mobility spectrometry (IMS) is an analytical technique in its own right
[6] and is used in a wide range of applications including detection of explosives
[7] and illicit drugs [8–10].
3.1 Drift tube ion mobility
Early IM-MS experiments for the analysis of proteins were carried out using
drift tube ion mobility mass spectrometry (DTIM-MS) [11–14]. The path of
ions through the drift tube chamber is linear and can be understood from
physical principles. The ion separation occurs due to a difference in mobility
(K ), which is dependent on the constant electric field strength (E) and the av-
eraged velocity for the ions to traverse the chamber (vd) with the relationship
shown in Equation 3.1.
K = vd
E
(3.1)
The ion mobility can then be represented as reduced mobility (K0), which
is standardised to atmospheric pressure (760 Torr, P0) and 0 ◦C (273.15 K,
T0). The relationship is described in Equation 3.2 where temperature is T
and buffer gas pressure is P of the experiment.
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K0 = K · P · T0
T · P0 = K ·
P · 273.15
T · 760 (3.2)
The CCS value (Ω) of an ion can then be calculated using the reduced
ion mobility, reduced mass of the ion-gas pair (µ, Equation 3.3), buffer gas
number density (N ), Boltzmann’s constant (kB), temperature (T ), the charge
state of the ion (z) and the charge of an electron (e), using Equation 3.4.
µ = mion ·mgas
mion +mgas
(3.3)
Ω = 3ze16N ·
√√√√ 2pi
µkBT
· 1
K0
(3.4)
The instrumentation used for the analysis of proteins was often a quadrupole
for mass analysis, followed by the drift tube [11]. In this case during ion mo-
bility experiments it was only possible to monitor a single ion charge state,
the quadrupole was used to select for a particular ion, and so only the ion
mobility separation, as drift time was the data acquired.
As DTIM-MS records the drift time, it is not well suited to ESI experi-
ments which generate a continuous flow of ions, whereas the pulsed ion flow
of MALDI experiments work well. In order to overcome this issue, the ESI-
DTIM-MS instrumentation was developed to utilise an ion trap interface be-
fore the drift cell, which stores ions and releases them at set intervals [15].
DTIM-MS instruments were developed in house generally by physical
chemists, and required expertise in areas such as electronic engineering and
software development. The result of this was that few labs were able to use
the instrumentation.
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3.2 Travelling wave ion mobility
In 2004 Giles et. al outlined a mass spectrometer that used a travelling wave
to achieve ion mobility separation [16], and this system was later engineered
into the first commerically available ion mobility mass spectrometer in 2006
[17]. The instrument included quadrupole and ToF mass analysers in addition
to the travelling wave ion guide (Figure 3.2).
Figure 3.2: Schematic representation of the Waters Synapt travelling
wave ion mobility mass spectrometer. Reproduced from [17].
The travelling wave system is known as a stacked ring ion guide (SRIG),
and prevents the radial diffusion of ions whilst traversing the instrumentation.
It is comprised of pairs of rings, which have opposite phases of RF voltage
applied to each adjacent ring. The rings are arranged perpendicularly to the
flow of ions so that the ions flow through the centre. The axial field created
with increasing strength towards the ring, confines the ions within the ring
orifice (as seen in Figure 3.3A).
The travelling wave instrumentation consists of three parts, the IM cell
and the trap and transfer ion guides, which have 61, 31 and 31 pairs of ring
electrodes respectively. The final pair of rings in the trap cell have a DC
only potential applied to them, and this voltage is periodically modulated in
order to trap or release ions into the IM cell [16]. The transfer cell is used
to maintain ion mobility separation after the IM cell. The trap and transfer
regions can be used as collision cells for CID by varying the voltage across
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them.
A
B
Figure 3.3: (A) Schematic representation of the stacked ring ion
guide (SRIG), with opposite phase RF voltages being applied to ad-
jacent rings. (B) Representation of how the travelling wave separates
ions by size. After the release of the packet of ions at the trap ion
guide voltage gate, ions are pushed through the ion mobility cell by
the travelling wave, generated by the SRIG. Smaller ions are pushed
straight through by the wave, whereas the movement of larger ions
is retarded by more collisions with gas molecules causing the ion to
go over the top of the wave. Figure adapted from [18].
The travelling wave is propagated by the SRIG and the RF voltage applied
to it. The pairs of rings can combine to apply a positive or negative voltage,
and so the amplitude of the travelling wave at a given time and position of
the wave can be produced by a pair of ring electrodes. This allows the wave
to work as a moving electric field pushing ions through the mass spectrometer
[16].
The ion mobility cell can also be operated as purely an ion guide for stan-
dard mass spectrometry experiments. When in use for ion mobility experi-
ments, it is filled with nitrogen gas, at up to 1 mbar pressure [17]. As the
travelling wave moves through the IM cell smaller ions experience few colli-
sions and so are pushed along by the wave, reducing the residence time in
the cell. Conversely larger ions experience more collisions, which causes resis-
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tance against the wave and so they can be pushed over the top of the wave,
as demonstrated in Figure 3.3B. The system leads to impressive separation
considering the IM cell is only 185 mm long [16].
A TWIM-MS experiment is made up of 200 separate mass spectra. This is
achieved using the trapping functionality of the trap cell [19]. A packet of ions
is released into the IM cell then the ion flow is stopped temporarily. The ions
then traverse the travelling wave system, and a pusher injects ions into the
ToF mass analyser 200 times for each packet of ions thereby acquiring mass
spectra. The rate at which this happens is known as the pusher frequency
(f ) with the pusher interval normally in the micro second range. The total
arrival time (tt) measured in an IM experiment is given by Equation 3.5.
tt = 200 · f (3.5)
This gives rise to multidimensional data as shown in Figure 3.4. Both
the mass spectrum (Figure 3.4A) and arrival time data (Figure 3.4) are ac-
quired simultaneously, with the intensity information for each data type being
recorded as a grid, which can then be shown as a heatmap (Figure 3.4C).
Comparing drift tube and travelling wave IM-MS
The functionality of the travelling wave system to act as an ion guide
leads to higher sensitivity than drift tube experiments. Drift tube separation
instrumentation, however, tends to have higher mobility resolution. This is
due to two factors, first the potential for very long drift tubes (potentially
infinite due to the development of a circular drift cell [20]), increasing the
length of a drift tube increases the difference in time separation, and so smaller
changes are easier to detect. The second is the use of helium instead of
nitrogen as mobility gas as well as the capability for higher gas pressures,
smaller gas molecules act as a smaller probe features in the surface of the
molecule, whereas larger gas molecules may not fit into crevices in the protein
surface, thereby distorting the measured collision cross section.
Nitrogen is more polarisable (1.740x10−24 cm3) than helium (0.205x10−24
cm3). The polarisability of the drift gas used has been shown to change the
54
3.2. Travelling wave ion mobility
A
B C
Figure 3.4: Example of the multidimensional data that can be ac-
quired simultaneously using a Waters Synapt TWIM-MS instru-
ment. Mass spectral data are shown, with the lowest charge state of
the monomeric, dimeric and trimeric species are labelled with yel-
low, blue and red spheres respectively (A). Arrival time distributions
for the lowest charge state of each oligomeric species are shown (B).
The overall intensity heatmap of mass spectral and arrival time data
also shown (C). Figure adapted from [18].
reported CCS value of analytes in IM-MS experiments. Figure 3.5 shows the
effect with drift gases of varying levels of polarisability on glycine peptides. It
can be seen that as the size of the peptide increases, the effect is lessened, with
the largest peptide analysed being 360 Da [21]. Further work by Ruotolo and
co-workers investigated this effect on the tryptically digested proteins, and
found there to be no appreciable effect on peptides analysed in the 500-3500
m/z region [22]. None of the samples investigated here are below 500 m/z so
this effect should not change the results.
Drift tube experiments typically use mass analysis, in the form of a
quadrupole, to select an ion, and then record an arrival time distribution
for the ion. A benefit of TWIM-MS is the ability to acquire mass spectra,
using the ToF, at the same time as recording arrival time. This gives rise to
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Figure 3.5: Effect on recorded radius of glycine oligomers using ion
mobility mass spectrometry. The data points in the series indicate
the polarisability of the buffer gas used, from low to high; helium,
argon, nitrogen and carbon dioxide. Figure reproduced from [21].
the multidimensional data shown in Figure 3.4, which is not possible using
most drift cell instruments.
The path of an ion travelling through a drift tube can be understood from
physical principles, and mobility and CCS have a linear relationship. This
allows for direct calculation of CCS values from these data. The path of an
ion through a TWIM-MS instrument is complicated due to the effect of the
travelling wave, this is compounded by the non-linear relationship between
arrival time and ion CCS [23], which is evidenced by the curved arrival times
of charge state arrival time distributions in Figure 3.4C. The result of this is
that it has not been possible to directly calculate the CCS values of ions from
TWIM-MS data [24].
TWIM-MS calibration
Travelling wave ion mobility mass spectrometry arrival time data can be
calibrated using ions of known CCS by several methods [5, 25, 26].
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The CCS values used for calibration are generally taken from experimental
data, acquired using drift tube mass spectrometers. Early on most TWIM-MS
calibrations were conducted using peptides or proteins in denaturing buffer [5,
19, 27], with particular interest in small proteins such as denatured myoglobin
[25]. The use of small denatured proteins resulted in a mass spectrum with
many charge states covering a large td range, and these two effects helped cre-
ate good calibration curves. Clemmer and co-workers developed the Clemmer
online database∗, which compiled several publications worth of experimental
CCS values for denatured proteins [12, 28, 29].
In 2012 Salbo et al. discovered that the calculated CCS values for native
proteins was more accurate when using native proteins as calibrants [30]. The
research was facilitated by a publication by Bush et al. which gave the CCS
values for several native and denatured proteins [31]. The study used a Wa-
ters Synapt instrument which had the travelling wave portion replaced by a
drift tube, this allowed several contributing factors to CCS determination to
be removed when comparing it to the same instrument with a travelling wave
installed. Another interesting feature of the dataset is that CCS values were
recorded for the calibrants using both helium and nitrogen (as used in trav-
elling wave) as the mobility gas. Several native and denatured proteins were
analysed and the collection in kept up-to-date on the Bush CCS Database†.
The different published methods for calibrating TWIM-MS data use differ-
ing equations to calculate CCS however they result in the same answer. An
explanation of the calibration process described by the Scrivens group [5] is
described here.
The time taken for the analyte to traverse the mass spectrometer after the
trap ion guide, through the IM separation cell, transfer ion guide and ToF
is given as a scan number (n). Conversion of this value to milliseconds is
achieved using Equation 3.6 using the pusher frequency (f ).
td = n · f (3.6)
∗http://www.indiana.edu/∼clemmer/Research/Cross%20Section%20Database/cs_database.php
†http://depts.washington.edu/bushlab/ccsdatabase/
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As the arrival time value has contributions which are not involved in IM
separation, these factors have to be corrected for. These factors are split into
those which are dependent (tdependent) and independent (tindependent) of the
m/z of the ion and so the correction is made using Equation 3.7.
t′d = td − tindependent − tdependent (3.7)
The m/z independent factors are contributed to by the time spent travers-
ing the ion mobility and transfer cells. The size of the contribution is related
to the wave velocity of the travelling wave (Vw), and the length of each of the
cells. The time taken to traverse a pair of stacked ring electrodes is 0.010 ms
at a wave velocity of 300 m/s. The ion mobility cell has 61 electrode pairs
and the transfer has 31, the relationship is described in Equation 3.8.
tindependent = (61 + 31)
(
0.01 · 300
Vw
)
(3.8)
The m/z dependent contribution to arrival time is the time taken for the
analyte ion to reach the detector after exiting the transfer cell. An ion with
an m/z value of 1,000 takes 0.044 ms to get from the T-wave to ToF and a
further 0.041 ms to reach the detector. The time is proportional to the square
root of the m/z value and the m/z dependent portion of the arrival time can
be calculated with Equation 3.9.
tdependent =
√m/z
1000 · (0.044 + 0.041)
 (3.9)
The experimental CCS values of the calibrants have to be corrected for
reduced mass (µ) using the mass of the ion (mion) and mass of the gas (mgas),
and the charge state (z) (Equations 3.3 and 3.10).
Ω′ = Ω/z ·
√√√√1
µ
(3.10)
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A power fit is then applied to the corrected CCS value (Ω′) against corrected
arrival time calibration curve using Equation 3.11) to determine the two fit
coefficients A and B. An example calibration curve for denatured myoglobin
is shown in Figure 3.6.
+12
Figure 3.6: A TWIM-MS calibration curve using denatured myo-
globin as the calibrant. The plot shows corrected arrival time (td’)
against corrected CCS (Ω’), and the curve fits the data with an R2
value of 0.9958.
Ω′ = A · t′dB (3.11)
The previous equations can be combined to give Equation 3.12. Using the
power fit coefficients, the CCS value of an analyte can be calculated and the
value is measured in squared Angstroms (Å2).
Ω = A · t′dB · z ·
√√√√1
µ
(3.12)
In drift tube experiments, careful monitoring of gas pressure, composition
and temperature is required to acquire reliable data. However as TWIM-
MS are compared to calibrant proteins which are acquired under the same
conditions, usually during the same experimental session, these factors can
be left out of the calibration procedure [30]. The error in CCS determination
using TWIM-MS was additionally shown to be under 5 % by Bush et al. [31]
and work by Leary et al. has shown that the CCS values calculated have good
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reproducibility when being analysed at separate laboratories [32].
3.3 Collision cross section calculations
As ion mobility mass spectrometry is able to report a physical characteristic
of the shape of proteins, in the form of CCS, it was necessary to compare this
to other structural biology techniques for analysis. The Protein Databank
(PDB)‡ is a repository of protein structures, in the form of nuclear magnetic
resonance (NMR), X-ray crystallography and model structures. X-ray crys-
tallography and NMR data are the most detailed information available for
the structure of proteins. The data are in the form of three dimensional co-
ordinates for each atom in the structure. In order to be able to compare the
PDB structures to IM-MS CCS data, it is necessary to calculate the CCS of
proteins represented as coordinates. There have been several proposed ap-
proaches to calculating this value and some of the most widely used methods
are discussed here.
Projection approximation
The fastest method of calculating the CCS of a PDB structure is using the
projection approximation algorithm (PA) [33]. In the algorithm, the atoms of
a protein are treated as opaque spheres, using Van der Walls radii as the radii
of the spheres. A 2D virtual grid with x and y axes is then created and the
model is projected onto it by collapsing the z axis, creating a ‘shadow’ [34].
Each square on the grid is then checked for whether it is occupied by an atom.
The number of squares containing atoms is then counted and multiplied to
give the cross sectional area of the projection. The protein is then rotated and
this process is repeated. The average CCS value of each rotation is calculated
and when the average converges within a certain tolerance level (e.g. 1 Å2),
then the algorithm exits. An alternative method for calculating the area is
using Monte Carlo integration [35], in this case the z axis is still collapsed, but
now x and y coordinates are randomly chosen and checked whether they fall
in or outside of the area of the protein. To calculate the area, the percentage
‡http://www.rcsb.org/pdb/
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of hits is multiplied by the area of the x and y axes grid, points keep being
generated and tested until the area of the single projection converges.
A
B
Figure 3.7: An illustration of the projection approximation (PA) al-
gorithm. The ion, shown in red (A), is projected onto a grid (B), the
number of grid squares covered by the ion is counted and multiplied
by the area of the square to get the area of the projection. The ion
is then rotated, and the process repeated (right), until the average
area of projections converges. Figure adapted from [18].
The PA is known to underestimate CCS values of protein structures. This
is because of the lack of gas molecules in the algorithm model. Long range
electrostatic interactions are ignored, as well as the potential for multiple
collisions for a single gas molecule, which is especially important in the case
of convex and complex protein shapes. This together suggests theoretically
that the algorithm underestimates the retardation caused by collisions with
the buffer gas, and this has also been shown to be true empirically [19, 32].
The PA algorithm is included in several software packages including
Sigma§, MOBCAL¶, and recently a fast PA algorithm has been developed
by Erik Marklund from the Benesch group and though is as yet unpublished,
is available to download‖.
§http://bowers.chem.ucsb.edu/theory_analysis/cross-sections/sigma.shtml
¶http://www.indiana.edu/∼nano/software.html
‖http://impact.chem.ox.ac.uk/
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Trajectory method
The trajectory method (TM) is the most accurate method for calculating
the CCS of a PDB structure [19, 35]. In this model gas molecules are fired at
the protein, and all interactions are taken into account, including Lennard-
Jones potentials and long range electrostatic interactions [33], and as with
the PA, the collisional area is calculated for many rotations to give the orien-
tally averaged CCS value [36]. The benefit of accuracy comes at the cost of
computation time, with calculations for large proteins being unfeasible even
on modern hardware, with some proteins taking months to analyse [35].
Exact hard sphere scattering
The exact hard sphere scattering algorithm (EHSS), was introduced as a
middle ground between the PA and TM. In this algorithm the atoms are
treated as hard spheres and no long range interactions are considered. The
algorithm fires gas molecules at the protein and determines if it passes straight
past or makes a collision. The angle of deflection is calculated, and the path
of gas molecule is followed, the collisional area is further increased if the gas
molecule makes an additional collision. This method is known to overestimate
the CCS value in comparison to the TM [32], though it is thought that the
accuracy is reduced by only a few percent [19, 37].
The simplifications of the model used in the EHSS result in a vastly reduced
computation time in comparison to the TM. Even though it does take longer
than the PA, CCS values for proteins take in the order of minutes to compute.
Projection superposition approximation
The projection superposition approximation algorithm (PSA) [35, 38, 39],
is a recently adapted version of the PA. The PSA uses a shape factor to es-
timate the extent of the convex nature of a protein, and calculates collision
probabilities rather than using hard spheres. The work has shown the algo-
rithm to be considerably faster than the TM and calculates CCS values which
are closest to the TM of the algorithms presented here [35].
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3.4 Gas-phase protein conformation
The success in ion mobility instrumentation raised the question of whether
proteins retained their native structure when analysed in vacuo. Early studies
by the Clemmer and Jarrold groups studied this question conducting electro-
spray ionisation drift tube ion mobility experiments on cytochrome c and
comparing the results to the calculated CCS values of X-ray crystallography
structures. In 1995 it was found that the IM analysis yielded a larger CCS
value than expected of natively folded cytochrome c, this however was largely
due to the use of 50:50 methanol to water as the solvent [11]. Work in 1997
resulted in very close correlation between experimental and theoretical CCS
values, even with the use of acetonitrile in the solvent [12, 40]. The work
found that the lowest charge states of ions have the closest CCS value to
the theoretical, as additional charges can cause unfolding due to coulombic
repulsion. It was also demonstrated that altering the velocity of ions entering
the drift tube, and so the energy gained from collisions with gas molecules
(known as injection energy), would cause unfolding and increases in CCS,
thereby suggesting that these voltages should be kept to a minimum in order
to maintain protein structure.
After the introduction of nanoelectrospray ionisation, aqueous ammonium
acetate could be used as solvent, making it easier to achieve native-like CCS
values by ion mobility and an example of this was in 2004 when Bernstein et al.
analysed α synuclein [4]. The introduction of TWIM-MS and work from the
Scrivens laboratory brought further validation of the possibility of analysing
proteins in native-like conformations [19, 41]. It was later shown that proteins
of larger and more complex shapes could be maintained. A demonstration of
this was shown in work done on trp RNA binding attenuation protein (TRAP),
the subunits of which form an 11-mer ring structure (∼80 kDa) which was
maintained in the gas-phase [42]. These advances in understanding allowed
the Bowers group to elucidate the repeating structure in Aβ42 fibrils which are
responsible for Alzeihmer’s disease by comparing experimental ion mobility
data to molecular models of potential structures [43].
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3.5 TWIM-MS experiments
An introduction to the methodology used to carry out TWIM-MS
experiments on a Waters Synapt G1 follows. First an experiment
aiming to compare with protein structure models is described fol-
lowed by a collision induced unfolding experiment.
Native structure TWIM-MS
Analysis of proteins using TWIM-MS experiments can achieve very similar
conformations to that of X-ray crystallography experiments.
In order to maintain a native-like protein conformation, it is necessary to
not expose the analyte to excessively violent collisions which causes collisional
heating and can result in the breakage of hydrogen bonds and the unfolding of
proteins or the dissociation of subunits from protein complexes. This can be
controlled by the user by changing the various voltages in the mass spectrome-
ter. The voltage of the capillary voltage and the cone voltages at the entrance
to the mass spectrometer maintain the potential difference that allows elec-
trospray to occur, must be above a certain value (dependent on the sample)
in order to maintain the ion flow. Once electrospray has been achieved, these
voltages should be optimised to be as low as possible whilst maintaining the
electrospray. The trap voltage and transfer voltages should also be minimised.
The acceleration provided by the trap voltage determines the initial velocity
of the ions as they enter the ion mobility cell and so should typically be higher
than the transfer voltage.
The nitrogen buffer gas pressure is also important in the trap and IM cells.
The IM buffer gas provides the separation of ions based on the CCS, and
so increasing the buffer gas pressure, increases the length of time taken to
traverse the IM cell and typically improves resolution as a result. The high
pressure of the IM cell (˜5 × 10−1mbar)would create a very large pressure
difference between the trap and IM cells, which would disrupt ion flow. To
combat this, during TWIM-MS experiments the gas pressure in the trap cell
is also increased.
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The travelling wave settings should be optimised to achieve the best sepa-
ration. This is primarily achieved by changing the wave height (voltage) and
wave velocity (m·s−1) of the IM cell. The wave height changes the probability
of an ion rolling over the top of the T-wave or being carried along with it.
It is important to optimise this for maximum resolution, this should be done
with care as higher voltage wave heights can cause protein unfolding. The
wave velocity increases the number of individual waves an ion experiences as
it traverses the IM cell, which also improves the data. This must be optimised
whilst observing the resulting ATD. Though higher wave velocities improve
the effectiveness of the T-wave, it also results in the ions traversing the IM
cell faster which results in a narrower ATD. As there are only 200 scans per
ATD, the ATD of the ion should span as many of the scans as possible to
acquire high resolution data. The optimisation process for the IM cell settings
then has to include the buffer gas pressure, T-wave wave velocity and height
at the same time to acquire the highest resolution data.
The resulting arrival time data can then be calibrated as shown in Section
3.2 and be compared to models.
These types of experiment are becoming increasingly prevalent to study
protein complexes that are not amenable to analysis by X-ray crystallogra-
phy or nuclear magnetic resonance (NMR). X-ray crystallography and NMR
analysis becomes difficult for very large protein complexes [44], and also the
structure of highly labile regions often is not determined, or have to be re-
moved in order to form crystals [45]. Both types of experiment have difficulties
with analysing heterogenous samples and require high protein concentrations
[46].
IM-MS is able to analyse heterogenous samples as the components in the
analyte solution are usually separated by mass, allowing the ion mobility
analysis of a particular analyte in isolation. Very low sample concentrations
are required (˜10 mM), and protein complexes of masses of over 400 kDa can
be analysed [45].
The result of this is that ion mobility mass spectrometry may become a vital
tool in structural proteomics, that has the aim of determining the structure
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of every protein in the proteome. By IM-MSthe CCS value of individual
subunits, sets of subunits and the total structure can be analysed. This can
be combined with in silico molecular modelling in order to determine high
resolution final structures, and would help with analysing protein complexes
which cannot be analysed by other structural techniques [44].
Collision induced unfolding
Collision induced unfolding (CIU) experiments, involve increasing the colli-
sion energy in the trap cell in order to unfold the protein. When carrying out
these experiments it is first necessary to optimise the settings for maintaining
a native conformation (as described above) to have as the starting point of the
experiment. The voltage should be increased until the signal of the ion peak
being analysed disappears. It should then be the checked that the travelling
wave parameters used are appropriate by examining an ATD of the ion. It
may be the case that roll over occurs, which manifests as baseline lift. If this
is observed then the travelling wave settings should be changed, typically this
would involve reducing the wave height and/or increasing the wave velocity.
With the settings of the ion mobility mass spectrometer setup, the data
can be acquired. The trap voltage should be increased at a user defined incre-
ment, acquiring each voltage step. It is important that the other settings are
not changed during the CIU experiment. Altering the buffer gas pressure or
travelling wave settings will cause changes in the resulting ATDs and changing
other collision energies will alter the degree of unfolding of the protein. The
experiment produces a set of ATDs for the ion peak which can be analysed
further.
One method of representing these data is known as CIU fingerprinting and
an example is shown in Figure 3.8. This representation consists of stacking
ATDs at increasing collision energy along the x axis, with the CCS or ar-
rival time (referred to in the figure as drift time) along the y axis and the
intensity along the z axis and represented by colours. In this experiment,
researchers investigated the effect of salt adducts on the gas phase stability
of the tetrameric protein complexes avidin and concanavalin A (ConA).
The portion of the experiment shown is the comparison between the pro-
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Figure 3.8: CIU finger print analysis of avidin (a) and concanavalin A
(b), in 100 mM ammonium acetate (above) and 100 mM ammonium
acetate with 2 mMmagnesium acetate (below). Figure adapted from
[47].
teins in ammonium acetate solution as well as with added magnesium acetate.
The use of magnesium acetate meant that the increased adduction was only
due to adduction of cations, as acetate ions are volatile and would evaporate.
The increased resistance to unfolding, is indicated by reduced increase drift
time as the collision energy is increased. This feature is shown by both pro-
teins in the presence of magnesium acetate, which shows that magnesium ions
had stabilised the conformation of the protein complexes [47].
Collision induced unfolding experiments will be investigated further in
Chapter 5.
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Chapter 4
Amphitrite
Ion mobility mass spectrometry can provide multidimensional data
for protein analytes. This chapter introduces new methods of data
analysis and representation; these use heat maps to incorporate the
extra dimension provided by IM-MS into the data representation,
and improve the reproducibility and accuracy of data extraction and
manipulation.
4.1 Introduction
4.1.1 Deconvolution of ESI mass spectra
Electrospray ionisation experiments produce spectra with several individual
peaks owing to differing numbers of charges. This is different to other meth-
ods such as matrix assisted laser desorption ionisation (MALDI) experiments
which typically produce a single peak corresponding to the singly charged
component. These extra peaks increase mass accuracy as the value taken
is an average, however the more crowded spectra, when multiple molecular
species are present, can make data analysis considerably more complicated.
The experiments described here were carried out in positive ion mode,
meaning that the multiple peaks were due to cation adduction. The vast
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majority of these are proton adducts, and the electrospray process produces
a distribution of charges, which is thought to be Gaussian in nature [1].
The increase in complexity of data analysis of ESI mass spectra required
new algorithms. In 1989 Fenn and coworkers introduced them/z equation still
used today, which incorporates the charge of the ion (z), along with proton
mass (mproton) and ion mass (mion) (Equation 4.1). They simultaneously
introduced the first mass spectrum deconvolution algorithm [1].
m/z = mion + z ·mproton
z
(4.1)
In the subsequent years, proteins analysed by ESI-MS have become larger
[2] and the number of charges on protein ions have increased concomitantly.
In order to calculate masses using Equation 4.1, an iterative computational
algorithm is used to determine the correct charge and the mass. As neigh-
bouring peaks have a difference of one charge, a charge state series is assigned
for the peaks, e.g. +1,+2,+3. The mass is then calculated for each peak
using Equation 4.1 and the standard deviation of all the calculated masses is
determined. The masses are then recalculated using one charge higher e.g.
+2,+3,+4 and the standard deviation is calculated. This process is repeated
and the correct charge state series is assigned to the series which produces
the lowest standard deviation of masses. Though this method had been used
previously [3], it was formally described by Winkler [4].
E.T. Jaynes introduced the concept of maximum entropy as an optimisation
criterion in 1957 [5, 6] and it was applied to mass spectrometry data in 1991
[7]. Maximum entropy was used as a forward algorithm, where a spectrum
was deconvoluted assuming that a certain mass was correct [8]. The result of
the algorithm would be a stick spectrum of masses, with noise removed, an
example of which is shown in Appendix 4.5.1. This algorithm has been kept
up to date and is included in the current edition of the MassLynx software
package (4.1, Waters Corp.). The algorithm however is not well adapted to
large potential mass ranges of analytes as it does not scale well [9] and the
“soft” ionisation technique of ESI has progressed from the study of cyclosporin
A (1.2 kDa) [10], to native-like analysis of non-covalent complexes over 18
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MDa [11].
Larger ions along with higher order oligomeric states led to the acquisi-
tion of crowded mass spectra containing overlapping peaks, making analysis
difficult. In 2006, a new approach called SOMMS (SOlving complex Macro-
molecular Mass Spectra) was released [9] and the program introduced the
simulation of mass spectra. The parameters to recreate a mass spectrum
of multiple components could be entered and a simulated mass spectrum be
generated. Manual adjustment of these parameters could create a near exact
replica of the original spectrum. This however is extremely time consuming,
and though the package has some semi-automatic functionality, it was prone
to getting stuck at local minima solutions which resulted in large errors. The
program was command line based and, as a consequence of the relatively high
knowledge barrier required to operate it, was not widely adopted.
We set out to develop a robust graphical user interfaced program for the
analysis of electrospray ionisation mass spectra along with travelling wave
ion mobility data. The ESI-MS portion of the program would enable users
to manually simulate as with SOMMS but would have a robust automation
procedure linked to a graphical user interface (GUI) to ensure easy operation.
After we succeeded in developing the simulation/deconvolution algorithm and
were developing the ion mobility portion of the program, a different group
published the Massign software that had very similar functionality [12, 13].
Massign was developed as a plug-in for the proprietary software LabView (Na-
tional Instruments, Texas, USA) which now represents an additional financial
barrier, and so we have not been able to try it.
Another new mass spectral deconvolution algorithm has been published,
named ‘Calculating Heterogeneous Assembly and Mass spectra of Proteins’
(CHAMP) [14]. This algorithm was designed to deconvolute complex mass
spectra where information about the proteins in the spectra are already
known, including the mass and accessible surface area (ASA) as taken from X-
ray crystallography structures. As the mass of the protein is predetermined,
the additional information is used to predict the behaviour of the protein
in the mass spectrometer in terms of the level of protonation (estimated us-
ing mass) and the number of adduct ions (estimated using mass and ASA).
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The presence and proportional abundance of potential complexes are then
optimised using non-linear least squares.
4.1.2 Ion mobility mass spectrometry data analysis
Ion mobility is a gas-phase technique that separates ions as they travel under
the influence of an applied electric field through a neutral target gas. The
time taken for an ion to traverse the cell is related to its mass, charge, and
the rotationally averaged collision cross section (CCS) of the ion [15–17].
Ion mobility coupled to mass spectrometry (IM-MS) is a powerful analytical
technique that was initially only available in a few laboratories capable of
building such specialised instruments. The primary means of performing IM-
MS separations was based on drift cell technology [18].
Early drift cell IM-MS experiments were focused towards small proteins
and peptides, usually under non-native conditions. Due to the simple ion
motion through the drift cell the absolute cross sections of ions could be
calculated from the arrival time distributions (ATDs). A typical example
of how these data could be represented is shown in Figure 4.1A. For each
ion charge state the collision cross section for each peak in the drift time
dimension was calculated and plotted. Different charge states can occupy
different conformations, with the higher charge states being unfolded, and
the lower charge states close to the native conformation.
In 2004 a commercial instrument capable of IM-MS experiments was in-
troduced [20]. The separation of ions was achieved using a travelling wave
(T-wave, TW) [21]. In contrast to drift tube instrumentation, a higher level
of sensitivity was possible, but the complicated movement of ions during the
separation meant that direct calculation of CCS values was not possible [22,
23]. At this time a common way to represent the data was to plot inten-
sity against the arrival time or scans for a single charge state as in Figure
4.1B. To rectify this situation algorithms were developed to calculate analyte
CCS values using calibrant proteins of known CCS (see Section 3.2) [24, 25].
One result of the calibration was that now intensity against arrival time plots
could be shown as intensity against CCS plots as was often used in drift tube
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Figure 4.1: (A) Classic ion mobility figure, altered from [19]. Demon-
strating the effect of charge state on the collision cross section of cy-
tochrome c ions in the gas-phase. Coloured ovals indicate two of the
four distinct conformations. Arrival time distribution of bradykinin
using TWIM-MS with three distinct protein conformations labelled
1-3 (B). Figure adapted from [20].
experiments [19].
The introduction of commercial ion mobility instruments resulted in an
increase in the popularity of the field, however developments in software have
been virtually non-existent with the only available software for the interpre-
tation of TWIM-MS data being Driftscope (Waters Corp.). In addition to
allowing the plotting of arrival time distributions, Driftscope can produce
plots of arrival time against m/z. This allows for the full visualisation of the
three dimensional data, and an example is shown in Figure 4.2.
The aims of this project were to create a deconvolution algorithm with an
easily usable graphical user interface and to link this to ion mobility data
analysis. The deconvolution portion of our software presented here, creates a
map of which regions of a mass spectrum are associated with which ion, this
allows the ATDs to be automatically extracted from the raw data files and
is instrumental in the program’s ability to easily create IM calibrations that
can then be applied to entire data sets automatically. The software can be
used to create CCS vs m/z heat maps that can be overlaid between different
experimental conditions, something that allows for a more in-depth probing
of the structural changes taking place between different conditions. Having
a program do these analyses allows for the standardisation of the data pro-
cessing, making the entire process more objective and reproducible between
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Figure 4.2: An m/z vs. arrival time plot showing the multidimen-
sional data available from a TWIM-MS experiment, with the corre-
sponding mass spectrum displayed as a trace on the right (adapted
from [26]).
different practitioners. A number of different uses of the program, with a par-
ticular focus, on commonly encountered structural biology applications are
illustrated using model proteins.
4.2 Methods
4.2.1 Sample sources
Cytochrome c from equine heart, myoglobin from equine heart, alcohol de-
hydrogenase (ADH) from Saccharomyces cerevisiae, bovine serum albumin
(BSA), and concanavalin A from Canavalia ensiformis were purchased from
Sigma Aldrich (St. Louis, MO). Serum amyloid P component (SAP) purified
from human serum was purchased from CalBioChem, Merck Biosciences Ltd.
(Darmstadt, Germany).
4.2.2 Sample preparation
In order to reduce adduction and the consequent peak broadening, samples
must be void of non-volatile salts. In order to maintain native protein struc-
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ture the ionic strength of the sample buffer must be maintained. For this rea-
son in the native MS experiments, protein samples were buffer exchanged into
250 mM ammonium acetate. This was achieved by three rounds of dilution-
concentration using Amicon Ultra 0.5 ml centrifugal filters (Millipore UK Ltd,
Watford UK), with final protein concentration corrected to 20 µM, using a
Qubit 2.0 fluorometer.
To further reduce adduction and to obtain more accurate masses, proteins
can be denatured. This exposes more amino acid side chains resulting in
increased protonation, which in turn increases the electron volts (eV ) expe-
rienced by the ion in the mass spectrometer. The result of this is reduced
adduction and a consequently cleaner mass spectrum. For denaturing exper-
iments, protein samples were buffer exchanged into a 49:49:2 (v:v:v) ratio of
H2O: methanol: acetic acid, and concentrated to 20 µM using Amicon Ultra
0.5 ml centrifugal filters.
4.2.3 Capillary preparation
Nano-ESI compatible capillaries were produced in house as described by Her-
nandez and Robinson [27]. Borosilicate capillary tubes (Harvard Apparatus,
Massachusetts, USA) with inner and outer diameter of 0.78 and 1.0 mm re-
spectively were pulled into needles using a Sutter Instrument Co. P-97. To
ensure propagation of the electric field the needles were gold coated using an
SC7620 sputter coater (Emitech (Quorum), Kent, UK).
4.2.4 nESI-MS calibration
Calibration was performed using 33 mM caesium iodide (Sigma-Aldrich), in
250 mM ammonium acetate. Caesium iodide (CsI) forms a wide array of crys-
tal sizes, whose mass-to-charge ratios (m/z) span beyond the m/z range inves-
tigated (500-12,000 m/z). Calibrations were performed by fitting a 5th degree
polynomial calibration curve using theoretically determined exact masses of
CsI oligomers, using Waters MassLynx software. Spectra obtained were com-
pared and calibrated iteratively until the overall error was less than 10 ppm,
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which is checked using the Waters MassDiff software (Figure 4.3).
Figure 4.3: Output of the MassDiff program which is used to test
if the instrument is properly calibrated. On the left there is an
unacceptable result, and the right an acceptable one.
4.2.5 TWIM-MS
Mass spectrometry experiments were carried out on a first generation Synapt
HDMS (Waters Corp., Manchester, UK) mass spectrometer [28]. 2.5 µl
aliquots of samples were delivered to the mass spectrometer in gold-coated
capillaries. Typical instrumental parameters were as follows unless otherwise
specified: source pressure 5.5 mbar, capillary voltage 1.10 kV, cone voltage
40 V, trap energy 8 V, transfer energy 6 V, bias voltage 15 V, IMS pressure
5.18x10−1 mbar, IMS wave velocity 250 m/s, IMS wave height 6 V, and trap
pressure 4.07x10−2 mbar. Arrival time to CCS calibration was conducted
using the method outlined in Section 3.2.
4.2.6 Experimental procedures
For the heating experiment ADH was incubated at 60 ◦C for 30 minutes in a
heat block. The sample was removed from the heat block and immediately in-
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troduced to the mass spectrometer. Instrumental parameters were optimised
as follows: source pressure 4.50 mbar, cone voltage 60 V, trap energy 15 V,
transfer energy 12 V, and IMS wave height 7 V. BSA and concanavalin A
were used as CCS calibrants.
For the collision unfolding experiment, the native fold of cytochrome c was
disrupted by increasing the bias voltage from 10 V to 80 V at 10 V increments.
Instrumental parameters were optimised as follows; source pressure 3.55mbar,
cone voltage 30 V, and IMS wave height 7 V. Denatured myoglobin and ADH
were used as CCS calibrants.
For the mixing experiment, ADH, BSA, and concanavalin A were mixed
in an equimolar ratio, and the instrumental parameters were optimised as
follows; trap energy 60 V, transfer energy 30 V, bias voltage 22 V. IMS wave
height 7 V. SAP, BSA, and concanavalin A were used as CCS calibrants.
Arsenite oxidase samples were analysed without IM separation using cone
and sampling cone voltages of 45 and 2 V, trap and transfer voltages of 15 V
and 10 V with a trap pressure of 8.60x10−3 mbar.
4.2.7 Software development
During a TWIM-MS experiment arrival time distributions (ATDs) are
recorded by synchronising the orthogonal acceleration time of flight (oa-ToF)
acquisition with the gated release of a packet of ions from the trap T-Wave.
For each packet of ions 200 mass spectra are acquired at a rate dependent on
the pusher frequency.
The program, Amphitrite, handles the data in the form of an N x 200 ma-
trix (where N is the number of m/z bin increments), with individual vectors
to describe the associated axes (i index is associated with the m/z dimension
and j with the time dimension). This matrix can be used to generate the full
mass spectrum aggregated over arrival time data points (t(i,j)) by summing
the elements to an N -length vector. Equation 4.2 describes the process of
calculating a single m/z value, ξi.
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ξi =
199∑
j=0
t(i,j) (4.2)
Additional manipulations can be carried out by selecting sections of the
matrix by index, for example each point in the arrival time distribution (tj)
of a particular ion could be extracted by supplying the lower (l) and upper
(u) m/z (ξ) index limits, and then summing along the m/z axis as shown
in Equation 4.3. The manipulations of this matrix form the basis of the
functionality of the program.
tj =
u∑
i=l
ξ(i,j) (4.3)
The software was developed using the Python programming language [29].
Several Python modules were utilised for data analysis including NumPy,
SciPy [30] and Matplotlib [31], and the graphical user interface was devel-
oped using wxPython [32]. The initial conversion of a raw TWIM-MS file
to an Amphitrite project file can only be run under Microsoft Windows as
the Waters proprietary library for extracting the data from MassLynx data
files is only compatible with Windows. All other aspects of Amphitrite are
cross platform and are compatible with GNU/Linux, Mac OS X systems and
MS Windows. The software was developed on a workstation with an Intel i7
2600 processor clocked at 3.4 GHz with 16 GB memory, running GNU/Linux
- Ubuntu 12.04. Processing times quoted are for a mid-2011 MacBook Air
with an Intel i5 1.7 GHz dual-core processor and 4 GB memory. The source
code for the project is available at github.com/gnsiva/amphitrite and the
compiled Windows executables are available from mscalculator.com and the
Thalassinos lab website∗.
∗http://www.homepages.ucl.ac.uk/∼ucbtkth/resources.html
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4.3 Results and discussion
Until now, Driftscope (Waters Corp.) has been the sole program used to dis-
play and manipulate raw TWIM-MS data. The introduction of Amphitrite
facilitates increased customisability of plots as well as the automation of pre-
viously labour-intensive, subjective and hence non-reproducible tasks. Using
model proteins, we describe various examples of how the software can be used.
4.3.1 Mass spectrum simulation
Programs capable of automatic and semi-automatic analysis of mass spec-
trometry data of proteins and protein complexes are becoming increasingly
available [9, 12, 14, 33]. Amphitrite also includes an algorithm for the decon-
volution of mass spectra, as fitting peaks to the mass spectrum is the first
process in the automatic extraction of corresponding ion ATDs. A Gaussian
model (Equation 4.4) [34] is used to represent the distribution of peak heights
of the ion peaks within a charge state distribution of a given molecular species,
and this is used as a constraint in mass spectral simulations. The individual
peaks, corresponding to a specific charge state, can be modelled as Gaussian,
Lorentzian (Equation 4.5) [35] or a hybrid peak shape which consists of Gaus-
sian and Lorentzian regions (Equation 4.6) where x is the m/z value, A is the
amplitude, µ the mean, and Γ is the full width half maximum (FWHM) of
the peak.
f(x) = Ae
− (µ−x)2
2
(
Γ
2
√
2 ln 2
)2
(4.4)
f(x) = A 1[
1 +
(
µ−x
Γ/2
)2] (4.5)
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f(x) =

Ae
− (µ−x)2
2
(
Γ
2
√
2 ln 2
)2
: x ≤ µ
A 1[
1+(µ−xΓ/2 )
2] : x > µ (4.6)
Figure 4.4: A typical nESI protein charge state peak (grey). Overlaid
are three peak models whose parameters were optimised to match
the experimental data; A: Gaussian, B: Lorentzian and C: hybrid.
A demonstration of the three peak models is shown in Figure 4.4, in each
case the fit for the experimental data was optimised using non-linear least
squares. Throughout this chapter the hybrid peak model has been used and
as a result the model for a single charge state series is described by Equation
4.7. z0 and zn represent the lowest and highest charge state in the series,
Az, µz and Γz represent the amplitude, mean and FWHM parameters for the
charge state series Gaussian distribution respectively and H+ is the mass of
a proton. Additionally the mass has been denoted as “mass” to distinguish
mass
z from mass-to-charge ratio (m/z), as readout by the mass spectrometer.
f (x) =
zn∑
zi=z0
Aze
−((
mass
zi
+H+)−µz)2
2·
(
Γz
2
√
2 ln 2
)2
·

e
− (µ−x)2
2·
(
Γ
2
√
2 ln 2
)2
: x ≤ µ
1[
1+(µ−xΓ/2 )
2] : x > µ (4.7)
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Figure 4.5: Different stages in extracting arrival time distribution
plots of serum amyloid P (pentamer). The user selects peaks of
the charge state series in (E) (numbers are unique peak identifiers),
the mass is calculated and the theoretical charge states are then
plotted over the spectrum (panel D), with the subsequent simulated
spectrum plotted in (C). (B) Mass mobility plot, using the simu-
lated spectrum each charge state can be identified and the ATDs
extracted. The ATDs have been displayed as overlaid ATD distri-
butions for each charge state as shown in (A).
After minimal user input the program can simulate a mass spectrum as
presented in Figure 4.5C with a computational processing time of under 2
seconds. To assess the quality of the fit an error statistic (E) is calculated as
the mean deviation using Equation 4.8, where f is the function in Equation
4.7, y is the experimental data, N is the total number of data points, s is
the space between m/z data points and Az,Γz,µz and Γ are the parameters
output by the fitting procedure. In the case of Figure 4.5C, the error was 0.47
% (of base peak intensity) per m/z.
E =
N∑
i=0
|f(xi, Az,Γz, µz,Γ)− y|
N · s ·maxy (4.8)
There are two ways in which one can specify the input required. If the
expected mass of the macromolecule is known, it can be manually entered,
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along with the charge state range over which to simulate that particular mass
e.g. +22 to +27 (Figure 4.5D). More than one mass can be entered and after
this, the program uses the non-linear least squares optimisation algorithm
[36] to minimise the difference between the simulated and experimental data.
If, however, the mass of the components in the spectrum is unknown, the
program aids the user in this process. The program uses the gradient to
automatically identify peaks (where f ′(m/z) = 0 and f ′′(m/z) < 0) in the
mass spectrum which are then given arbitrary unique numerical identifiers as
shown in Figure 4.5E.
The user then selects the sequential charge state peaks of a particular
species using the numerical peak identifiers. The mass of the species is calcu-
lated using the m/z values of the peak tops. The theoretical m/z values for
charge states are calculated (default +1 to +100) and are displayed as vertical
markers along with the calculated mass and error (Figure 4.5D). Both of these
features help to ensure that peaks were correctly identified, as incorrect peak
picking would result in misaligned theoretical charge states and large mass
errors. The program automatically estimates the charges to simulate, which
the user can edit. After this process has been completed for each species, the
program can fit simulated data to the supplied spectrum using least squares
optimisation with the result shown in Figure 4.5C. If the user then notices that
a species was missed, it can be added to the simulation by repeating the steps
described above. The data simulation algorithm can identify and deconvolve
overlapping peaks and peak shoulders (see example in Figure 4.8C).
4.3.2 ATD extraction
Standard m/z against arrival time (td) plots like those displayed by Driftscope
can be drawn by Amphitrite (as previously shown in Figure 4.5B) and a key
improvement is the resolution of these images. In Amphitrite, the user can
determine the space between each data point in the m/z space i.e. how wide
a particular m/z bin is. For the figures shown here a spacing of 2 m/z units
was used.
Extracting ATDs across all charge states of a given spectrum has now
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been streamlined as the fitting procedure previously described determines the
FWHM and peak centre of each of the peaks in the mass spectrum, and uses
this information to automatically extract the corresponding ATD for each
charge state, with the results shown in Figure 4.5C.
In experiments where multiple spectra are obtained of the same protein
under different conditions, the ATDs corresponding to a single charge state
can be extracted for all the files in a similar manner as exemplified in Figure
4.11.
4.3.3 Calibration
Protocols to convert TWIM-MS arrival times to CCS have been described pre-
viously [24, 25, 37, 38], and Amphitrite automates the calibration procedure
outlined in Section 3.2, thereby reducing subjectivity that can be introduced
during the ATD extraction and subsequent td peak selection.
The process for creating a calibration is shown in Figure 4.6. From a user
input perspective, the program is given the calibrant raw data file and the
name of that calibrant, in this case myoglobin. Creating a calibration with
more than one calibrant protein is also possible. It then automatically selects
the charge states (vertical bands in Figure 4.6A) that have corresponding
published CCSs [39]. Low abundance charge state peaks can be deselected
and ignored in order to improve the fit. The program automatically takes
td value corresponding to the highest intensity to use in the calibration and
produces the output shown in Figure 4.6C. Another way in which outliers can
be addressed, is that the program allows the user to move the arrival time
used in the calibration from the highest intensity point, this can help with
skewed distributions and noise.
Outliers can be addressed by specifying alternate peak apexes (which are
also automatically detected), by specifically providing a td value as input, or
by removing the peak from the calibration.
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Figure 4.6: Creation of a CCS calibration using denatured myo-
globin. Amphitrite automatically selects charge states (A), which
correspond to published CCS†. From the selected peaks, the ATDs
are extracted and plotted (B). The peak tops are automatically
picked and displayed. A calibration curve, using a power fit to the
data, is then calculated and plotted. Poor fits can be recalculated
by manually adjusting the peak tops selected in the previous stage.
The calibration procedure used has been described in [24].
4.3.4 Applying a calibration
The ability to read the raw data files has allowed a more fine-grained approach
to applying a calibration to TWIM-MS data. To illustrate this method, the
calibration equations from Section 3.2 have been simplified to create Equation
4.9 (see Appendix 4.5.2 for derivation), where t is the drift time and ξ is the
m/z value.
Ω = A · z√
µ
·
t− 276
Vw
− 0.085 ·
√
ξ
1000
B (4.9)
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The existing method for calibrating TWIM-MS data is described in Equa-
tion 4.10. Here the drift time is represented as a summed portion of the data
matrix as described in Equation 4.3, m/z value’s index is k corresponding to
the m/z value of the centre of the peak in the mass spectrum.
Ω = A · z√
µ
·
 u∑
i=l
ξ(i,j)
− 276
Vw
− 0.085 ·
√
ξk
1000
B (4.10)
The new calibration method (Equation 4.11) however, allows each td value
to be associated throughout the calculation with the correct m/z value,
thereby reducing error caused by only using a single m/z value to indicate
the m/z range covered by a mass spectrum peak.
Figure 4.7: Charge state collision cross section plots of cytochrome
c. A calibration similar to that shown in Figure 4.6 was applied to
the td data to generate the CCS data. A dot in panel A represents
each peak top in the td for that particular charge state. The same
data are shown in panel B as a heat map with peak intensity being
represented by the colour intensity and the CCS of peak tops shown
as a white dash. Panel C shows these data normalised by individual
peak volume.
Ω =
u∑
i=l
A · z
(u− l) · √µ
ξ(i,j) − 276
Vw
− 0.085 ·
√
ξi
1000
B (4.11)
In Figure 4.7A an archetypal IM-MS experiment result is shown, CCS vs.
charge state for denatured cytochrome c. This is a common way found in the
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literature to present IM-MS data, however, a lot of the original information in
the data is lost. Where more than one conformation exists for a given charge
state, such as for the +8 charge state shown in Figure 4.7, there is no way
of deducing the relative intensities of the different conformations. It is also
not possible to infer the width of each conformation in the CCS dimension.
Biologically, this can be very informative as an increase in the width of a CCS
distribution can indicate increased conformational flexibility [12, 40] and as
shown recently can, in certain cases, also limit the observed ATD resolution
of higher resolving instruments [41]. Comparing two proteins by overlaying
figures like those shown in Figure 4.7A can miss important conformational
changes as the peak CCS can remain the same, while the width of the CCS
distribution can change between two conditions [40]. The figures generated
by Amphitrite (Figures 4.7B and C) also provide visual information regarding
the width of the MS peak (in the x-axis direction) that was used to reconstruct
the ATDs. The program displays the CCS dimension peak tops, as shown in
Figure 4.7A, and these are calculated automatically (where f ′(Ω) = 0 and
f ′′(Ω) < 0).
Features of low abundance can be visualised by using a different method
of normalising the peak intensities. In Figure 4.7B the colour saturation is
normalised to the intensity of the base peak in the mass spectrum, i.e. to
the maximum intensity in the entire matrix holding the data, so that one can
see that the +7 charge state is the most intense peak in the mass spectrum.
In Figure 4.7C the intensity of each charge state is normalised to the total
intensity for that m/z slice. This allows for less abundant features to be
visualised by increasing the dynamic range of the display for lower abundance
charge states and for the conformational flexibility and adduction to be readily
assessed.
4.3.5 Complex mixture analysis
The program’s mass spectral deconvolution algorithm can be coupled with the
modified calibration approach described in Section 3.2 to analyse complex
ion mobility spectra, and to make sense of the complicated td vs m/z plot
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Figure 4.8: IM-MS analysis of a mixture of BSA, concanavalin A
and alcohol dehydrogenase. The mass spectrum was deconvoluted
into its component parts (C), with the raw arrival time distribution
shown in panel A. Using the deconvolution data and CCS calibration
(like that shown in Figure 4.6), the raw arrival times can be separated
and converted into CCS vs. m/z information for each molecular
component (B). The colouring is consistent between panels A and
B (concanavalin A monomer - red, dimer - blue, tetramer - purple,
BSA monomer - green, dimer - brown, ADH tetramer - magenta).
produced by Driftscope.
As seen in Figure 4.8C the program successfully deconvolutes the mass
spectrum by identifying and calculating the mass and the charge state dis-
tribution parameters for all species. Additionally the individual ion peak
widths are determined (as in Figure 4.8C). The typical td vs. m/z plot is
shown in Figure 4.8A and when observed in isolation does not easily allow
one to identify the number of species present. Using the parameters deter-
mined in Figure 4.8C, a calibration like the one shown in Figure 4.6 can be
applied, transforming the td vs. m/z plot into a CCS vs. m/z plot (Figure
4.8B). This conversion into absolute cross section separates out the individual
species and results in a plot which can be more readily analysed.
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4.3.6 Spectral averaging
Figure 4.9: Spectral averaging. Panel A, shows the variation for
the same sample measured using different capillary needles. Each
individual spectrum has been overlaid and coloured differently. A
peak at approximately 5,150 m/z has been enlarged to portray more
clearly the variation between each experiment (panel B). The aver-
age of the three spectra in panel A is plotted in panel C. The same
enlarged peak in panel B is again shown in panel D, with the min-
imum and the maximum of the three spectra plotted as light blue
lines and the mean plotted in black.
Collecting multiple mass spectra can help reduce the error and electrospray
variation caused by certain factors such as needle-to-needle variation and nee-
dle positioning. Figure 4.9A and B show the effect of obtaining three mass
spectra of the same sample using the same instrumental conditions but with
three different needles. From the analysis of mass spectra of samples under
different conditions (e.g. temperature), peak intensities and areas can offer
information additional to the mass of the ions.
By comparing the integrals of different oligomeric species under differing
conditions (e.g. temperature), the formation or disappearance of oligomers
in response to conditions of interest can be inferred. It is advantageous to be
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able to average technical replicates and compare those between conditions in
order to assess whether changes are due to differing conditions rather than
technical variability.
Using the program one can average spectra in the mass spectrum, td and
CCS space. Figure 4.9D shows the band between minimum and maximum
intensities for a peak, with the average in the centre. The program can also be
set to display the error range in terms of standard deviation, quartile ranges
and percentage errors. Peak areas and heights can be automatically extracted
to be used in further analyses.
4.3.7 Comparing different conditions
Figure 4.10: Comparison of heating experiments of alcohol dehydro-
genase at 20 ◦C and 60 ◦C. Data at each temperature was replicated
and averaged as shown in figure 4.9. Panel A and B show the dis-
tribution of collision cross sections for 20 ◦C and 60 ◦C respectively.
A difference plot is shown in panel C, where overlapping CCS dis-
tributions in pane A and B have been subtracted from one another.
Spectral averaging was performed on the heating experiment spectra used
in Figure 4.10. IM-MS can be used to monitor the effect on conformation of a
discreet stressor such as heating [42]. To demonstrate this, ADH spectra were
acquired with the protein at room temperature (20 ◦C), and after heating
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at 60 ◦C for 30 minutes. For each condition three technical replicates were
acquired. In addition to the CCS vs. m/z plot of the sample at 20 ◦C (Figure
4.10A) and 60 ◦C (Figure 4.10B), a difference plot can also be drawn. This
is shown in Figure 4.10C, with the colours matching those used in Figure
4.10A and B. In this figure the 20 ◦C and 60 ◦C spectra have been normalised
to the volume within the plot, as this helps to make the comparison more
representative. The data show that the process of heating ADH causes it to
adopt a more open conformation as demonstrated by the increase in CCS.
4.3.8 Collision induced unfolding
A unique and very informative IM-MS experiment is gas-phase, collision-
induced unfolding which can be achieved by accelerating ions into the gas filled
region, prior to their entry into the T-Wave mobility cell (Figure 4.11). This
experiment can probe the unfolding of protein ions by monitoring changes
in ATDs/CCSs upon increasing collision energies [43–46] and is covered in
more detail in Chapter 5. This experiment can be used to probe a number
of experimental conditions and their effect on protein conformation/stability,
however, it can generate a large number of data files as each time the collision
energy is changed a different raw data file is recorded. The automation offered
by Amphitrite greatly facilitates the processing of such datasets.
Figure 4.11 shows the results of the collision induced unfolding for the +6
charge state of cytochrome c. Data were recorded at eight different collision
energies. The program uses the data file which was acquired at the lowest
collision energy to identify and perform a fit (in order to calculate a FWHM
for that peak) to the mass spectrum as previously described in the materials
and methods section. Alternatively, explicit mass ranges can also be entered
manually. The m/z range is then used to automatically extract ATDs from all
files in the dataset. If a CCS calibration is provided at this stage, all ATDs are
converted to CCS values. The reduced amplitude for the peaks seen for 10 and
20 V are due to the peak broadening effects of bound adducts which lessens
as the collision energy is increased. This highlights the benefit of the new plot
(Figure 4.11A); changes in both the m/z and the ATD / CCS dimensions can
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Figure 4.11: Collision induced unfolding of cytochrome c. The CCS
distribution of the 6+ charge state is shown in panel A as the col-
lision energy is increased from 10 V to 80 V at 10 V increments.
Intensities for panel A have been normalised to the total ion inten-
sity for each three dimensional peak. The corresponding CCS plot
for each voltage increment is shown in panel B. The relative intensity
of each peak top identified from the CCS plots is also monitored as
the bias voltage is increased (panel C).
be visualised simultaneously providing a means of globally monitoring ion
structural changes during collision induced unfolding experiments. Finally,
the program can track the peak intensities of given CCS or td values as shown
in Figure 4.11C.
4.3.9 Arsenite oxidase
To further illustrate the benefits of the new software some data from research
into arsenite oxidase will be shown. In order to investigate the constituents of
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Figure 4.12: Deconvolution of an arsenite oxidase mass spectrum.
the purified protein the spectrum in Figure 4.12 was collected. The protein is
a tetramer made up of two heterodimers (AioA-AioB). The sample is further
complicated as each subunit in the heterodimer has a different iron-sulphur
cluster and each the dimer is also associated with a cofactor. Amphitrite
successfully deconvoluted the initial complex spectrum, assigning masses to
its constituents and confirming the purity of the sample.
Figure 4.13: Diagram of the four potential assembly pathways of
arsenite oxidase. Blue circles represent subunit AioB and red rings
represent AioA.
An X-ray crystallography model was created for the protein, however the
model does not define the assembly pathway of the complex. The potential
pathways that the protein could form are shown in Figure 4.13 [47]. Mass
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E
D
C
B
A
Figure 4.14: (A,B,C) Assembly pathway analysis of arsenite oxidase.
Investigating the change in relative abundance of oligomeric states
of arsenite oxidase in relation to ionic disruption by means of am-
monium acetate concentration. Dimer component trace is blue, and
tetramer is grey. (D) Summary of the integrals. (E) The program
indicating the theoretical charge states of the mass of a potential
trimer.
spectrometry can be used to probe the assembly pathway by altering the
ionic strength of the buffer and observing the resultant oligomer distribution.
The ammonium acetate concentration was increased (Figure 4.14A, B and C)
and a simplified deconvolution was performed using Amphitrite to track the
proportional abundance of the two most common species by calculating their
integrals. As the ammonium acetate concentration increased the proportion
of heterodimer (blue trace) increased, this demonstrates that increased ionic
stress causes a larger proportion of the protein to exist as a heterodimer.
Pathways A and B are disproven by the absence of any peaks at trimer m/z
values (Figure 4.14E), similarly pathway C is not as no peaks were found to
indicate the mass of either homodimer.
The software allowed the checking of the purity and validity of the protein
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expression and purification. It was also used to track the change in abundance
of differing species in response to external stimuli and was able to check for
the presence of species of given mass by displaying the theoretical m/z values.
4.3.10 Current state of software development
The code for the Amphitrite project is open source and available from
github.com/gnsiva/Amphitrite. The code is well documented, and users
can create their own scripts to analyse their data.
Software package also contains prototype graphical user interfaces (GUIs)
which are able to carry out all of the analyses shown in this Chapter, a
screenshot of each of these is provided in Appendix 4.5.3. All of the GUIs
with the exception of SpectralAveragingGui have been compiled to Windows
binaries that are available on mscalculator.com.
It is hoped that this project will be continued by hiring full-time software
developers to further develop the GUIs. In addition my supervisor has indi-
cated that he would take the responsibility of creating tutorials (webpage or
video) to help users with using Amphitrite.
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4.4 Conclusion
Amphitrite introduces a simple, robust and reproducible method for deconvo-
luting complex spectra. The simulations performed have the added advantage
of being able to estimate peak area and so the relative abundance of molecular
components as well as determining their mass and charge state distribution
parameters.
The fitting functionality introduced substantially enhances the processing
of TWIM-MS data, making the process automated and less prone to user
subjectivity. It also allows for a more detailed analysis of the data acquired
and the automatic comparison of entire TWIM-MS datasets between different
experimental conditions. The data presented here demonstrated common ap-
plications in structural mass spectrometry as well as new ways of representing
and analysing the data. The developments facilitate the analyses required to
interpret the native MS experimental data throughout the Ph.D.
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4.5 Appendix
4.5.1 Example maximum entropy (MaxEnt) spectrum
Figure 4.15: Maximum entropy spectrum produced by the MaxEnt
3 function of Waters MassLynx software. The most abundant molec-
ular species is a 1,226 Da peptide.
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4.5.2 Simplifying calibration equations
Determining corrected arrival time t′d
The following equation is the same as Equation 3.7, the parameters other
than the corrected arrival time are; the experimental arrival time (td), the
portion of the arrival time which is independent of m/z (tindependent) and the
m/z dependent time contribution (tdependent), such as time spent in the ToF.
t′d = td − tindependent − tdependent (4.12)
Substitute in tindependent from Equation 3.8 and simplify. The new param-
eter Vw is T-wave velocity measured in m/s.
t′d = td − (61 + 31)
(
0.01 · 300
Vw
)
− tdependent (4.13)
t′d = td − 92 ·
300
100 · Vw − tdependent (4.14)
t′d = td −
276
Vw
− tdependent (4.15)
Substitute in tdependent using Equation 3.9 and simplify. ξ is the mass-to-
charge ratio of the ion.
t′d = td −
276
Vw
−
√
ξ
1000 · (0.044 + 0.041) (4.16)
t′d = td −
276
Vw
− 0.085 ·
√
ξ
1000 (4.17)
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Determining collision cross section (Ω)
The following equation is the same as Equation 3.12 which calculates the
collision cross section using the powerfit parameters (A and B), the reduced
mass (µ), charge state (z) and corrected arrival time.
Ω = A · t′Bd · z ·
√√√√1
µ
(4.18)
Substitute in the corrected arrival time (t′d) using the new Equation 4.17
and simplify.
Ω = A · z ·
√√√√1
µ
·
td − 276
Vw
− 0.085 ·
√
ξ
1000
B (4.19)
Ω = A · z√
µ
·
td − 276
Vw
− 0.085 ·
√
ξ
1000
B (4.20)
110
4.5. Appendix
4.5.3 Amphitrite graphical user interfaces
Figure 4.16: ImProcessorGui from Amphitrite. This program allows
users to batch convert MassLynx ion mobility files into Amphitrite
data files (.a). The user selects the directory containing data files
(usually the data from a day’s experiment), they can then select
which files are to be converted. The conversion process currently
only works in Windows as the MassLynx conversion library only
supports this operating system.
Figure 4.17: ApplyCalibrationGui from Amphitrite. Uses data from
“Copy Spectrum List” of an ATD in MassLynx. Allows for the
display of ATDs and the calibration to CCS using an Amphitrite
calibration file.
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Figure 4.18: AtroposGui from Amphitrite. This program allows
the user to deconvolute mass spectra and export the deconvolution
parameters as a Amphitrite mass spectrum fit (.afit) file to be used
with other Amphitrite programs. The input data can be from “Copy
Spectrum List” of a mass spectrum in MassLynx, or as the output
data from Amphitrite’s ImProcessorGui.
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Figure 4.19: CalibrationGui from Amphitrite. CalibrationGui allows
the user to automatically extract the ATD for each charge state
of a calibrant protein, and automatically plot a calibration curve.
Individual charge states can be removed if of low quality, the position
of the ATD peak can also be moved. The calibration can then be
exported as an Amphitrite calibration file (.acal).
Figure 4.20: IesGui from Amphitrite. This GUI allows users to anal-
yse multiple acquisitions of the same protein simultaneously and was
designed to analyse collision induced unfolding data. After multi-
ple Amphitritre data files are loaded, with an Amphitrite fit file, a
particular charge state can be extracted, thereby showing the ATDs,
and unfolding contour plots. These can additionally be calibrated to
show the data in terms of CCS instead of arrival time. The program
can also monitor abundance of conformational families using peak
heights in ATDs/CCSDs.
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Figure 4.21: SpectralAveragingGui from Amphitrite. Spectral aver-
aging allows users to produce a representative spectrum (top) and/or
ATD (bottom) from replicated acquisitions. The GUI allows users
to do this with MS, ATD and CCSD data. The left plots show the
average in black, with the range between minimum to maximum val-
ues across the three spectra shaded in blue. On the right the three
original mass spectra and ATDs are shown. data are taken from 3
voltages of CIU to make the effect clear. The user can then export
the data either as an Amphitrite data file or a text file.
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Challenger
In the previous chapter, basic collision induced unfolding (CIU) data
analysis was introduced. This chapter introduces several new meth-
ods for analysing these data, which aim to be more accurate and
quantitative than existing methods.
5.1 Introduction
5.1.1 Gas-phase unfolding of proteins
Many studies have shown that with careful control of instrument parameters,
protein collision cross section (CCS) values obtained using ion mobility mass
spectrometry (IM-MS) are closely related to their native solution structure [1–
3]. It was also determined that during IM-MS higher charge states represent
unfolded species, increasing the reported CCS. It was found that to achieve
the most native-like conformation the lowest charge state should be used [4,
5]. This raises the question, would it be useful to intentionally unfold proteins
in the gas-phase?
Proteins with higher charge states are likely to be more unfolded due to
the coulombic repulsion between the adducted protons causing disruption to
the protein structure. Additionally, the kinetic energy of ions by electric
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fields in the mass spectrometer is proportional to the number of charges on
the protein. The additional velocity results in more violent collisions with
inert gas molecules, causing ion heating, due to friction, and subsequently
causes protein unfolding. Analysing protein unfolding using ion charge state
is suboptimal as the charges on the ion are integers, so transient conformations
could be missed. Another problem is that coulombic repulsion does not relate
to a process that happens in solution, whereas collisional heating is similar
to the effect of solution temperature as the unfolding is caused by gradual
increasing the internal energy of the ion, as heat, through many collisions.
The early experiments using drift tube instruments were capable of protein
unfolding IM-MS experiments. Quadrupole isolated ions were accelerated into
the drift cell, where collisions with the mobility gas caused ion heating and
unfolding. The ions quickly decelerate and ion mobility data can be acquired.
These experiments are known as injection energy studies [6].
Injection energy studies were used by the Clemmer group [7] to show that
disulphide bonds stabilise protein conformation in the gas-phase as well as in
solution and the observation indicated that alterations to solution structure
stability could also affect gas-phase stability.
Another use of injection studies by the Bowers group was to determine
the oligomeric states of ions that had been quadrupole isolated [8]. When
analysing oligomers of Aβ42, it was difficult to determine the oligomeric size
as, for example, a dimer with twice the number of charges as a monomer will
have the same m/z value. This problem was compounded by the low signal
intensity achieved when analysing these oligomers. By using increments in
injection energy, they caused the oligomer to dissociate and determined the
oligomeric state of the original ion and product ions by the IM-MS drift time
[8, 9].
Another technique that causes the collisional heating of ions is collision
induced dissociation (CID) [10, 11]. The instrumentation used is a dedicated
collision cell, where ions are accelerated by an electric field and collisions with
inert gas cause the increase in the internal energy of the ions. The Waters
Synapt travelling wave ion mobility mass spectrometer has a collision cell
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after a quadrupole mass analyser and before the IM separation cell and time-
of-flight (ToF) mass analyser. The instrumentation allows for the initial mass
selection of an ion charge state, followed by ion mobility separation and mass
determination using the ToF.
Figure 5.1: Gas-phase unfolding of apo (dashed trace) and holo (solid
trace) myoglobin. Vertical line indicates the CCS of holo myoglobin
as calculated from an X-ray crystallography structure. Reproduced
from [12].
An important use for gas-phase unfolding is to investigate the stability of a
protein in the presence and absence of a ligand. Hopper and Oldham investi-
gated the stability of apo and holo myoglobin by measuring changes in arrival
time distributions caused by increasing the collision energy using TWIM-MS
[12]. The results are shown in Figure 5.1. At low collision energies both forms
of the protein have similar CCS values, however as the collision energy is in-
creased, the apo form unfolds more readily. Solution-phase experiments have
found holo myoglobin to be more stable than the apo form [13], and so the
TWIM-MS data shows that this characteristic is maintained in the gas-phase.
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(a) (b)
Figure 5.2: Gas-phase unfolding and conformational abundance
tracking of wild type and L55P mutant tetrameric transthyretin
(TTR). (a) Arrival time distributions of the +15 charge state of
wild type TTR at increasing collision energies. Individual confor-
mations are labelled A-E. (b) Conformational abundance tracking
of each conformation A-E using the ATD peak intensity for wild
type (filled) and L55P mutant (open) TTR. Conformation abun-
dance is reported as the proportion of the summed peak intensities
for all conformations per ATD. Figure reproduced from [14].
The data reported for gas-phase unfolding studies have shown that protein
and protein complexes do not gradually unfold in a linear manner, rather
unfolding occurs through a series of distinct transient conformational families
[4, 14–18].
The CCS values of each individual ion (of a particular analyte), when ag-
gregated, form a Gaussian distribution. The reason for this is that several
structural elements of a protein will be interconverting between different po-
sitions, and the conformational family (also referred to as a conformation) is
a mixture of all of these small movements. With distinct conformations, a
non-interconverting structural change has taken place, and this once again has
a Gaussian distribution of CCS values as the smaller vibrational movements
continue to occur around a different mean CCS value.
The static mean of a distinct conformational population means that the
abundance of individual conformational families in an unfolding experiment
can be determined by monitoring the peak height at the mean and an example
118
5.1. Introduction
is shown in Figure 5.2 [14]. Ion mobility data are of low resolution and so con-
formation peaks often overlap, as seen with conformations A and B in Figure
5.2(a). This leads to distortion in the reported abundances when analysing
ATDs using conformational peak heights. In some studies, researchers have
used statistical software such as Fityk [19] to fit Gaussian distributions to
single ATDs in order to give a better representation of the abundance of
conformations [20, 21].
Figure 5.3: Demonstration of CIU fingerprint analysis, applied to the
protein kinase domain of Bcr-Abl. (left) Protein structure diagrams
showing the binding position of type I and type II inhibitors. Gas-
phase unfolding data, of the complexes from each inhibitor class, are
represented as CIU fingerprints (centre). ATDs are extracted from
the data in the dashed area of the CIU fingerprints (right). This
shows that there are clear differences between the way the protein
unfolds when bound to type I or type II inhibitors. Figure repro-
duced from [17]
A new method for analysing gas-phase protein unfolding data was recently
developed called collision induced unfolding (CIU) fingerprinting, which gives
a visual representation of the pattern of unfolding. The method involves
extracting ATDs for a particular ion across several acquisitions at voltage
increments. These these sets of two-dimensional data are stacked with the
voltage increment along the x axis, the arrival time along the y axis and the
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ion intensity as the z axis to give a three-dimensional heatmap, an example
of which is shown in Figure 5.3.
Using CIU fingerprinting, it was demonstrated that although binding type
I or type II kinase inhibitors of the protein kinase domain of Bcr-Abl did
not substantially alter the conformation at low collision energies, gas-phase
unfolding the protein and analysing the data with CIU fingerprints showed
different unfolding patterns for each of the types of ligands. These different
unfolding patterns could then be used to class putative inhibitors as hav-
ing a type I or II binding mechanism, without the need for obtaining X-ray
crystallography structures for each complex (Figure 5.3) [17].
5.1.2 Aims
The introduction of commercially available instrumentation for IM-MS anal-
ysis [16, 22] has led to an expansion in the number of laboratories that have
access to such technologies. A consequence of new types of data acquisition
methods, however, is the need for development of new computational methods
that are able to cope with the complexity and extract the maximum infor-
mation from such new data, something that has been lacking for the IM-MS
field. To ameliorate this, we developed the software package Amphitrite [23]
introduced in Chapter 4. It can be used to deconvolute the MS data and use
this information to then automatically extract ATDs from the raw data files
and automatically apply a collision cross section (CCS) calibration to them.
Amphitrite introduced some basic methods of analysis for CIU data, including
the ability to assess the abundance of conformations using peak heights.
The open source codebase for Amphitrite makes it easy to extract ATDs
from MassLynx data files in an automated fashion, and then manipulate the
data programmatically. This development led us to investigate the short-
comings of current methods of data analysis used with gas-phase unfolding
data.
The first problem is the quantitative representation of large unfolding
datasets. After a certain number of voltage increments, representing the data
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as stacked arrival time distributions is unfeasible. The alternative CIU fin-
gerprint allows for a useful visual representation of the unfolding process,
however, the data are not quantitative and so statistical or automated com-
parisons between analytes would not be possible. In order to achieve these
characteristics, methods of numerically summarising ATDs that go beyond
using peak tops were investigated and are presented here.
The second issue was the representation of conformational abundances.
Tracking the abundance of transient partially folded species during unfolding
experiments can impart important information when comparing two analytes.
The peak height method is susceptible to overlapping peaks and so a decon-
volution approach is proposed which utilises a purpose built GPU (graphics
processing unit) accelerated genetic algorithm.
The frequent focus of ion mobility unfolding experiments on ligand inter-
actions suggests the possibility of using the technique for testing stability in
high-throughput drug screening. A method and tool to automate unfolding
experiments on the Waters Synapt instrument are presented here. In combi-
nation with the ability for automated ATD extraction afforded by Amphitrite,
and automatic sample changing using tools like the Advion Nanomate, this
work could increase the viability of the technique in drug screening experi-
ments.
5.2 Methods
5.2.1 Sample sources
Lysozyme from hen egg white, myoglobin from equine heart, β-lactoglobulin
from bovine milk, concanavalin A from Canavalia ensiformis and bovine
serum albumin (BSA) were purchased from Sigma Aldrich (St. Louis, MO).
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5.2.2 Mass spectrometry sample preparation
The proteins were analysed in 200 mM ammonium acetate which was pur-
chased from Sigma Aldrich (St. Louis, MO). Buffer exchange was carried out
using BioRad (Hercules, CA) BioSpin 6 columns, with additional concentra-
tion and dilution steps using Amicron Ultra 0.5ml centrifuge filters (Millipore
UK Ltd, Watford, UK). The concentration of these samples were monitored
using a Qubit 2.0 fluorometer (Life Technologies, Carlsbad, CA), samples were
analysed after diluting to 10 µM.
5.2.3 IM-MS procedures
The experiments were performed on a Synapt HDMS mass spectrometer (Wa-
ters Corp., Manchester, UK) [16]. The instrument was mass calibrated using
30 µM caesium iodide (Sigma Aldrich, St. Louis, MO) dissolved in 250 µM
ammonium acetate. 2.5 - 4.5 µl aliquots of sample were delivered to the mass
spectrometer using gold coated borosilicate capillaries, which were prepared
in house [24].
Calibration curves were calculated using BSA and bradykinin [25] acquired
using the same ion mobility parameters as the samples. The data was ex-
tracted and calibrations applied using the Amphitrite software package [23,
26].
Ion mobility experiments were carried out after quadrupole isolation of
a particular charge state for each analyte. This allows for the analysis of
dissociation products of the CID process without interference from different
charge states which receive different energies at a given voltage. Additionally
the T-wave ion mobility device can exhibit reduced separation due to charge
state saturation, by using quadrupole isolation the ions entering the IM cell
are limited to those that are to be analysed during the experiment.
Ion mobility data was acquired after quadrupole isolation of a particu-
lar charge state (+7 lysozyme, +8 myoglobin and +8 β-lactoglobulin). The
instrument settings for the unfolding experiments are shown in Table 5.1.
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Setting Value
Capillary Voltage 1.1 kV
Sampling Cone 20 V
Extraction Cone 1 V
Source Temperature 40 ◦C
Trap Collision Energy Variable
Transfer Collision Energy 5 V
Trap Pressure 5 mbar
Mass Range 1,000-8,000 m/z
Bias Voltage 20 V
Backing Pressure 0.24 mbar
IM Wave Height 9 V
IM Wave Velocity 350 m · s−1
Transfer Wave Height 8 V
Transfer Wave Velocity 150 m · s−1
IMS pressure 5.20x10−1 mbar
LM/HM Resolution 5/15
Table 5.1: IM-MS settings table for unfolding experiments on model
proteins.
5.2.4 Genetic algorithms
Genetic algorithms are a class of artificial intelligence optimisation algorithms,
which mimic evolution in order to find an optimal solution. At the start of
the process, a randomly generated population of individuals (also known as
chromosomes) is created. An individual contains all the parameters that are
to be optimised, which are known as genes. For this algorithm, individuals
can contain values for calculating a Gaussian distribution such as amplitude
and full width half maximum (FWHM).
The next stage is to select the better optimised (higher fitness) individuals
for two new populations. This is carried out using tournament selection, for
each individual in each population n individuals are randomly selected from
the previous population and the fittest individual is used. The fitness of an
individual is determined by simulating the Gaussian distributions that they
describe, summing them together and calculating the absolute difference to
each of the experimental data points. The additive inverse of the square of the
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summed error vector is used as the fitness, resulting in a maximum fitness of
zero. The two populations are then merged into one through recombination,
an individual is taken from each population (parents) and a new individual is
created by randomly selecting genes. The last step is to introduce mutations
into the new population. A mutation rate is given as a probability. This is
applied to all genes and individuals, and where mutation occurs a new value
is randomly generated, within a preset range of values.
At this stage, the fittest individual from the population is determined and if
its error is sufficiently low, the algorithm terminates and the fittest individual
is returned as the solution. If the error is higher, the population undergoes
another round of evolution, starting from the tournament selection step, how-
ever during this round the fittest individual is not changed in a process called
elitism. If the algorithm does not find the solution after a certain number of
generations, the algorithm will terminate, returning the fittest individual as
its solution [27].
5.2.5 Software development
Three implementations of the Challenger algorithm were developed using dif-
ferent technologies. The first was developed in the Python programming
language [28] and a Python genetic algorithm library, PyEvolve [29]. The
second version was developed in the C programming language [30]. The fi-
nal version, which is used throughout this chapter, was written in Cuda C
[31]. The final Cuda C version has been tested on GNU/Linux (64 bit) and
Microsoft Windows 7 (64 bit).
The Python programming language [28], in conjunction with Python mod-
ules NumPy, SciPy [32, 33], Matplotlib [34], and Amphitrite [23], handles the
processing and displaying the results generated by the genetic algorithm.
Processing times quoted are for a GNU/Linux desktop computer with an
Intel i5 3570K overclocked to 4.4 GHz, 16 GB RAM and an nVidia GeForce
GTX 660 Ti graphics processing unit (GPU).
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5.3 Results and discussion
5.3.1 Automation of unfolding experiments
Increasing the collision energy increases the amount of kinetic energy experi-
enced by the ion traversing the trap cell. Whilst the ion is crossing the trap
cell, it experiences collisions with inert gas molecules, increasing the internal
energy of the molecule and causing it to unfold. Monitoring the resultant
unfolding by means of IM-MS have been important experiments for the field.
They have also gone by different names including injection energy studies
[5] and collision induced unfolding [35]. The procedure involves acquiring
short (1-2 minute) sets of data, altering the collision energy and reacquiring,
repeatedly. It seemed that this procedure would be well suited to automation.
A program was developed to generate tune files containing instrument set-
tings that were compatible with the Waters Synapt G1, and it should be
straightforward to adapt for use with newer Waters Synapt instruments. A
screenshot of the program’s graphical user interface is shown in Figure 5.4.
Using this software, sets of tune files can be generated with ascending trap
cell collision energies for use in the experiments described here. Additionally
other parameters can be altered, for instance the sampling cone collision volt-
age could be ramped if the user needed to use quadrupole mass selection after
the unfolding event.
The instrument’s software (MassLynx 4.1) can be set to be able to trigger
and cease data acquisitions. This allows the user to create a sample list file,
and enter the different tune files to be used for each acquisition. This process
has to be done manually so the program outputs tune files with names in the
format ipr_xxx.ipr where xxx is the voltage increment index. For example
when acquiring an unfolding experiment which starts with a trap voltage of
5 V and increases in 5 V increments, then the first tune file will be labelled
ipr_001.ipr (5 V), and the second ipr_002.ipr (10 V). This means that the
manually entered sample list can be used for many experiments with different
sets of automatically generated tune files.
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Figure 5.4: GUI for automatically generating mass spectrometer
settings files (.ipr) for the Waters Synapt.
When using this method the dead time between acquisitions is consistently
under 2 seconds, this contrasts to a user based method which would be slower
at its fastest, and would not have the same level of consistency.
This automation procedure also facilitates overnight experiments, very fine
grained unfolding analyses could be left to run for several hours making use of
time when the instrument is not being used and the increased amount of data
reduces the chance of missing conformations which are only present within
small collision energy windows.
Once these data have been acquired, the arrival time distributions need to
be extracted from the numerous raw data files. Using MassLynx to accomplish
this extraction is a multi-step process for each file, including an important
operation where the m/z range of the peak in the mass spectrum is selected
by the user. Using the Amphitrite software package [23] all data files can be
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processed and extracted in an automated fashion. The m/z range used can
either be entered by the user or can be calculated using a mass spectrum fit
generated by the program, thereby removing variability in extraction of data.
The automation of data acquisition would allow for 24 hour operation for
high-throughput experiments when used alongside a system such as the Ad-
vion Nanomate to switch between samples.
5.3.2 Summarising IM-MS unfolding data
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Figure 5.5: Arrival time distributions of the gas-phase unfolding of
lysozyme, β-lactoglobulin and myoglobin.
Unfolding curves
The large amount of data produced by collision energy ramps can be dif-
ficult to represent graphically. In some cases in the literature 3-5 ATDs are
displayed by vertically stacking them [12], this allows a figure to show the key
points of each distribution clearly. However, when increasing the number of
distributions represented in this way to more than 10, it becomes difficult to
see important features (see Figure 5.5). Additionally it would be helpful in a
drug screening environment to have a quick overview of whether a particular
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ligand changes the conformational flexibility or stability of the target protein.
This way ligands that do not have the desired effect can be discarded without
thorough investigation of the unfolding process.
Figure 5.6: Dummy data representing different arrival time dis-
tributions which would have the same arrival time based on peak
top value; (a) sharp distribution,low variation in protein conforma-
tion, (b) compound distribution, consisting of two conformations but
where one is not a peak shoulder, (c) wide single distribution, rep-
resenting large structural flexibility without distinct conformational
families. The td corresponding to the peak apex is indicated by a
dashed blue line,the red line indicates the weighted average td value,
and the values for weighted standard deviation and area under curve
are shown in the top right of each panel.
Figure 5.6 shows three synthetic arrival time distributions, in all three
distributions the maximum intensity is found at an arrival time of 10 ms.
Though the distributions are quite different, peak top analysis would represent
them to be the same.
Distribution (a) is comprised of a single narrow conformational family and
(b) has an additional conformation at a later arrival time. In order to sum-
marise the arrival time value of these distributions, additional conformations
after the most abundant would have to be included in the calculation.
To determine a number which represents the central arrival time of an
ion, aggregated over all potential conformations present, the weighted mean
was calculated (Equation 5.1, where I is the intensity, t is arrival time and
n is the number of data points in the arrival time axis). This metric is
indiscriminate of individual conformations and so can accurately summarise
the bulk conformation.
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tw =
Σni=1Iiti
Σni=1Ii
(5.1)
For analysing the protein standards, the arrival time values are converted
to collision cross section (CCS) before the calculation, additionally the voltage
was converted to laboratory voltage, eV (charge state multiplied by voltage).
This allows different proteins, of different charge states to be directly com-
pared and the result is shown in Figure 5.7(A).
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Figure 5.7: Unfolding curves for model proteins monitoring; collision
cross section (CCS) (A), change in cross section in comparison to the
lowest collsion energy acquisition, monitored as, absolute CCS (B)
and percentage change in CCS (C).
β-lactoglobulin and myoglobin are larger proteins (18.4 kDa and 17.6 kDa
respectively), and so, as expected the smaller protein, lysozyme (14.2 kDa)
starts with a smaller CCS (Figure 5.7(A)). Lysozyme is highly stable in part
due to its structure being maintained by four disulphide bonds [7, 36]. This
explains the much lower increase in cross section, in comparison to the other
proteins, as the collision energy is increased. The structure of β-lactoglobulin
is maintained by two disulphide bonds [37] as opposed to none for myoglobin,
potentially explaining the difference in gas phase stability between them. To
aid in the visualisation, a similar graph is shown in Figure 5.7(B), where the
change in cross section from the lowest voltage aquisition is shown.
129
Chapter 5. Challenger
The experiment was carried out on the holo version of myoglobin. Due to
the two stage mass analysis of the instrument (m/z window isolation using
the quadrupole, followed by ToF analysis), the apo form can be excluded from
the final ATD analysed. It has been previously shown that the protein is more
stable in holo form [13].
After the CCS of myoglobin reaches its highest value, the CCS starts to
reduce. This effect is likely due to the haeme group dissociating from the
most extended conformational family, causing a m/z shift out of the analysed
range and consequently we see an over representation of the more compact
conformations (Figure 5.5 and Appendix 5.20).
Conformational variability curves
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Figure 5.8: Monitoring the conformational variability of three model
proteins during gas-phase unfolding.
In addition to the mean CCS, analysing the bulk sample can also produce
information regarding conformational flexibility. This is demonstrated by
the comparison of distributions in Figure 5.6(a) and (c). Distribution (c) is
much wider, which would indicate a greater conformational flexibility. In this
case, the peak top analysis would not be misrepresenting the data, as both
distributions are symmetrical around the same centre, though the information
regarding conformational flexibility would be lost.
The weighted standard deviation (Equation 5.2) can be compared between
multiple arrival time distributions directly. This produces a value which is
representative of the conformational flexibility displayed in the distribution.
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The calculated standard deviation values are indicated in Figure 5.6, and
as expected distribution (a) has the lowest value, and distribution (c) being
higher than (b).
sdw =
√√√√Σni=1Ii(ti − tw)2
m−1
m Σni=1Ii
(5.2)
Applying this calculation to the unfolding data for the model proteins
yields Figure 5.8. Regions with higher standard deviation values are indica-
tive of conformational change; the protein likely exists in several transient
conformations increasing the spread of the ATD. This behaviour is observed
in myoglobin at 100-200 V, following this there is a two-stage decline. This
phenomenon is observed when the protein stabilises a particular conforma-
tional family, and the second decline is likely caused by the dissociation of a
more extended conformation (see Appendix 5.20).
The effect observed with lysozyme is in stark contrast to myoglobin. The
variability of the ATD increases almost uniformly, indicating that the protein
is still unfolding and has not begun converging on a structure, and rather is
continuing to unfold.
CIU fingerprint analysis
Figure 5.9: Collision induced unfolding (CIU) fingerprints of three
model proteins; lysozyme (top), β-lactoglobulin (middle) and myo-
globin (bottom).
CIU fingerprint analysis has also been carried out on the model proteins
(Figure 5.9); in this case, the arrival time axis has been converted to CCS
using Amphitrite. The general trends observed are similar to those found
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using the summarising techniques; however, it is not possible to quantify
them. This precludes automated analysis, as a user would need to manually
inspect the data.
The Challenger program outputs tables of xy coordinates for the summary
statistic results as well as figures, and a screenshot of the graphical user
interface is shown in Figure 5.10. These tables can then be accessed by a
script or opened in Microsoft Excel/LibreOffice Calc.
Figure 5.10: Graphical user interface for calculating and plotting
summary statistics, as well as plotting CIU fingerprints. The pro-
gram can also output the data as a table. An Amphitrite calibra-
tion can be added to convert arrival times to CCS. Main program is
shown on left, with the dialog box for setting the voltages used in
the unfolding experiment on the right.
These data can be directly accessed and so conditions can be decided for
filtering samples. For example the selection criterion could be that the analyte
has to have a smaller than 20 % increase in CCS at collision energies up to
300 eV. This criterion would select lysozyme and reject the other proteins in
Figure 5.7C. This is similarly relevant to changes in conformational variability.
The summary statistics add a quantitative measure to changes in unfolding
and variability which is not afforded by CIU analysis. This is beneficial in
scenarios where there are small changes in the values as well as for automation.
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The analysis is also objective and reproducible as no fitting is required.
Additionally the analysis allows for the quantification of the differences in
stability and conformational flexibility between analyte and the two compli-
menting techniques reduce the amount of data which has been lost.
5.3.3 Challenger algorithm development
Unfolding analysis of proteins often yields several transient conformational
families [18]. Tracking the changes in abundance of these conformations dur-
ing unfolding can be used for comparison between different proteins or proteins
under different conditions. Thus far, peak heights have been used to represent
the abundances of conformational families [14, 38]; here we describe a novel
algorithm for the fitting and deconvolution of gas-phase unfolding arrival time
distributions.
Ion mobility mass spectrometry instrumentation produces low resolution
data, the result of this is that arrival time distributions conformations are
rarely baseline separated. The poorly resolved data can cause problems when
trying to fit Gaussian peaks using gradient descent optimisation techniques
such as non-linear least squares [39, 40] as they are vulnerable to optimising to
a local minima, which causes the algorithm to terminate [41]. For this reason
a genetic algorithm approach was utilised which incorporates exploratory as
well as exploitative optimisation [42].
A purpose built framework for deconvoluting unfolding data has been de-
veloped and is presented here. An important feature of proteins revealed in
the ion mobility data is that, as a protein unfolds in the gas-phase, it shifts
between discrete conformations and does not progressively unfold in a linear
manner (this phenomenon can be seen in Suppl. Figure 5.5). This feature is
used as a constraint in the fitting procedure; multiple ATDs are deconvoluted
simultaneously but the peak centres of each conformation must stay constant
across all ATDs. The method for creating the simulated data are shown in
Equation 5.3, d is the number of data points per ATD, n the number of Gaus-
sian distributions (conformations) being fit, S is the vector of simulated data
points and µ, Γ and A are, respectively, the mean, full width half maximum
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(FWHM) and amplitude of the Gaussian distribution.
S =
d∑
j=1
n∑
i=1
Aiz
− (xi,j−µi)
2
2(Γi/2
√
2ln2)2 (5.3)
The fitness (F) of a chromosome is calculated as the additive inverse of the
error. Two methods for calculating error are used here, the sum of absolute
differences and sum of squares. The equation for calculating fitness based
on these error values are shown in Equations 5.4 and 5.5 respectively, with a
being the number of ATDs in the dataset.
The algorithm uses sum of squares error. This approach adds a greater
penalty for large deviations, in comparison to sum of absolute differences,
between experimental and simulated data allowing it to more aggressively
optimise against larger problems in the solution. The result of this is that
the algorithm reaches fits which are close to the original data within fewer
generations. When used in figures (such as 5.13B) the axis is explicitly labelled
to indicate that sum of squares error was used in the calculations.
F = − a∑
k=1
d∑
j=1

∣∣∣∣∣∣∣∣∣
n∑
i=1
Ai,kz
− (xi,j,k−µi)
2
2(Γi,k/2
√
2 ln 2)2 − yj,k
∣∣∣∣∣∣∣∣∣
 (5.4)
Sum of absolute differences is used when comparing to data derived from
methods other than solutions generated by the algorithm, such as Figure 5.12
and is labelled ‘Error’.
F = − a∑
k=1
d∑
j=1

n∑
i=1
Ai,kz−
(xi,j,k−µi)2
2(Γi,k/2
√
2 ln 2)2

2
− y2j,k
 (5.5)
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Considerations of computation time
With the ability to automatically analyse the stabilising potential of pu-
tative ligands or drug molecules, the amount of processing time required to
analyse the data becomes important. A gas-phase unfolding experiment can
take approximately 30 minutes per sample, which means up to 48 samples
could be run per day. The summary statistic analysis can be used to screen
ligands to see if they stabilise/destabilise proteins as required, and the pro-
cessing time is a matter of seconds. If a suitable ligand is found once per day,
it would be problematic if the deeper analysis with the Challenger algorithm
took weeks of processing time, this makes it important to reduce computation
time as much as possible.
There is an existing Python library for running genetic algorithms called
PyEvolve [29]; initially the algorithm was to be developed with this resource.
It was quickly evident that the data processing would be too slow for use
with our experimental data. When analysing the experimental data, it is
beneficial to run the algorithm with different information regarding the peak
centres (i.e. how many Gaussians to fit or the mean values for static mean
analysis) to achieve an optimal solution.
In place of this, a purpose built genetic algorithm was developed in the
C programming language [30]. The 32 fold speed increase is shown in Fig-
ure 5.11, 1,000 generations were computed using a simplified synthetic data
set containing two ATDs comprising of 20 data points and 2 conformations
when using dynamic means fitting. The calculation of error in our algorithm
requires the majority of computation time. For each generation each indi-
vidual (default 2,000), the error is determined by calculating the Gaussian
distributions described by the individual and summing them, after this each
simulated value for intensity is subtracted from the solution and absolute error
is summed to give an error value.
The calculation lends itself to massively parallel solutions and GPGPU
(General-Purpose computing on Graphics Processing Units) calculations so
an implementation of the algorithm was created using Cuda [43]. For each
individual in the population a GPU thread is spawned, which then spawns
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Figure 5.11: Comparison between execution times for the three im-
plementations of the algorithm. The y axes are given as a propor-
tion of the time taken to execute the Cuda version, for example the
Python implementation was over 700 times slower. The inset is a
magnified version of the main figure to emphasise the relationship
between the C and Cuda implementations.
further threads for each data point in the arrival time axis. The calculation
of each described Gaussian distribution, the summation to create a potential
solution and the determination of absolute difference to the data can then
be done in parallel potentially reducing computation time dramatically. The
summing of the array result to produce the error is also parallelised, rather
than taking the number of times it takes to calculate a sum multiplied by the
number of data points (n) the calculation completes after log2(n).
The development of the algorithm was done on an inexpensive consumer-
level graphics card and the result of this parallelisation was a 23 fold reduc-
tion in computation time when timing 1,000 generations of evolution at a
population size of 2,000 for experimental lysozyme data with 16 ATDs and 4
Gaussian distributions in comparison to the C implementation.
When collecting results based on the optimum parameters determined in
Section 5.3.4 (population size 2,000, mutation rate 0.0001, uniform crossover,
200,000 generations) for lysozyme, the Cuda algorithm implementation takes
approximately 1 hour to run, and so the equivalent time for the Python im-
plementation would have been approximately 30 days.
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Algorithm testing with synthetic data
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Figure 5.12: Deconvolution algorithm run on synthetic collision en-
ergy ramp data shown in (A). The deconvolution result (red) is
shown in (B) with the original data as black traces and the indi-
vidual conformations with other colours. The peak height (plain
line) and peak area analysis (solid line with dot markers) for the
data are shown in (C); In part (D) the error of 1 million randomly
generated solutions is shown as a histogram and as a fitted Gaussian
distribution in green, the error generated by the algorithm solution
is the vertical red line.
In order to test the efficacy of the deconvolution methodology, a synthetic
set of data representing an unfolding experiment was created (Figure 5.12A)
and the deconvolution algorithm achieved very good agreement with the orig-
inal data (Figure 5.12B).
In order to test the effectiveness of the algorithm against generating random
solutions, 1 million random solutions were generated and are plotted on Figure
5.12C. The average error was calculated for the solution determined by the
algorithm (3 replicates) and was plotted as a vertical red line.
The random solution error was tested for normality using the Anderson-
Darling test [44], and by integrating above and below the algorithm error, it
was determined that the probability of a random solution having the same
error or less was 1.06 × 10−23. Conversely the genetic algorithm only tested
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in the order of 108 solutions before completing. The improvement using peak
areas as opposed to peak heights for abundance analysis was also tested and
the result is shown in Figure 5.12D.
5.3.4 Challenger algorithm optimisation
Crossover
Crossover is a method used to simulate the biological process of recombina-
tion. The genes of two parent chromosomes are mixed together to create the
offspring. There are several different crossover implementations, and two com-
mon methods are compared here. In single point crossover a point along the
chromosome is randomly chosen, the genes after that point are taken from
one parent chromosome and the genes before from the other. The second
method is uniform crossover where for each gene a random number between
0 and 1 is generated. Which parent the offspring’s gene comes from is then
determined by whether the number is above or below 0.5.
The single point crossover is most true to the biological process of recombi-
nation and only requires a single random number to be generated. In compar-
ison for uniform crossover random numbers have to be generated, which can
cause a significant increase to computation time and so it would be preferable
to use single point crossover.
To test the two crossover methods, the lysozyme data set was run with a
population size of 2,000, using three different mutation rates. The algorithm
was run 32 times using different random number generator seeds to ensure
that the different algorithm runs followed different evolutionary paths and the
results are shown in Figure 5.13A.
Single point crossover outperformed uniform crossover at the highest mu-
tation rate, however this was not maintained for lower mutation rates. The
lowest average error achieved by single point crossover was 170 when a muta-
tion rate of 0.001 was used. The error was higher than when using uniform
crossover which achieved an error of 131 for the same mutation rate. Addi-
tionally the lowest average error achieved overall was uniform crossover at a
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Figure 5.13: Optimising the mutation rate and crossover parameters,
for experimental data. The algorithm was run 32 times for each
combination of settings using the lysozyme dataset and a population
size of 2,000, and the results are shown in (A). The error bars indicate
the spread of 2 standard deviations. (B) Histogram comparing the
error results for the two best performing configurations, uniform
crossover with mutation rates of 0.001 and 0.0001.
mutation rate of 0.0001 (128), where single point crossover only achieved an
error of 178.
Calculating the time difference between the methods showed that the single
point crossover took 81 % of the time taken by the uniform method when all
other factors were constant. This is in comparison to the percentage error
difference where the single point method resulted in 33 % higher error when
comparing the best result from each method. The additional time taken to
run the uniform crossover is sufficiently beneficial to rule out the use of the
single point crossover method. Users of the Challenger algorithm can pick
which crossover implementation to use, but for the rest of the analysis in this
thesis the uniform crossover method is used.
Mutation rate
Genetic algorithms utilise the biological process of genetic mutation to im-
prove algorithm performance. Optimisation is required to determine an ap-
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propriate mutation rate, which is the probability that a gene will be mutated
each generation, and the implementation is that a new randomly generated
number replaces the current value of the gene. High mutation rates mean
that a larger array of values can be tested, which is especially important with
small population sizes. Detrimentally, high mutation rates can disrupt the
progression of the genetic algorithm by introducing too much randomness for
the other simulated evolutionary processes to function.
Three mutation rates, 0.01 (1 % mutation chance), 0.001 and 0.0001, were
compared and the results are shown in Figure 5.13A. The highest mutation
rate performed very poorly, with much higher error values than the lower mu-
tation rates. The total number of genes in each chromosome for this dataset
was 132. This means that on average there would be 1.32 mutations per chro-
mosome, which has been of detriment to the genetic algorithm’s performance
when searching for a solution.
The difference between mutation rates 0.001 and 0.0001 is closer, and
though the average error is lower using lowest mutation rate, the standard
deviation is higher. To further investigate this, a histogram was plotted (Fig-
ure 5.13B), and here we can see that though the variability is greater for the
lowest mutation rate the distribution of the error values is better in compar-
ison to the 0.001 mutation rate.
There is additionally a small time benefit for using lower mutation rates,
as new values have to be generated less frequently. Upon testing, the 0.0001
mutation rate took 5 % less time to complete than the 0.001 mutation rate.
For these reasons, the 0.0001 mutation rate has been used throughout the
work presented in this thesis.
Population size
An important factor in the performance of a genetic algorithm is the pop-
ulation size, or number of chromosomes per generation. Larger population
sizes improve the chance that the solution to a problem can be constructed
from the initial population without having to rely on mutation to generate
appropriate genes. This comes at the cost of the run time of the program
as the amount of computation required scales linearly with the number of
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chromosomes which are to be processed.
In order to select an appropriate population size to use for experimental
data the lysozyme dataset was tested again. Uniform crossover was used with
a 0.0001 mutation rate for a variety of population sizes. The algorithm was
run for 200,000 generations and each result was replicated six times using
different random number seeds, the results are shown in Figure 5.14.
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Figure 5.14: Optimising the population size for experimental
lysozyme data. The algorithm was run for 200,000 generations and
the error for each population size (as coloured in legend) was checked
every 50,000 generations. The error bars show the spread of 2 stan-
dard deviations, and the inset is a magnification of the main figure.
The smaller population sizes, 50, 500 and 1,000, all perform substantially
worse than 2,000 and 8,000. The difference between population sizes 2,000
and 8,000 is much smaller. The larger population does consistently perform
better but it may not be worth the additional computation time.
Though the amount of computation required scales linearly to the popu-
lation size with double the population size requiring twice the computation,
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it may not be reflected in the increase in processing time as the Challenger
algorithm has been massively parallelised using a GPU. Testing the time in-
crease between population sizes of 2,000 and 8,000 showed that a population
size of 2,000 takes 26.5 % of the time taken to process the larger population.
As a rough cost-benefit analysis, the error at 50,000 generations for 8,000
population size can be compared to the error at 200,000 generations for the
2,000 population size, as the computation time would be approximately equal.
The average error for the smaller population was 76.5 against 100.8 for the
population size of 8,000. This reason led to the use of a population size of
2,000 for the figures presented in this thesis, however the algorithm had to
be run hundreds of times, so when trying to get the best fit possible, higher
population sizes should still be considered.
Number of generations
The algorithm runs for a certain number of rounds of simulated evolution,
with each round known as a generation. The error from one generation to the
next never worsens, due to elitism, where the best chromosome from the last
generation is retained.
Generation Error ∆Error
0 5,587.1 n/a
50,000 106.4 -5,480.7
100,000 95.0 -11.4
150,000 85.1 -9.9
200,000 77.8 -7.4
Table 5.2: Table showing the average error and the change in error
over the previous 50,000 generations for the population size of 2,000.
data are taken from Figure 5.14.
The comparison of the effect of generations is shown in Figure 5.14. Gener-
ation 0 indicates the error for the fittest chromosome in the starting popula-
tion, and the biggest reduction in error is shown in the first 50,000 generations.
Table 5.2 shows the reduction in error from each additional set of 50,000 gen-
erations, and it shows that though the initial decrease in error is the largest,
there is still consistent improvement until 200,000 generations. This indicates
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that the algorithm could still achieve a lower error, and the result of this
test is that when running the algorithm it is preferable to run it for as many
generations as possible.
On the computer used for these calculations, it takes approximately 1 hour
to run using the optimum settings shown here for 200,000 generations and 15
minutes for 50,000 generations.
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5.3.5 Experimental data deconvolution
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Figure 5.15: Deconvolution, abundance analysis and comparison to
summary statistics of lysozyme gas-phase unfolding. (A) Deconvo-
luted ATDs, experimental data are shown in black and the simula-
tion is red, individual conformations are coloured the same through-
out the figure. (B) Conformational abundance analysis as area cal-
culated from the deconvolution. (C) Conformational abundance de-
termined using peak height analysis. (D) The results of the summary
statistic analysis with the unfolding curve (weighted mean) in red
and the variability curve (weighted standard deviation) in blue.
Using the optimised settings outlined in Section 5.3.4 and running the
algorithm for 100,000 generations on the lysozyme dataset has yielded the
data shown in Figure 5.15.
The deconvoluted arrival time distributions are shown in Figure 5.15A. All
of the deconvoluted conformations summed together create simulated ATDs,
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which are shown in red and show good agreement with the original experi-
mental data, coloured black. The abundances of each conformation are dis-
played in Figure 5.15B, in terms of relative conformational abundance. That
is the proportion of summed area of all conformations determined by the ge-
netic algorithm for a particular ATD. Additionally the relative abundance as
calculated from peak heights (Figure 5.15C) are shown with the results of
summary statistics analysis shown in Figure 5.15D.
To assess the number of conformations which were used, the deconvoluted
arrival time distributions should be inspected. An indication that there have
not been enough conformations fitted is that there are intensity regions in
the arrival time distribution which are not present in the simulated data. An
example of this is the extended conformation, which appears as a peak shoul-
der, seen in Figure 5.16A. The opposing scenario is when several simulated
conformations are fit to a single experimental feature and would be known as
overfitting. An example of overfitting is shown in Figure 5.16B, where there
are two or three conformations present in the data, but eight conformations
have been fit.
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Figure 5.16: Examples of an experimental ATD (black) with poor
fits. (A) A single conformation is fit resulting in a large difference in
the simulated (red) and experimental data. (B) The data has been
fit with 8 conformations, though the simulated and experimental
data are very similar, there are many individual conformations (other
colours) fitting to each single feature in the experimental data, which
is known as overfitting and is unlikely to be a true representation of
the conformational families that combine to make an experimental
ATD.
The deconvolution shown in Figure 5.15 simulated four conformations. By
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examining the Figure 5.15A, it can be seen that there are no unidentified
features in the ATDs, and there are not multiple very close together or low
intensity conformations. Thus we can conclude that this is a good fit.
The conformational abundance analysis from the lysozyme deconvolution,
using deconvoluted peak areas and peak top intensity are shown in Figure
5.15B and C respectively. The data show that the most closed conformation
(grey) is overrepresented consistently after the lowest voltage, and is due
to the conformation overlapping with a more open conformation (blue). At
the highest collision energy, the blue conformation is represented the most
abundant, whereas the deconvolution shows that it is the second scarcest
conformation.
The unfolding and variability curves are included in the figure (Figure
5.15D) to compare with the results for conformational abundance via decon-
volution (Figure 5.15B). In Section 5.3.2, it was proposed that the continually
increasing level of unfolding and conformational variability could be due to the
protein occupying more conformations as the collision energy increased, and
that as the variability was still high, the protein would not have converged on
a particular structure. The conformational abundance analysis shows these
statements to be true, as the collision energy increases, additional conforma-
tions are detected (purple and green). The protein has not converged on a
single conformation by the end of the collision energy ramp, with four con-
formations being present, three of which make up over 20 % each of the total
abundance, and the most abundant conformation makes up less than 50 % of
the total area of the ATD.
5.3.6 Algorithm limitation
The determination of peak centres by the algorithm is not always perfect.
Difficulties arise when many ATDs are very similar, the result of this is that
there is a bigger advantage to solving the fit for that region as opposed to
areas of intensity which only occur in a few ATDs. An example of this is
shown using the β-lactoglobulin dataset in Figure 5.17.
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Figure 5.17: Demonstration of a limitation of the deconvolution al-
gorithm when analysing data with many similar ATDs. (A) The
β-lactoglobulin unfolding dataset as ATDs. (B) The deconvolution
result, with experimental data shown in black, simulated data in red,
and individual conformations using different colours.
With this dataset, 10 of the 16 ATDs are very similar (280-640 eV ), and the
algorithm has fitted these ATDs very well. The four lowest collision energy
ATDs look to require three conformations in order for them to be fit correctly,
and the algorithm has only assigned one (grey).
The summary statistic results in Section 5.3.2 show that there is little
change to the degree of unfolding or conformational variability after 300 eV .
In conjunction with the incidence of very visually similar ATDs after that
point, we can remove some of those ATDs from the analysis without losing
information.
The ATDs from 400 eV and above were removed from the dataset, and the
Challenger algorithm was run again. The results are shown in Figure 5.18,
and the fitting to the ATDs is much better. There is no overfitting in any
areas, and all key features of the dataset are described appropriately with
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simulated conformations.
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Figure 5.18: Deconvolution of a reduced β-lactoglobulin dataset. (A)
Deconvoluted arrival time distributions coloured as in Figure 5.17.
Abundance analysis using deconvoluted areas of each conformation
(B) and the peak top intensity (C). (D) Summary statistic analysis of
the dataset with unfolding curve shown in red and variability curve
in blue.
The comparison between peak areas (Figure 5.18B) and heights (Figure
5.18C), once again show that overlapping peaks cause distortion in the re-
ported abundance for the peak height method. This is evident in the com-
parison between the two most closed conformations (grey and blue) at lower
energies. The variability curve of β-lactoglobulin (Figure 5.18D), shows rises
to a peak at 100-200 eV , and then falls. This phenomenon would be predicted
to be caused by an unfolding event, where multiple species are present, before
converging towards fewer conformations. This can be confirmed by examining
Figure 5.18B, at low collision energies there is a single predominant conforma-
tion, at 100-200 eV there are four conformations present. Finally, the protein
converges to two conformations, with the three most closed conformations
having abundances near to 0 %.
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5.3.7 Current software development state
The summary statistic algorithms, originally accessed as a Python library,
has now had a graphical user interface (GUI) developed for it. This allows
users to quickly and easily create CIU fingerprints, a table of results and
the unfolding and variability curves introduced in this chapter and can be
seen in Figure 5.19. The table of results gives the output of the summary
statistic calculations so that users can create plots with their favourite plotting
program. The data can be calibrated to CCS using an Amphitrite calibration
file and data can be provided in comma separated value (CSV) format.
Figure 5.19: Graphical user interface for calculating summary statis-
tics and CIU fingerprints from unfolding data.
For the Challenger algorithm, users can create a simple Python script in
order to run the analysis. There are several input parameters and so a GUI
has not yet been created. An example script is shown below.
import challengerClasses.RunChallenger as RunChallenger
# ================
# Setting input variables
popSize = # Population size
nGens = # Number of generations to run
nGauss = # The number of conformations to be fit
nAtds = # Number of ATDs in the input data file
repBak = # How often, in generations, the algorithm should report back progress
crossover = # 0 for uniform crossover, 1 for one point cross over
mutationRate = # Mutation rate e.g. 0.01 for 1 % of alleles mutated each generation
dataFn = # Filename/path of input data
outputDir = # Path to directory to store results
seed = # Random number generation seed. False to not use a seed.
# ================
# Setup, compile and run
ob = RunChallenger.ChallengerSetup(popSize,nGens,nGauss,nAtds,repBak,crossover,mutationRate)
ob.compile()
ob.run(dataFn,outputDir,seed)
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5.4 Conclusion
This chapter has introduced a method of summarising an ATD to two values,
weighted mean and weighted standard deviation. This approach has been
shown to be more representative of the original data than using the peak
apex method, by including information about secondary conformations and
the amount of total conformational variability. This is achieved whilst still
maintaining the quantitative nature of the data. This contrasts to the recently
introduced CIU fingerprint technique for analysing unfolding data, which is
a qualitative visual data representation technique, potentially leading to sub-
jectivity in analysis. CIU fingerprints are still a complimentary technique to
summary statistic analysis, so the software presented is able to automatically
generate figures for CIU fingerprints, unfolding curves and variability curves.
A method of automating the data acquisition for gas-phase unfolding ex-
periments has also been introduced. This allows the instrument to be used
continuously, acquiring unfolding data for many analyte mixtures. This makes
the tool amenable to high-throughput drug discovery experiments. The sum-
mary statistic analysis is well suited to this environment due to its quantitative
nature. Target values for degree of unfolding (∆CCS) and variability can be
set for different collision energies. During the high-throughput screening pro-
cess, each new ligand could be analysed automatically. If a ligand meets the
target values set, then it could be selected to be examined in greater detail
using the Challenger algorithm.
The Challenger algorithm presented here is the first program developed
for the deconvolution of IM-MS arrival time distributions. The results have
shown that it allows for a more accurate determination of the abundances
of individual conformations than using peak intensity. The algorithm also
computes the centre of each conformation, which is likely more accurate and
reproducible than operators selecting peak apexes by eye.
The results of the deconvolution can be used in a wider variety of data
analysis applications than have been covered here. One such example would
be the deconvolution of CIU fingerprints as shown in Appendix 5.22. This
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gives a visual representation of the conformational variability (as width) of
each conformation as well as intensity during the course of the unfolding ex-
periment. It is preferable to the standard CIU data representation technique
as each conformation can be seen clearly and overlapping conformations do
not exhibit increased colour intensity.
It has been shown that the limitation of the Challenger algorithm covered
in Section 5.3.6 can be overcome by removing large numbers of highly similar
ATDs. A potential future solution for this problem would be to break the
deconvolution process into two parts. The set of ATDs could be grouped
using a similarity method, and a single ATD would be taken from each group.
These ATDs would then be analysed using the standard Challenger algorithm,
giving accurate determination of the centres of conformations present. The
analysis would be fast as there would be less data to analyse. With the
peak centres determined, a second round of deconvolution using the whole
set of ATDs would be performed where the peak centres are not fit. This
would greatly reduce the potential combinations of genes, leading to shorter
computation times in comparison to the full Challenger algorithm. As a proof
of principle the full β-lactoglobulin dataset was deconvoluted using static peak
centres and the results can be seen in Appendix 5.21. The approach fixed the
issue with all the simulated and experimental data being very similar and the
second round of deconvolution only took 15 minutes to complete.
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Figure 5.20: Challenger algorithm deconvolution of myoglobin.
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Figure 5.21: Deconvolution of β-lactoglobulin data when not fitting
for conformational centres.
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Figure 5.22: Using results of the Challenger algorithm to deconvo-
lute lysozyme CIU fingerprints. (A) The CIU fingerprint. (B-E)
Deconvoluted CIU fingerprints, with plot for each conformation (the
conformation centre is labelled). (F-I) The same data as (B-E), but
the y axis is the change in arrival time from the centre of the confor-
mation, which is useful for observing the conformational variability.
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α1-antitrypsin
This thesis has introduced several new method of the data analy-
sis and representation of ion mobility mass spectrometry data. To
demonstrate the efficacy of these methods, they have been applied
to new research on the α1-antitrypsin system here.
6.1 Introduction
α1-antitrypsin is a member of the serpin (serine protease inhibitor) super-
family. The superfamily is homologous with similar tertiary structures; the
proteins are composed of three β sheets, nine alpha helices and a reactive cen-
tre loop (RCL) as shown in Figure 6.1 [2]. The proteins function by binding a
protease to the reactive centre loop where one end of the RCL is cleaved from
the protein by the protease between the P1 − P ′1 residues and the P1 residue
forms a covalent bond with the substrate enzyme. The reactive loop is then
free to move and inserts into the central position in β sheet A between the
two parallel strands 3 and 5 (s3A and s5A) as a strand in the anti-parallel
direction (s4A) completing the anti-parallel β sheet [3]. This mechanism con-
comitantly pulls the substrate to the opposite end of the serpin sheet which
disrupts the catalytic site and inhibits the activity of the protease. The apo
protein is metastable with thermal stability up to 50-60 °C, conversely the
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Figure 6.1: X-ray crystallography structure of α1-antitrypsin, with
secondary structure elements labelled. Helices are labelled hx where
x indicates which helix. Strands are labelled with the format snx
with x representing the β-sheet the strand belongs to and n being
the strand number. Figure adapted from [1].
inhibitor-substrate complex is stable to over 100 °C [2]. These proteins are of
specific research interest due to the ability to form highly stable aggregates
due to point mutations. In this field aggregation is referred to as polymeri-
sation and the disease state is caused by the homopolymerisation of serpins
and the diseases are collectively referred to as the serpinopathies [4].
6.1.1 Pathology of severe α1-antitrypsin deficiency
α1-antitrypsin is the most abundant protease inhibitor found in plasma un-
der normal conditions (1-2 mg/ml) [5, 6]. It was first discovered in 1955 [7]
and was linked to emphysema and liver disease in 1963 [8] and 1969 [9] re-
spectively. These features are now known to be caused by polymerisation of
α1-antitrypsin.
α1-antitrypsin is predominantly synthesised in the endoplasmic reticula
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of hepatocytes. In the case of severe α1-antitrypsin deficiency, the protein
forms linear polymer chains which then form Schiff positive inclusions bodies,
which accumulate within the hepatocyte compromising function and inducing
cell death [2]. The increased apoptotic rate of hepatocytes can then lead to
cirrhosis of the liver [9] and neonatal hepatitis [10].
The primary target of α1-antitrypsin is neutrophil elastase, an acute phase
serpin protease which can kill gram-negative bacteria [11]. However its broad
specificity means that it can also attack host tissue [11]. Without the in-
hibitory protection of α1-antitrypsin due to retention in hepatocytes the un-
controlled proteolytic activity can cause damage to lung tissue leading to early
onset panlobular emphysema [12].
6.1.2 Naming of α1-antitrypsin variants
It was discovered early on that there were numerous α1-antitrypsin variants,
and so the Pi (protease inhibitor) test was created to determine what the effect
of different variants would be [13]. The variants are given letters dependent on
their mobility in isoelectric focusing gel electrophoresis; F for fast mobility, M
for medium, S for slow and Z for very slow [13–15]. F bands are rare and are
caused by a more closed conformation of the protein, and patients carrying
such a form of α1-antitrypsin can also develop lung disease [16]. M bands are
where protein with the wild type genotype is found (M is glycosylated and
so wild type is used in reference to the non-glycosylated form). Proteins in
the S band are mildly polymerogenic and are of high abundance in southern
European populations [17], and it is rare for carriers to show symptoms [18].
The homozygous Z allele is responsible for severe α1-antitrypsin deficiency
and is caused by the mutation E342K, which is positioned at the top of β-
sheet A where it disrupts a salt bridge (E342 - K290), thereby disrupting the
structure of the protein and promoting polymerisation. The mutation is car-
ried heterozygotically by approximately 4 % of people of Northern European
descent and 1 in 2,000 are homozygous [14].
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6.1.3 Treatment of severe α1-antitrypsin deficiency
10-13 % of patient mortality from severe α1-antitrypsin deficiency is due to
liver cirrhosis [12, 17]. Currently there is no treatment for the build up of
polymers in the liver. When the liver fails, patients undergo liver transplan-
tation with a 5 year survival rate of 83 % [19]. As the liver is taken from a
patient who does not carry the Z allele, the treatment cures α1-antitrypsin de-
ficiency as the transplanted liver produces M α1-antitrypsin giving adequate
protection to lung tissue [19].
Respiratory failure is responsible for 50-72 % of deaths caused by α1-
antitrypsin deficiency [12, 17, 20]. This issue normally initially manifests
as chronic obstructive pulmonary disease (COPD), and treatment for this is
the same as with non-α1-antitrypsin related disease, such as influenza vaccina-
tions, bronchodilators and oxygen administration [21, 22]. These therapeutic
strategies however, do not treat the underlying cause that is lack of function-
ing α1-antitrypsin.
A direct treatment for COPD caused by α1-antitrypsin deficiency involves
transfusion of purified and pooled human plasma α1-antitrypsin. This was
suggested as a treatment in 1981 [23], and was approved by the United States
Food and Drug Administration (FDA) for use as treatment in 1987 [24]. The
effectiveness of this treatment is questionable and the governments of many
other countries, including the UK, have still not granted a licence [25].
The augmentation therapy is administered weekly as a 60 mg/kg infusion
[26]. This is said to increase the blood concentration to a protective threshold
of 11 µmol/L which prevents emphysema by adequately controlling levels of
neutrophil elastase [27]. This replacement therapy does not however remedy
the build up of polymers in hepatic cells and the associated cirrhosis.
6.1.4 Evolutionary benefit of α1-antitrypsin deficiency
The Z mutation is of higher prevalence than would happen by chance [28] and
this indicates that there is likely an evolutionary benefit to the allele. It has
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been shown that patients carrying the Z allele display an increased inflamma-
tory response [28]. This could reduce the mortality risk from infections, and
thereby increase the life span of carriers.
Inflammation is an endogenous response to infection and so causes upregu-
lation of acute-phase proteins such as α1-antitrypsin. The liver produces more
protein, which increases the concentration of α1-antitrypsin at the site of in-
flammation. This effect is amplified as the lungs [29] and gut [30] can both
produce α1-antitrypsin and are the two most common sites for pathogenic
invasion. The inflammation response also causes an increase in temperature
and a lowering of pH. These two factors in combination with the increase in
α1-antitrypsin concentration cause an increase in the propensity for Z mutant
α1-antitrypsin to polymerise [31], resulting in polymer formation at the site
of infection [32]. These polymers are a chemoattractant for cytokines and
other inflammatory response proteins creating a positive feedback loop and
amplifying inflammation [33, 34].
The increased inflammatory response leads to a lower probability of infec-
tions spreading. In 1928, Alexander Fleming discovered penicillin, prior to
this the most common cause of death was due to infections. In 1900, 40 %
of deaths in the USA were caused by gastroenteritis, tuberculosis, pneumonia
and influenza [28], and so reduced risk of infection would be a highly beneficial
trait.
The deleterious nature of α1-antitrypsin deficiency has been amplified due
to the dramatic reduction in mortality caused by infection, and it wasn’t
until the 1960’s that α1-antitrypsin deficiency was discovered and linked to
emphysema and liver disease [8, 9].
During the 19th century the average life expectancy was 43 years in the USA
[28], thereby precluding the risk factor of contracting emphysema (median
age for detection of emphysema in ZZ patients is 53 for non-smokers [12]) as
half the population would not live to the age where this risk factor becomes
significant. A large exacerbating factor for α1-antitrypsin deficiency derived
emphysema is tobacco smoking which was also a recent introduction in the
context of evolutionary time scales [35].
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Infant mortality during the 19th century was over 10 % in the UK [36],
whereas the risk of mortality during childhood due to ZZ α1-antitrypsin defi-
ciency induced liver disease is only 1-2 % [28].
These factors combined show that in the pre-antibiotic era, the Z mutation
could be of more benefit than harm, explaining the high prevalence of this
allele.
6.1.5 Loop-sheet polymerisation model
Figure 6.2: The α1-antitrypsin loop-sheet model of polymerisation.
The reactive centre loop (RCL) is coloured red and β-sheet A is
coloured blue. (left) The native conformation of α1-antitrypsin, the
position of the Z mutation is shown by the arrow head, and the
numbering of the strands of β-sheet A are also shown. (middle)
Pre-polymerisation intermediate conformation of α1-antitrypsin, the
RCL is partially inserted into β-sheet A. (right) The classical
model of polymerisation showing the interaction between two α1-
antitrypsin molecules. Figure adapted from [37].
The ‘classical’ model for polymerisation involves the RCL (loop) of one
molecule inserting into the centre of β-sheet A (sheet) of another, between
β-strands s4A and s5A, mimicking the native interaction with a protease and
consequently creating highly stable polymers (Figure 6.2). As this interaction
leaves the RCL of the second molecule exposed, it is able to bind into the
β-sheet of the next protein allowing for linear chains of polymers as seen
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in electron microscopy images [38]. The Z mutation destabilises β-sheet A
of the molecule facilitating the occupation of an intermediate conformation
(M*) [38] and allowing the insertion of the reactive centre loop [31, 39].
The validity of this model was supported by an X-ray crystallography struc-
ture of α1-antichymotrypsin in an intermediate M* state similar to the α1-
antitrypsin conformation shown in Figure 6.2 (centre). The protein was the
mutant form Leu-55-Pro, which is known to polymerise [40]. This model was
uncontested until a crystal structure of a serpin polymer was published in
2008 [41].
6.1.6 β hairpin polymerisation model
Figure 6.3: β hairpin model of serpin polymerisation. Antithrom-
bin molecules are coloured grey and green, the grey models have
β-sheet A coloured red and the reactive centre loop coloured yellow.
Shown are a X-ray crystallography structure of a self-terminating
antithrombin dimer (A), and a model for how linear polymers could
be created with this linkage. Figure adapted from [41].
The β hairpin polymerisation model involves a more extensive domain swap
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than in the loop-sheet model. α-helix I is unfolded which allows β-strand s5A
to form a β-hairpin with the RCL. This protruding hairpin can then insert
into β-sheet A of another molecule by displacing s5A [41], as shown in Figure
6.3.
The polymerisation model was extended to α1-antitrypsin from an X-ray
crystallography structure of a different serpin, antithrombin. The structure
was of a wild type antithrombin dimer, and polymerisation was achieved using
low pH as a denaturant. The dimer was self-terminating (Figure 6.3A), but
a model was also produced to show how linear polymers could form (Figure
6.3B).
2C1 is a monoclonal antibody which was raised to bind to Z mutant ex
vivo polymers which were extracted from the livers of patients. It has been
shown that this antibody also binds to M α1-antitrypsin polymers which are
created by heating the protein [37, 42]. A study in 2009, largely discredited
the β hairpin polymerisation model for α1-antitrypsin as these polymers did
not bind 2C1. An additional ion mobility mass spectrometry analysis was
conducted where heated M polymer CCS was compared to molecular models
of the loop-sheet and β hairpin. As the M protein is glycosylated and the
models were void of glycosylates, the experiment compared the percentage
change in CCS from monomer to dimer rather than the absolute CCS values.
The results showed that the percentage increase in CCS for the experimental
data (174 %) was close to that of the loop-sheet model (176 %), but the
increase was substantially larger for the β hairpin model (225 %) [37].
6.1.7 C-terminal domain swap polymerisation model
Following the β hairpin model, Yamasaki et al. published a crystal structure
demonstrating a new mechanism for α1-antitrypsin polymerisation consisting
of a C-terminal domain swap [43]. In this model the β-strands s4B, s5B
and s1C which are on the back of the protein in relation to β-sheet A are
not folded as in the native protein structure. Instead β-strands s4B and
s5B form a β hairpin which then fill their equivalent positions in another α1-
antitrypsin molecule (Figure 6.4). The increase in the stability of the polymer
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A B C
Figure 6.4: X-ray crystallography structure of a self-terminating α1-
antitrypsin trimer displaying the C-terminal domain swap model
(A). Additionally shown is a model for how linearised polymers could
form (B). (C) Labelled structure, coloured from N-C terminus as blue
to red. Strands in β-sheet A are numbered. Figure adapted from
[43].
occurs through insertion of the RCL into the centre of β-sheet A, mimicking
the interaction with proteases. It is proposed that this fold would not occur
spontaneously, rather polymers would occur during protein folding, with the
coupling being made before β-sheet C had folded.
In order to create the X-ray crystallography structure, the researchers mu-
tated residues on β-strands s5A (cysteine 292) and s6A (cysteine 339), to allow
the formation of a disulphide bond holding these two strands together. This
created short polymers which were resistant to further elongation and were
able to be crystallised. These polymers were additionally found to bind to the
2C1 antibody, supporting the model as the physiological polymer structure
[43].
6.1.8 Peptides block polymerisation
Blocking the polymerisation of α1-antitrypsin would alleviate the pathogenic
effects within liver cells. For this reason small molecules [45] and peptide ho-
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Figure 6.5: Proposed model for Ac-TTAI-NH2 binding with α1-
antitrypsin. Figure reproduced from [44].
mologs of the RCL [46] have been produced which target the RCL insertion
point for polymerisation. Previously the shortest peptide shown to block poly-
merisation was a 6-mer [47]. Following this a tetrapeptide was found which
had similar efficacy to the 6-mer [48], the importance of reduction in peptide
length is due to the increased pharmacological significance as a potential drug
molecule. The same group in 2009 used a combinatorial chemistry approach
and the tetrapeptide Ac-TTAI-NH2 was identified [49]. This molecule had
improved specificity and it was shown that a 2hr incubation in a 10:1 (pep-
tide:Z α1-antitrypsin) molar ratio was sufficient to achieve the binary complex
as probably the most abundant species. It was additionally shown that un-
der these conditions no M-peptide complex was detectable by polyacrylamide
gel electrophoresis (PAGE) [49]. The group has proposed a mechanism of
binding as shown in Figure 6.5, where a single Ac-TTAI-NH2 molecule binds
in the centre of β-sheet A through a similar mechanism as with the native
interaction with a protease increasing the thermal stability of the molecule
[44].
6.1.9 Aims
This chapter aims to investigate the interaction between α1-antitrypsin and
Ac-TTAI-NH2 using the tools introduced in this thesis. These studies will
then be able to provide further information towards the feasibility of testing
putative drug molecules using wild type, M and Z α1-antitrypsin as well
as in a high throughput environment. Finally, the different polymerisation
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mechanisms will be investigated with Z polymers extracted from human liver
using ion mobility mass spectrometry.
6.2 Methods
6.2.1 Sample sources
β-lactoglobulin from bovine milk and concanavalin A from Canavalia ensi-
formis were purchased from Sigma Aldrich (St. Louis, MO). Ac-TTAI-NH2
was ordered from Pepceuticals (Leicester, UK).
6.2.2 Recombinant α1-antitrypsin expression and pu-
rification
The α1-antitrypsin gene, encoded in cDNA with a 6*HisTag, was ligated
into the pQE31 plasmid vector (kindly provided by Dr. Nyon) and trans-
formed into BLT-21 where gene expression is inducible through the addition
of isopropyl β-D-1-thiogalactopyranoside (IPTG). Once optical density of the
culture at OD600 reaches 0.6, protein expression was induced through the ad-
dition of 1 mM IPTG and incubated for 8 hours at 30 ◦C to maximise protein
expression. Cells were pelleted through centrifugation and resuspended in a
solution of sodium phosphate buffer (10 mM, pH 8.0), NaCl (0.5 M), and im-
idazole (20 mM) before exposure to a cell disruptor where lysis released the
expressed product. Centrifugation was used to remove the insoluble cellular
debris and the supernatant containing any soluble protein was loaded directly
onto a HisTrap Crude FF column (5 ml; GE Healthcare), then washed and
eluted using increasing concentrations of imidizole ranging from 20 mM – 200
mM. In order to concentrate and further purify the protein, the fractions re-
leased from the column were subject to dialysis in 10 mM Tris, pH 8.0, 1 mM
EDTA, and 1 mM β-mercaptoethanol before a final filtration when loaded
onto a a HiTrap-Q Sepharose column (5 ml; GE Healthcare). Incremental
concentrations of NaCl from 0-0.5 M were used to elute the his tagged prod-
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uct and fractions were collected and combined before another stage of dialysis
against 25 mM Na2HPO4, 50 mM NaCl and 1 mM EDTA at pH 8.0.
6.2.3 Ac-TTAI-NH2 α1-antitrypsin titration
α1-antitrypsin was buffer exchanged into 250 mM ammonium acetate (pH 7)
by 3 rounds of dilution-concentration with 10 kDa Millipore Amicron Ultra
centrifuge filters. The protein concentration was then determined using a
Qubit 2.0 fluorometer. Two Ac-TTAI-NH2 stocks were made at 30 µM and 250
µM to minimise error from pipetting small volumes. The α1-antitrypsin was
aliquoted, peptide was added at relevant volume and the samples were diluted
with 250 µM ammonium acetate to a final α1-antitrypsin concentration of 15
µM in 100 µL. Samples were then incubated for 72 hours at 37.5 ◦C before
analysis. The mass spectrometer settings used are shown in Table 6.1.
Setting Titration Plasma Z Oligomers
Capillary Voltage 1.2 kV 1.1 kV 1.0 kV
Sampling Cone 45 V 40 V 50 V
Extraction Cone 1 V 1 V 1 V
Source Temperature 40 ◦C 40 ◦C 40 ◦C
Trap Collision Energy 6 V 6 V 20 V
Transfer Collision Energy 4 V 4 V 10 V
Trap Pressure 1.5x10−2 mbar 1.5x10−2 mbar 2.5x10−2 mbar
Bias 4 V 4 V 4 V
Backing Pressure 0.21 mbar 0.21 mbar 0.545 mbar
Table 6.1: Mass spectrometer settings used for; Ac-TTAI-NH2 α1-
antitrypsin titration experiments, Z α1-antitrypsin extracted from
plasma, and M and Z oligomer experiments.
6.2.4 Ac-TTAI-NH2 α1-antitrypsin unfolding experi-
ments
α1-antitrypsin dissolved in 25 mM Na2HPO4, 50 mM NaCl and 1 mM EDTA
at pH 8.0 at a concentration of 1.5 mg/ml was incubated with Ac-TTAI-NH2
in 20 mM ammonium acetate at a 20:1 peptide to protein molar ratio for
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20 hours. The protein was then buffer exchanged into 150 mM ammonium
acetate (pH 7.4) using a BioRad BioSpin column followed by 2 rounds of
dilution-concentration with 10 kDa cut-off Millipore Amicron Ultra filters.
Samples were then analysed after quadrupole isolation of the +13 charge
state of the apo and double bound forms of the protein. The ion mobility
mass spectrometry calibration curve was determined using β-lactoglobulin
monomer and dimer as well as concanavalin A tetramer. The mass spectrom-
eter settings used are shown in Table 6.2.
Setting Unfolding Z Oligomers
Capillary Voltage 1.1 kV 1.0 kV
Sampling Cone 30 V 50 V
Extraction Cone 1 V 1 V
Source Temperature 40 ◦C 40 ◦C
Trap Collision Energy Variable 20 V
Transfer Collision Energy 10 V 10 V
Trap Pressure 5 x10−2 mbar 5 x10−2 mbar
Mass Range 1,000-8,000 m/z 1,000-16,000 m/z
Bias Voltage 20 V 20 V
Backing Pressure 0.42 mbar 0.545 mbar
IM Wave Height 10 V 10 V
IM Wave Velocity 350 m · s−1 350 m · s−1
Transfer Wave Height 8 V 8 V
Transfer Wave Velocity 150 m · s−1 100 m · s−1
IMS pressure 5.20x10−1 mbar 5.20x10−1 mbar
LM/HM Resolution 5/15 15/5
Table 6.2: Ion mobility mass spectrometry settings used for Ac-
TTAI-NH2 α1-antitrypsin gas-phase unfolding experiments and
oligomeric Z α1-antitrypsin extracted from hepatocytes.
6.2.5 M polymer preparation
Monomeric M protein was kindly donated by Dr. Imran Haq who extracted
the protein from healthy human patient plasma. Polymers were created in
vitro by incubating 0.5 mg/ml purified protein solutions under various con-
ditions. Heat induced polymers were incubated in a pH 7.4 solution of 10
mM Na2PO4, 100 mM NaCl and 0.02 % NaN3 at 50 ◦C for 48 hours. Acid
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induced polymers were formed by incubating at 25 ◦C for 7 days in a 0.1
M solution of sodium acetate at pH 4.8. Urea denaturing induced polymers
were created by incubating for 14 days at 25 ◦C, in pH 8.0 solution of 40 mM
Tris containing 4 M urea. Guanidine hydrochloride (GuHCL) was also used
to create polymers, the protein was incubated for 11 days at 25 ◦C in pH 8.0
Tris in addition to 3 M GuHCL.
The polymers were then fractionated using size exclusion chromatography,
and the fractions were assessed for degree of polymerisation with polyacry-
lamide gel electrophoresis. Fractions with high levels of polymerisation were
selected, pooled and dialysed into 5 litres of pH 7 150 mM ammonium acetate
for 48 hours.
Before MS analysis the samples were concentrated, diluted and concen-
trated again with Millipore centrifuge tubes and pH 7 150 mM ammonium
acetate.
6.2.6 Glycosylated ion mobility Z α1-antitrypsin exper-
iments
Z mutant ex vivo polymers were provided by Sarah Faull. In brief the liver
tissue was removed from disease state liver after a patient transplant. Af-
ter filtration to remove fibrous tissue, the inclusion bodies were separated
using sucrose gradient fractionation. The inclusion bodies were ruptured us-
ing sonication, releasing the soluble α1-antitrypsin polymers. Finally ultra-
centrifugation was used to separate insoluble protein and debris, with the
protein removed as supernatant. The protocol is described in greater detail
elsewhere [50, 51].
To prepare the sample for mass spectrometry analysis, the protein was
first dialysed into 5 litres of 200 mM ammonium acetate at pH 7 for 48 hours.
The sample was then filtered with Corning Costar (NY, USA) Spin-X 0.22 µM
centrifuge tubes to remove debris before an additional step of buffer exchange
using a BioRad BioSpin tube, and finally concentrated using a 50 kDa cut off
Millipore Amicron Ultra centrifuge tube. The ion mobility calibrants used in
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the analysis were monomeric and dimeric β-lactoglobulin and concanavalin A
tetramer, and the mass spectrometer settings are shown in Table 6.2.
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6.3 Results and discussion
6.3.1 Ac-TTAI-NH2 titration with wild type α1-antitrypsin
The interaction between Ac-TTAI-NH2 and the Z mutant is thought to mimic
the interaction with the reactive centre loop (RCL) of α1-antitrypsin, thereby
stabilising the protein as in its native interaction with proteases. Previ-
ous studies have found that Ac-TTAI-NH2 does not bind to wild type α1-
antitrypsin [48, 49], presented here is evidence to the contrary.
Figure 6.6: Deconvolution of the 0.3:1 peptide to protein mass spec-
trum using the Amphitrite Atropos graphical user interface. The
individual deconvoluted components are shown; apo (grey), single
bound (blue) and double bound (purple). The sum of the simulated
parts is shown in red and the original experimental data are black.
Figure 6.6 shows a mass spectrum of wild type α1-antitrypsin after being
incubated for 3 days at 37 ◦C with Ac-TTAI-NH2. The wild type protein has
bound to the Ac-TTAI-NH2 with a stoichiometry of 2:1 (ligand:protein). This
means that the current model for binding which involves a single Ac-TTAI-
NH2 molecule should likely be revised if the Z mutant binds similarly. The
finding could further support the hypothesis that the interaction mimics the
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interaction with the RCL.
During the interaction with a protease, a large groove is created and filled
by the RCL, which is evidenced by the X-ray crystallography structure in Fig-
ure 6.7 (1EZX.pdb). The reactive centre loop insertion is coloured alternately,
per residue, in red and orange and this representation shows that there are
11 RCL residues in the cleft. The finding that two 4 residue Ac-TTAI-NH2
molecules bind to α1-antitrypsin, as shown in Figure 6.6, further supports
the hypothesis that the molecules are binding in the cleft and mimicking the
protease interaction.
Figure 6.7: Crystal structure of α1-antitrypsin (blue) in complex
with a protease, trypsin (green). Additionally the reactive centre
loop has been coloured red and orange with the colour alternating
per residue (1EZX.pdb) [3].
These data suggests that the interaction is cooperative as the double bound
form is of higher abundance than the single bound form. To investigate this
further a titration was performed with varying Ac-TTAI-NH2 concentrations
and the results are shown in Figure 6.8.
The titration data shows that the single bound species is evidently less
abundant than the double bound species at Ac-TTAI-NH2 concentrations of
0.5:1 and above, further confirming the cooperativity of the interaction.
At the highest peptide concentration there is the appearance of an addi-
tional peak corresponding to the mass of one α1-antitrypsin and 3 Ac-TTAI-
NH2 molecules. The spectra were acquired straight after incubation and so
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Figure 6.8: Titration mass spectra of Ac-TTAI-NH2 and α1-
antitrypsin.
there was still a high peptide concentration in the buffer, potentially suggest-
ing that this additional interaction is non-specific. To reduce the contribution
of non-specific binding, after incubation the sample was concentrated and re-
suspended several times using a 10 kDa molecular weight cut off filter. This
amounts to a 10,000 fold dilution for unbound Ac-TTAI-NH2 (>500 Da), and
so it could be approximated that the final molar ratio of unbound Ac-TTAI-
NH2 to protein would be 0.003:1 and as seen in Appendix 6.24, this indicates
that it is highly unlikely that the interaction observed is due to non-specific
binding.
The process of dilutions with concentration columns changes the distribu-
tion of bound species as it changes the solution equilibrium. For this reason
the incubation had to be conducted in a mass spectrometry compatible buffer
(ammonium acetate). The interaction between Ac-TTAI-NH2 and wild type
α1-antitrypsin is very slow (see Appendix 6.23) and during the time taken for
the reaction to reach equilibrium, much of the protein precipitates due to the
ammonium in the buffer [52]. This means that the dissociation constant (Kd)
cannot be calculated for the interaction as the apo monomeric folded protein
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concentration ([P ]) needs to be known for the calculation (Equation 6.1) as
well as ligand concentration ([L]) and complex concentration ([PL]).
Kd =
[P ] · [L]
[PL] (6.1)
With the target of creating a framework for analysing new ligands which
could have faster reaction rates, it is still useful to assess the implementation
of the new methodology towards the determination of species abundance for
Kd calculations. Existing examples of estimating abundance for calculating
Kd values have used peak heights [53]. The problem with using peak heights
is demonstrated in Figure 6.9.
Figure 6.9: Synthetic data based on the 0.3:1 Ac-TTAI-NH2:α1-
antitrypsin mass spectrum (A). When analysing A using peak
heights, this graph shows the percentage error from the proportional
abundance of each of the bound states (B).
A native protein mass spectrometry peak consists of a single peak of the
unadducted protein as well as several n ·adduct+protein peaks which overlap
to form the overall peak seen in the mass spectrum. Different charge states
have different numbers of adduct peaks as lower charge ions have lower internal
energy in the mass spectrometer, which reduces the level of desolvation and
adduct stripping. For these reasons, it is correct to use the peak areas instead
of peak heights.
The second problem with using peak heights is that protein and ligand
peaks can overlap, often resulting in an overrepresentation of low abundance
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peaks which occur at the samem/z value as the peak shoulder of a larger peak.
To demonstrate this issue a synthetic mass spectrum was created using the
masses of α1-antitrypsin alone and with one and two Ac-TTAI-NH2 molecules
bound (Figure 6.9A). The difference between the areas of the components of
the synthetic data and the peak heights are shown in Figure 6.9B. The single
bound species is overrepresented by over 20 % as its peak height is increased
due to overlap with the apo and double bound species, concomitantly both
of the other species are underrepresented.
Figure 6.10: Deconvoluted abundances of Ac-TTAI-NH2, α1-
antitrypsin titration. Results are shown as a proportion of all three
states.
The peak areas can be deconvoluted using the mass spectrum fitting algo-
rithm of Amphitrite, and the results are shown in Figure 6.10. The double
bound species is more abundant than the single bound after a molar equiva-
lence of 0.2:1 once again confirming the cooperativity of the interaction. Due
to the precipitation of the protein during the long incubation time required
to reach equilibrium it is not possible to calculate dissociation constants Kd
using these data.
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6.3.2 Unfolding experiments
Now that it has been determined that wild type α1-antitrypsin binds to Ac-
TTAI-NH2, it would be beneficial to further characterise the interaction. It is
logical that the blocking of aggregation caused by Ac-TTAI-NH2 binding to Z
mutant α1-antitrypsin, would be as a result of the stabilisation of the protein.
This hypothesis is tested here, using gas-phase unfolding experiments and
the methodology outlined in Chapter 5. If the technique is able to determine
changes in stability caused by Ac-TTAI-NH2, it will be possible for the finding
to be used in future studies for screening putative drug molecules which block
α1-antitrypsin aggregation.
Figure 6.11: Stacked plot of arrival time distributions (calibrated to
CCS), for apo and holo α1-antitrypsin.
Existing data analysis techniques
After completing the automated unfolding experiment as described previ-
ously, the relevant information from the MassLynx raw files is extracted and
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converted to CCS using the Amphitrite software package. The CCSDs (cal-
ibrated ATDs) are displayed in Figure 6.11, the apo distributions appear to
generally be wider than for the holo protein, indicating Ac-TTAI-NH2 bind-
ing results in a reduction in conformational variability as a result of binding.
There also appears to be additional partially resolved peaks in the apo data,
further confirming the reduction in conformational variability.
These observations are generally self-evident from the graphs; however,
they are not quantitative and so it would be difficult to screen many putative
ligands, as it would require an operator to manually check the data. It is
also non-trivial to assess the extent of the unfolding from these plots, and
additional data analysis would be required to elucidate any changes.
Figure 6.12: Collision induced unfolding (CIU) fingerprint analysis
of apo and holo α1-antitrypsin gas-phase unfolding.
CIU fingerprint analysis was also carried out on the unfolding experiment
data, and is shown in Figure 6.12. Similarly to the stacked CCSD data rep-
resentation (Figure 6.11) it is axiomatic that the conformational variability is
greater for the apo protein. This is shown as the increased width of the distri-
butions along the CCS axis. Using this method however has lost the informa-
tion regarding the additional partially resolved peaks in apo α1-antitrypsin
CCSDs. Observing the difference between low and high energy regions for
each protein, it can be seen that the difference in peak top CCS is greater for
the Apo. This indicates that the interaction with Ac-TTAI-NH2 reduces the
amount the protein unfolds as well as reducing conformational variability.
As with the stacked CCSDs, this method is not quantitative and so it would
require a trained human to manually check whether a putative ligand was
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affecting the conformational stability and variability and so is not appropriate
for automated analysis.
Summary statistics
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Figure 6.13: Summary statistic analysis of apo and holo α1-
antitrypsin. Unfolding curves (A), variability curves (B), change
in CCS from lowest collision energy represented as an absolute value
(C) and as percentages (D).
The summary statistic analysis as introduced in the Chapter 5 was per-
formed on the data and the results are shown in Figure 6.13. Looking at the
average cross section of the bulk protein (Figure 6.13A) shows that the aver-
age cross section is higher at low energy (5 V) for the holo form of the protein
(3,176 Å2) versus the apo form (3,112 Å2). Contrastingly, as the collision en-
ergy increases the average CCS of the apo protein increases more readily with
similar values observed at the highest energies. To normalise for the higher
initial starting CCS of the holo protein, the difference (Figure 6.13C) or per-
centage difference (Figure 6.13D) in CCS from lowest collision energy can be
analysed. In both forms of the analysis, the change in CCS is less for the holo
form throughout the unfolding experiment, with the effect more pronounced
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in the percentage difference plot. This shows that the ligand interaction sta-
bilises the protein and reduces the extent to which it unfolds. The variability
curve is shown in Figure 6.13B, throughout the experiment the holo protein
has a lower standard deviation indicating reduced conformational variability.
As all of these results give numerical values, they can be represented in
tables as shown in Table 6.3 and 6.4. When screening putative drug molecules,
threshold values could be given for whether the molecule should be brought
forward for manual analysis. An example of this would be to select ligands
where at 30 V the percentage change in CCS is under 5 % and the standard
deviation is under 150 Å2.
30 V 50 V
Apo ∆CCS 6.46 % 18.52 %
Holo ∆CCS 4.44 % 16.24 %
Table 6.3: Table showing the change in CCS from the most native-
like analysis to a given collision energy as a percentage.
5 V 30 V 50 V
Apo σ CCS 94.02 Å2 170.60 Å2 145.93 Å2
Holo σ CCS 70.95 Å2 122.79 Å2 84.41 Å2
Table 6.4: Table showing the weight standard deviation values of
apo and holo α1-antitrypsin at 3 collision energies.
Multicomponent analysis
The confirmation that the Ac-TTAI-NH2 interaction stabilises α1-antitrypsin
has, so far, been observed on a bulk level. To understand what is happening
with individual conformations, the data was deconvoluted using the Chal-
lenger algorithm. The results are shown in Figure 6.14 and the CCS value of
the centre of each conformation is shown in Table 6.5. At low collision ener-
gies, the holo protein predominantly occupies a single conformation, whereas
the apo protein shows a high abundance of two conformations. This would
explain why the conformational variability is higher for the apo protein at low
energies (Table 6.4). At the two highest collision energies there are two similar
abundance conformations present for the apo protein whereas there is only
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Figure 6.14: Deconvolution of gas-phase unfolding data for apo (A)
and double bound (B) α1-antitrypsin. Experimental data are shown
in black, with the sum of the deconvolution in red. The deconvoluted
distribution of each conformation is shown with coloured lines and
the mean arrival time for each conformation is shown in Table 6.5.
The abundance analysis of each conformational family determined
by the deconvolution is shown for the apo (C) and holo (D) protein.
Arrival time and CCS values for the centre of each conformation is
given in Table 6.5.
one for the holo form. This is likely due to experimental constraints, where
if one or more ligands dissociate from the holo complex, it will no longer be
registered as it moves out of the quadrupole isolated m/z window. The likely
result of this is that the conformation demonstrated by the holo form is the
most open conformation the protein can populate without the dissociation of
a Ac-TTAI-NH2 molecule.
These effects are demonstrated in Figure 6.14C and D as well. These data
show that the main distinguishing factor between the apo and holo form is that
ligand binding stabilises a single conformation at lower collision energies in
comparison to the apo protein. This feature could then be used for assessing
putative ligands; if a ligand is shown to stabilise the protein in terms of
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CCS, reduces the conformational variability and the deconvolution shows that
there is initially a single predominant conformation, then it is likely that the
ligand will have a similar binding mechanism as Ac-TTAI-NH2 and will block
α1-antitrypsin aggregation. For completeness an analysis of the change in
conformation of dissociated holo protein is included in Appendix 6.5.1.
Colour Apo (td) Apo (Å2) Holo (td) Holo (Å2)
Grey 6.5 3074.8 7.3 3172.8
Blue 7.3 3171.9 7.9 3234.9
Purple 9.2 3358.9 9.0 3347.8
Green 11.3 3538.8 11.0 3514.2
Brown 13.6 3696.5 13.1 3665.5
Table 6.5: Collision cross section values of α1-antitrypsin conforma-
tions, as determined using the Challenger deconvolution algorithm.
6.3.3 Analysis of ex vivo α1-antitrypsin
We were able to obtain small amounts of Z mutant α1-antitrypsin extracted
from human plasma, in monomeric form, as well as extracted from hepatocyte
inclusion bodies as oligomers. Various tests for analysing the feasibility of
monitoring drug molecule + Z α1-antitrypsin using native MS and IM-MS
are presented here.
Plasma Z α1-antitrypsin
Homozygous Z mutant α1-antitrypsin patients still have some protein in
their circulation. Some of this protein was extracted from a patient’s plasma,
and the mass spectrum acquired is shown and deconvoluted in Figure 6.15.
Each charge state is made up of multiple peaks owing to glycosylation. The
mass as calculated from sequence is 46,589.40 Da (mutation added to UniProt
entry P01009), showing that the protein without glycosylates is either not
present or at extremely low abundance. Glycosylation can cause problems
with native mass spectrometry protein-ligand analysis due to overcrowding of
spectra. In an effort to assess whether this would be a problem, a simulation
was performed of a mass spectrum with Ac-TTAI-NH2 and the glycosylated
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Figure 6.15: Mass spectrum of plasma Z mutant α1-antitrypsin, de-
convoluted using Amphitrite. Grey, blue and purple traces are of
different glycosylation states, of monomeric protein.
Z mutant (Figure 6.16).
The simulation was based on the 0.5:1 peptide to protein mass spectrum
shown earlier (Figure 6.8). The peak FWHM values were taken from the Z
deconvolution in Figure 6.15, with the single and double bound peaks using
the same peak FWHM as the unbound form of the same glycosylated species,
and the charge state Gaussian FWHM was similarly calculated. The mass
was determined by adding the mass of one or two Ac-TTAI-NH2 molecules
to the mass determined by the Z mutant deconvolution. The charge state
distribution Gaussian centre was calculated using the m/z difference between
differing bound species from the titration deconvolution and adding it to the
Z mutant deconvolution result.
Examining the result of the simulation shows a highly congested spectrum,
however it would be possible to extract ion mobility data or quadrupole isolate
the double bound form of the protein (shaded pink area). This could allow
for analysis as shown in Section 6.3.2 to assess the stabilising effect of Ac-
TTAI-NH2 on the Z mutant protein.
When searching for new ligands they may have less mass or only bind
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Figure 6.16: Simulation of what a mass spectrum of plasma Z α1-
antitrypsin with Ac-TTAI-NH2 could look like. The three glycosy-
lated molecular species are labelled sp1-3, and a potential extraction
window for ion mobility analysis is highlighted in pink.
with a 1:1 stoichiometry, this would make it more difficult to separate bound
species with a quadrupole. The simulation is however, a worst-case example.
If the 3:1 mass spectrum was used instead, the bound forms of the protein
would be vastly more abundant allowing for analysis of the bound species,
with a control sample without ligand being used as the apo analyte.
The work here shows that it is likely that analysis of new ligands identified
by interactions with wild type α1-antitrypsin, would be able to be similarly
analysed with the much more scarce Z mutant protein.
Analysing oligomeric glycosylated α1-antitrypsin
The mass spectra of glycosylated polymeric protein are likely to be highly
congested. To test the feasibility of native MS analysis of ex vivo polymers of
Z mutant α1-antitrypsin, glycosylated wild type α1-antitrypsin (M) oligomers
were analysed (Figure 6.17). These analyses also indicate whether it will be
possible to analyse small molecule binding with this technique.
PAGE analysis has shown that α1-antitrypsin polymers can be created
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using various denaturing conditions [37]. Four of these conditions are tested
here and oligomeric species are identifiable up to at least trimer in all cases.
Figure 6.17: Mass spectra of M (glycosylated wild type) α1-
antitrypsin after incubating at different polymerising conditions.
The inset shows the +13 charge state peak under heating condi-
tions with the blue line indicating the theoretical m/z value of the
largest extent of glycosylation on the monomer in addition to two
Ac-TTAI-NH2 molecules.
Individual peaks are well separated and the m/z ratio of the largest glyco-
sylated species of the heated polymer bound to two Ac-TTAI-NH2 molecules
is shown in the Figure 6.17 inset. The heated polymers are the most relevant
for putative drug screening experiments as heating is the only method for
creating polymers (without mutating the protein), which are detected by the
2C1 antibody [37]. The m/z region where the double bound protein peak
would appear (blue line) does not overlap with other peaks and so unfolding
and ion mobility experiments would be straight forward.
The success of the M polymer experiments facilitated the acquisition of a
small amount of Z α1-antitrypsin oligomers, extracted from human hepatocyte
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endoplasmic reticulum inclusion bodies.
Figure 6.18: Mass spectrum of Z mutant α1-antitrypsin polymer
extracted from human liver.
The sample was not pure with large amounts of residue left after centrifu-
gation which could be lipids. Several rounds of optimisation were performed
including: adding dialysis to protein preparation, adding low methanol con-
centrations (5%), and using high molecular weight filters (100 kDa) for both
dialysis tubing and centrifuge filters used for buffer exchange. The most
successful attempt is shown in Figure 6.18, the monomeric protein (primary
series) peaks are resolved, with the dimer partially and trimer and tetramer
peaks being poorly separated. There are additional high charge peaks of
monomeric mass; this is due to the metastability of the protein, as a sec-
ondary more open protein conformation would expose more basic side chains,
leading to an increase in protonation.
These results show that it is unlikely that it will be possible to observe
small molecule binding to the ex vivo oligomers, but this is not necessary for
this experiment to be a success. Potential drug molecules for blocking and
reversing aggregation, like Ac-TTAI-NH2, could be added to aliquots of the
sample and the relative abundance of signal in oligomer regions against the
monomer signal could be compared. If the ligand is reversing aggregation
then the oligomer abundances will drop indicating that the ligand is working
as expected.
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6.3.4 Ion mobility analysis of ex vivo polymers
Ekeowa et al. used ion mobility mass spectrometry to analyse the CCS per-
centage difference between monomeric and dimeric α1-antitrypsin. They anal-
ysed heated M α1-antitrypsin monomers and dimers as well as the loop-sheet
and β hairpin models for polymerisation [37]. We have replicated this study as
closely as possible, whilst including the new C-terminal model for polymerisa-
tion and using experimental CCS values from ex vivo Z mutant α1-antitrypsin
instead of data from the M variant.
Figure 6.19: α1-antitrypsin polymer models used to compare to ex
vivo Z mutant dimeric α1-antitrypsin. β-sheet A strands are coloured
purple and the RCL is coloured red. The models shown are loop-
sheet (A), β hairpin (B) and C-terminal domain swap (C). In model
C the s4B strand is shown in orange and s5B in yellow.
The α1-antitrypsin loop-sheet and β hairpin models used in the previous
analysis [37] were kindly donated by Dr. Bibek Gooptu (Figure 6.19A and
B) and the percentage difference in CCS was calculated from a monomeric
crystal structure of α1-antitrypsin. For this analysis a model was created for
the C-terminal domain linkage, the crystal structure which was uploaded to
the PDB was a single monomer out of the total trimer as the monomer was
the repeating unit (PDB 3T1P). The SymmDock server [54] was used to get
the structure of the trimer, and the PDB file was edited manually to remove
one of the chains to create a dimer (Figure 6.19C).
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The original study carried out the comparison with differing sequence cov-
erages, with the loop-sheet missing N46 as well as having one residue missing
from the N-terminus (N24) in comparison to the hairpin dimer. The mod-
els for hairpin dimer and C-terminal trimer start at N24 and finish at K394
with no missing residues. To maximise similarity with the original study it
was decided to follow the hairpin dimer coverage, and so the loop-sheet and
C-terminal domain swap model were used with amino acids N24-K394. The
monomer structure (QLP1) used in the previous study had sequence coverage
from F23-K394, and was also kept the same. The monomer pdf file contained
solvent molecules, which were stripped before analysis. None of the other
model files contained solvent.
The CCS values were calculated using Impact∗, which is an implementa-
tion of the projection approximation algorithm [55]. The percentage increase
in CCS (p) of dimer (Ωd) from monomer (Ωm), was calculated as shown in
Equation 6.2, and the values were used to compare the differences found in
models with experimental data.
p = ΩdΩm
· 100 (6.2)
The peaks in the ex vivo Z α1-antitrypsin mass spectrum are poorly sepa-
rated (Figure 6.20A) and so thorough analysis of the m/z window used for ion
mobility was required. First, the mass spectrum was collected (Figure 6.20A),
and the peak region for each charge state was determined. Following this the
sample analysed with quadrupole isolation, with iterative improvements being
made before settling on the mass spectra shown in Figure 6.20B-G. Following
this Amphitrite was used to select only the regions determined to be relevant
to a particular charge state, with the final limits shown in Figure 6.20 as
shaded regions.
The arrival time distributions extracted were converted to collision cross
section distributions (CCSD), using Amphitrite, and the results are shown in
Figure 6.21A. The CCS values of the different charge states are similar for
the monomer and dimer distributions, exact values for the peak top CCS and
∗http://impact.chem.ox.ac.uk/
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Figure 6.20: Mass spectra of ex vivo polymers of Z mutant α1-
antitrypsin, with data extraction limits used in ion mobility analysis.
Full mass spectrum used for deciding quadrupole isolation settings
(A) and ion mobility mass spectra of each charge state used for anal-
ysis (B-G).
weighted average are shown in Appendix 6.6.
The lowest charge state of the monomeric and dimeric protein were used
to calculate the percentage increase in CCS between the two states and the
result is shown as a red line in Figure 6.21 (for table of numerical values see
Appendix 6.7). The experimental value is similar to that of the loop-sheet and
C-terminal domain swap models of polymerisation, with the β hairpin being
substantially larger. The percentage difference in CCS found by Ekeowa et
al. (176 %) is similar to that of the Z (169 %) further supporting that they
have the same structure.
The models used by Ekeowa et al. do however look unrealistic especially
as gas-phase structures and so the C-terminal model may not be the most
closely agreeing model. In the case of the loop-sheet model, the RCL of the
blue molecule in Figure 6.19A is more extended than is likely to occur in the
gas-phase where it would be likely that the loop would collapse to be closer to
the molecule [56]. Additionally the RCL of the green protein is only partially
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Figure 6.21: (A) CCS distributions for monomeric and dimeric ex
vivo Z mutant α1-antitrypsin liver polymers. (B) Bar chart show-
ing the percentage difference in CCS from monomeric protein, PDB
structure 1QLP is used for calculating values for the models (bars)
and experimental Z mutant monomer CCS is used for calculating
the percentage change to experimental dimer (red line).
inserted into the β-sheet. As the interaction is so strong it is likely that the
RCL would insert more fully into the β-sheet, as seen in the protease binary
complex structure, thereby pulling the two proteins closer together. These two
features together would result in a lower CCS value being calculated for the
dimer and so making the result closer to what was found experimentally. A
similar situation can be seen with the β hairpin dimer, with the hairpin linkage
of the green protein (Figure 6.19) fully extending away from the protein in a
way that is highly unlikely in the gas-phase.
In order to improve on this work, our collaborators who specialise in molec-
ular modelling will be creating more realistic structures for these molecules,
using techniques such as structural energy minimisation, which can be com-
pared with the experimental data. They will additionally be adding glyco-
sylates to the models so that CCS values can be used in comparisons in-
stead of percentage change in CCS. This could be of special importance if the
monomeric Z protein has a higher observed CCS value as it is more unstable
and could occupy a more unfolded monomeric conformation.
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6.4 Conclusion
The work presented here has elucidated several characteristics of the inter-
action between α1-antitrypsin and Ac-TTAI-NH2, including that the peptide
binds to the wild type form of the protein. The protein is now known to
bind with a 2:1 peptide to protein ratio, the binding site is likely to be in the
centre of β sheet A as the cleft has been shown to be large enough to bind two
Ac-TTAI-NH2 molecules and is logical as the peptide was originally designed
to be an analog of the RCL. This interaction would mimic the standard in-
teraction with a protease, which increases the stability of the protein. The
unfolding studies have shown that the double bound form of α1-antitrypsin has
increased stability and reduced conformational variability, further supporting
the conclusion. Furthermore the deconvolution of unfolding data suggests a
specific pattern in the way in which Ac-TTAI-NH2 stabilises α1-antitrypsin.
At low collision energies the apo form of the protein exists in two conforma-
tions whereas the holo form predominantly occupies a single conformation,
the inference is then that the binding inhibits the occupation of a secondary
conformation, which is potentially related to the aggregation process.
The interaction has been found to be cooperative, this is likely due to the
first binding interaction opening the cleft in β sheet A enabling the second
peptide to bind more readily. This explains why in the initial experiments,
only a single binding event was detected as the second binding event would
occur rapidly after the first, leading the researchers to believe that in the case
of the Z mutant a single peptide binds, which now seems unlikely.
In developing a framework for future drug discovery experiments, this chap-
ter introduces work with Z mutant protein. As it is not possible to express
monomeric Z mutant α1-antitrypsin in E. coli, the protein has been obtained
from human samples and hence is glycosylated. Using mass spectral simu-
lation it has been shown that, with additional sample, it would be possible
to carry out ion mobility unfolding experiments to analyse the interaction
Ac-TTAI-NH2 and Z mutant α1-antitrypsin.
Additionally analyses of glycosylated α1-antitrypsin oligomers were con-
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ducted. It was shown that using monomeric wild type protein extracted from
human plasma, which was polymerised in vitro, it was possible to get peak
separation for oligomeric states up to tetramers. The success of this analysis
means that it should at least be possible to monitor the reversal of polymeri-
sation in the presence of drug molecules if not to actually get adequate peak
separation to carry out quadrupole isolation experiments.
Finally the first mass spectrum of an ex vivo polymer is presented. The
sample was extracted from hepatocyte inclusion bodies, and the sample con-
tains high concentrations of impurities. It is, however, possible to determine
the m/z regions belonging to monomer, dimer, trimer and tetramer. After
having screened M, wild type and/or plasma Z with potential drug molecules
for binding using Amphitrite, and assessed increases in stability using Chal-
lenger; it would be possible to test the best molecules on a sample like this
one. The relative abundance of monomer to oligomer could be analysed and
this would give strong evidence as to whether the drug molecule could reverse
polymerisation and clear out the inclusion bodies of patients with severe α1-
antitrypsin deficiency syndrome.
The ion mobility mass spectrometry analysis of ex vivo Z polymers was suc-
cessful and this will hopefully lead to the acquisition of more protein which will
allow replication of the results, thereby increasing accuracy. It was shown that
the percentage change in CCS was similar for Z ex vivo dimer and dimeric M
from heating, supporting evidence that the two proteins have similar dimeric
structure. More accurate readings could then be compared to ion mobility
CCS values of the M polymer further supporting this conclusion in terms of
absolute CCS, thereby removing the potential factor of variation in monomer
structure.
It was found that the C-terminal model for polymerisation had the most
similar change in CCS value to those experimentally derived. Hopefully the
results will lead to further work into the modelling aspect of the analysis
allowing for a more robust comparison between the models and experimental
data.
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Contributions
All mass spectrometry experiments and data analysis was conducted by
Ganesh N. Sivalingam. Z mutant α1-antitrypsin as purified from plasma was
provided by Dr. Imran Haq. Extraction of ex vivo Z polymers from liver
samples, and M α1-antitrypsin from plasma, was carried out by Sarah Faull.
Preparing samples for mass spectrometry experiments was conjointly con-
ducted by Sarah Faull and Ganesh Sivalingam.
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6.5 Appendix
6.5.1 Analysis of dissociated holo in CIU experiments
The dissociation products of the CIU experiment are analysed here, and the
results are shown in Figure 6.22. As expected the mass spectra of the apo
protein changes very little as the collision energy increases, with no reduced
charge species appearing (Figure 6.22A).
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Figure 6.22: Analysis of dissociated holo in the CIU experiment. The
mass spectra of the apo protein throughout the CIU experiment are
shown in A. The mass spectra for the holo protein are shown in
B, with the shaded regions showing the m/z regions for the +13
apo (blue), single bound (green) and holo (black). The m/z regions
highlighted in B are extracted to show the CCS distributions for the
dissociated apo and single bound protein, and are displayed in C.
The mass spectra of the holo experiment are shown in Figure 6.22B. The
holo protein is stable until 27.5 V, where dissociation begins to occur to a
detectable level. Between 27.5 and 35 V, the dissociation primarily occurs
via the dissociation of one Ac-TTAI-NH2 molecule with a proton, resulting
in a peak for single bound +12 α1-antitrypsin. As the voltages increase there
also appears a +12 apo peak, meaning that both Ac-TTAI-NH2 molecules
have dissociated, whilst removing only one charge. At higher voltages a peak
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corresponding to +11 apo α1-antitrypsin also appears, indicating that two
Ac-TTAI-NH2 molecules dissociated with 2 charges. Interestingly no single
bound protein is found with a charge state of +11, which means that Ac-
TTAI-NH2 does not dissociate with two protons, to a detectable level.
Examining the +13 apo and single bound species shows that as the voltage
increases, the single bound species is initially more abundant than the double
bound, with the double bound species becoming most abundant at the highest
collision energies.
When the collision energy is above 37.5 V, there is sufficient signal for ion
mobility analysis of the +13 apo and single bound species, and the results are
shown in Figure 6.22C. For 47.5 and 50 V collision energies, there is a very
close similarity in the CCSDs of all three bound states, with single bound
seeming to be starting to occupy an even more unfolded conformation.
The CCSDs corresponding to 40 and 42.5 V show differences between the
species. At 40 V the apo and single bound forms are close in CCS to the final
unfolded holo form of the protein. This is of interest as it is likely that the
conformation that allowed for the initial dissociation was the most unfolded
conformation.
The apo and holo forms of the protein do not occupy any more unfolded
conformational families than the most abundant seen at 50 V. The single
bound, however, appears to be unfolding further, with an additional confor-
mation being detectable at 3955 Å2. This suggests that the single bound
form is more unstable than the apo form, and could explain why the binding
interaction is cooperative.
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6.5.2 Ac-TTAI-NH2 - α1-antitrypsin titration
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Figure 6.23: Time course of wild type α1-antitrypsin binding to
Ac-TTAI-NH2. The experiment compares apo with double bound
intensities at a peptide:protein ratio of 0.1:1.
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Figure 6.24: Mass spectrum of Ac-TTAI-NH2 bound to wild type
α1-antitrypsin after incubation and buffer exchange. Peaks marked
with red dots indicate apo protein, with single and double bound
α1-antitrypsin respectively marked with blue and green dots.
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6.5.3 Tables of CCS values for ex vivo analysis
Oligomer Charge Peak CCS (Å2) Mean CCS (Å2)
Monomer +14 3,639.1 3,669.6
Monomer +15 3,684.6 3,700.7
Monomer +16 3,744.3 3,821.9
Dimer +20 6,148.8 6,191.0
Dimer +21 6,229.6 6,262.6
Dimer +22 6,339.1 6,345.8
Table 6.6: Table of collision cross section (CCS) values of monomeric
and dimeric charge states of ex vivo polymer Z mutant α1-
antitrypsin, given as peak top values and weighted mean CCS values.
Protein CCS (Å2) Monomer CCS (%)
Experimental monomer 3,639 100.0
Experimental dimer 6,149 169.0
1QLP Monomer 2,695 100.0
Loop-sheet 4,753 176.4
β-hairpin 6,078 225.5
C-terminal swap 4,617 171.3
Table 6.7: Table of the CCS values and percentage increase in CCS
for three polymerisation models and experimental data of ex vivo Z
mutant α1-antitrypsin polymer.
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7.1 Amphitrite
Amphitrite introduces a new method for deconvoluting mass spectra, which
includes a graphical interface for ease of use. This functionality was impor-
tant throughout the work presented here. A particularly important example
was the analysis of α1-antitrypsin-Ac-TTAI-NH2 binding where it offered the
benefit of greater accuracy for bound state abundance analysis.
Several new methods for IM-MS data analysis were also introduced; in-
cluding spectral averaging for creating representative spectra for replicated
data and heatmap difference plots for the comparison of analytes or analyte
conditions. The automated calibration functionality was the most useful as-
pect for the work presented in this thesis. In addition to automating the
extraction of calibrant data and calculation of calibration curves, it allowed
for the automatic conversion of ATDs to CCSDs, and the ability to convert
the arrival time axis on heatmaps to CCS.
The work for Amphitrite, early in my Ph.D., facilitated rapid data analysis
and the progress made herein, was as a result of this development process.
There are, however, still areas in which the project could be further improved.
The back-end of the software is very strong, as it has seen continual use and
improvement producing statistically robust and accurate data; however, the
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graphical user interface is still at a prototype stage. It was too large a project
to be perfected by a single person within the available time, especially with
obligations to complete several other projects. It is my hope that the work of
Amphitrite will inspire additional work in the area. As the software is open
source, the back-end could be built upon directly, requiring only an improved
interface to ensure ease and accessibility to the tecnical aspects of the tools
within for a wider range of researchers.
The mass spectral deconvolution aspect has worked well, but for highly
complex mass spectrum, the user input can still be quite time consuming.
It seems possible to accomplish a fully automated deconvolution, and there
is more than one way this could be implemented. Tseng et al. introduced
a method of automatic mass assignment [1], this method could be used as
initial information for a deconvolution algorithm. A second method could
be to utilise the arrival time data of TWIM-MS data. Figure 3.4 shows the
characteristic non-linear curve in travelling wave arrival time for the charge
states of a particular ion. A two-dimensional deconvolution method could use
the arrival time information to group together the charge states of a peak and
the mass spectral deconvolution to assign mass and peak characteristics. The
work contained herein is but a step from which a diversity of improvements
could proceed.
7.2 Challenger
The open source Amphitrite back-end allows for the programmatic manipu-
lation of TWIM-MS data files, and this was used to develop the Challenger
algorithm and associated tools. New methods were introduced that sum-
marise ATDs allowing for quantitative assessment of the degree of unfolding
for use with gas-phase unfolding data. The methods were applied to the un-
folding of apo α1-antitrypsin and when bound to Ac-TTAI-NH2. The results
obtained showed clear differences in the gas-phase stability and conforma-
tional variability between the bound states, confirming the hypothesis that
Ac-TTAI-NH2 blocks α1-antitrypsin polymerisation by stabilising the protein.
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The Challenger algorithm is a purpose built genetic algorithm for the de-
convolution of gas-phase unfolding data. It calculates the centre, and so CCS,
of a conformation more accurately than would be determined by eye. It uses
the position of a conformation in the multiple ATDs produced by unfolding
experiments to accurately assign the centre. The deconvolution methodology
allows for a much more accurate determination of the abundance of different
conformations in comparison to peak height analysis. This is used to track the
proportional abundances of conformations throughout unfolding experiments.
When this methodology was applied to α1-antitrypsin and Ac-TTAI-NH2, it
revealed clear distinctions in the pattern of unfolding between apo and holo
α1-antitrypsin that were not detectable using CIU fingerprints. This infor-
mation can be used when selecting new ligands; if the pattern of unfolding
is similar to holo α1-antitrypsin, it is likely that the interaction stabilises the
protein with a similar binding mechanism to Ac-TTAI-NH2, and so would be
likely to block α1-antitrypsin polymerisation.
The Challenger chapter also introduces a method for automating the ac-
quisition of IM-MS unfolding experiments. These experiments can be very
challenging, as it is preferable that the data for all analytes are collected in
the same experimental session as well as the data for the IM calibration. The
automation means that operators can have time to think and plan while the
unfolding experiment is running, and I found personally that this substantially
increased the success rate of often tumultuous experimental sessions.
In the future, the Challenger algorithm could be adapted to a multi-stage
deconvolution. A statistic could be created that would group together sets of
similar ATDs, creating an initial reduced dataset. Spectral averaging could
then be used to create a representative ATD from the members of the group.
This reduced dataset could then be analysed using the current Challenger
algorithm, greatly reducing the run time and ameliorating issues caused by
overrepresentation of ATD features during conformational centre determina-
tion. This could then be followed by a second algorithm, which does not
optimise for the conformational centre. This would then be applied to the en-
tire dataset using the conformational centres determined in the previous step,
once again with a reduced run time in comparison to the current Challenger
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implementation.
7.3 α1-antitrypsin
α1-antitrypsin can form polymers due to deleterious point mutations, and the
polymerisation can be blocked by Ac-TTAI-NH2 binding. Presented here is
evidence that demonstrates that the peptide binds with a 2:1 stoichiometry,
raising questions about the existing binary complex model. The interaction
has been analysed by a variety of IM-MS techniques in conjunction with the
new data analysis techniques presented in this thesis. The results show that
IM-MS can be a viable technique for high-throughput drug screening towards
finding alternative small molecules with the ability to block α1-antitrypsin
polymerisation.
The first IM-MS analysis of a protein aggregate extracted from a patient is
also presented. This was in an effort to further understand the mechanism of
polymerisation, a highly contested question in the α1-antitrypsin field. It was
found that the loop-sheet and C-terminal domain swap models best fit the IM-
MS data, and it may be the case that polymers formed by both mechanisms
are present in a disease state liver. Future work will include improvements to
the coordinate files used to represent the models, preferably with the inclusion
of glycosylates, for a better comparison to the samples used in the IM-MS
analysis. With access to more of this sample, it would be possible to use
ex vivo polymers as the final stage of mass spectrometry testing after drug
screening analysis.
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7.4 Final remarks
Software development for the analysis of IM-MS data is starting to become
more abundant and it seems like this could be an important area for the ex-
pansion of the field. This movement will bring new challenges that I have
already experienced during my Ph.D. The most important development, in
my opinion, would be an open data format with easy to use and freely avail-
able conversion tools. The mass spectrometry proteomics field has mzMl for
this purpose [2], and there are several tools available for converting data from
different mass spectrometer manufacturers to the same format. These data
are in a format that is based on XML(eXtensible Markup Language), which is
plain text and so can be easily accessed and manipulated. This is in stark con-
trast to the binary files used by instruments such as the Waters Synapt, which
cannot be read without proprietary libraries. The most difficult challenge with
the development of Amphitrite has been the access to the Synapt data. The
current iteration of our software works with data from the Synapt G1, but
not with newer instruments. Additionally, we are under the impression that
we are not permitted to distribute the MS Windows-only proprietary library
that is required to open the data files. This means that users have to find
the library file and copy it to a specific location. The problem is further com-
pounded by the fact that it only works with the version of the library which
ships with the Synapt G1 version of Driftscope. Working together with Wa-
ters (and potentially other manufacturers), this problem could be overcome
and would greatly reduce the barrier for entry for non-computational mass
spectrometrists to employ the full functionality of software like Amphitrite.
Publications featuring an X-ray crystallography structure are now required
to deposit the coordinate file to the publically available Protein Databank.
This has been very successful, and there are many researchers who work di-
rectly with the PDB, without ever having carried out an X-ray crystallogra-
phy experiment. It allows many levels of meta-analysis, sometimes involving
thousands of coordinate files. This would never have been possible if the same
laboratory doing the analysis also had to create all of the crystal structures.
The multidimensional data produced by IM-MS experiments contains a
213
Chapter 7. Conclusions
wealth of information, and in my opinion would benefit greatly from a pub-
lic data repository. Statisticians and computer scientists could benefit the
field by creating new tools and methods of analysis, without having to pur-
chase and learn to use the required equipment. Once again the, currently
impossible, potential amount of data that could be analysed together could
bring large advances in the understanding of mass spectral data. A salient
example that comes to mind is that in 1989 Mann and Fenn said of ESI “the
spectrum comprises a sequence of peaks with an intensity distribution that
is near Gaussian” [3], while this is true, the distribution of peak heights is
not truly Gaussian. A large publically available dataset of IM-MS data would
make it straightforward for a mathematically minded scientist to solve this
fundamental aspect of ESI mass spectra.
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